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The aim of this thesis was to assess the ability of a self-paced (SPV) cardiopulmonary 
exercise test (CPET) in assessing patient fitness prior to elective surgery, and its ability 
to predict postoperative outcomes. The SPV is a 10 minute test which is comprised of 5 
× 2 minute stages. Each stage is fixed to a level on the ratings of perceived exertion (RPE) 
scale, in an incremental format (RPE: 11, 13, 15, 17 and 20). This test eliminates the need 
of practitioners having to choose the most appropriate work rate increments to ensure a 
patient reaches volitional exhaustion within the recommended time period (8-12 min).  
 
Study 1 aimed to assess the reliability of the maximal exercise test parameters obtained 
from the SPV. Twenty-five (12 females, 13 males) healthy participants completed three 
SPV tests on three separate occasions. Results demonstrated a coefficient of variation 
(CV) for 9%cO2peak (ml·kg-1·min-1) of 4.2% (95% CI: 3.4-5.6%) for trials 2-1, and 5.1% 
(95% CI: 4.2-6.8%) for trials 3-2. Repeated measures ANOVA analysis demonstrated no 
significant difference in 9%cO2peak across the repeated tests (p > 0.05). The limits of 
agreement (LOA) were ± 5.59 ml·kg-1·min-1 for trials 2-1, and ± 5.86 ml·kg-1·min-1 for 
trials 3-2. The mean intraclass correlation coefficient (ICC) was 0.95, which represents 
good reproducibility. It was concluded that the SPV is a reliable indicator of the main 
CPET derived variables in a healthy population, with comparable values to previous work 
on standard CPET protocols.  
 
Study 2 investigated the physiological responses between the SPV and a standard CPET 
(sCPET) protocol between a young (18-30 years) and a middle aged to older adult (50-
iv 
 
75 years) population. This was in the attempt to gain an understanding of the response to 
the protocol and whether these responses differ with age. Expired gases, Q, SV, muscular 
deoxyhaemoglobin (deoxyHb) and electromyography (EMG) at the vastus lateralis were 
recorded throughout both tests. Results demonstrated a significantly higher 9%cO2max in the 
SPV ( ml·kg-1·min-1) vs. a sCPET ( ml·kg-1·min-1) in the young, 
but no differences in the middle aged to older adult group (> 0.05). Q and SV were 
significantly higher in the SPV vs. a sCPET in the young (< 0.05) but no differences in 
the middle aged to older adult group (> 0.05). No differences were seen in both age groups 
in the deoxyHb and EMG response (> 0.05). Findings from this studyVXJJHVWWKDWLQWKH
\RXQJJURXSWKH639SURGXFHVKLJKHU9%c22max values as a result of an increase in oxygen 
delivery (enhanced Q). However, likely due to age-related differences, particularly in the 
cardiovascular response to exercise, the middle aged to older adult group achievedVLPLODU
9%c22max values regardless of them reaching a higher physiological workload. 
 
Study 3 aimed to assess the validity and reliability of the SPV in post myocardial 
infarction (post-MI) patients, this was the first study to assess the use of the SPV in a 
clinical population. Twenty-eight post-MI patients completed one sCPET and two SPVs 
in a randomised, counterbalanced crossover design. Each patient completed one sCPET 
and two SPVs. Results demonstrated the SPV to have a coefficient of variation for 9%cO2peak 
of 8.2%. The limits of agreement were ± 4.22 ml·kg-1·min-1, with intraclass correlation 
coefficient of 0.89. There was a significantly higher 9%cO2peak achieved in the SPV (23.07 
± 4.90 ml·kg-1·min-1) against the sCPET (21.29 ± 4.93 ml·kg-1·min-1). It was concluded 
that the SPV is a safe and valid test of exercise capacity in post-MI patients, with 




Study 4 DLPHGWRGHWHUPLQHLIWKH639FDQDVVHVVSDWLHQW¶VSUHRSHUDtive risk similar to 
sCPET and if exercise variables obtained from the test can accurately predict post-
operative outcome. Fifty patients with cardiovascular related co-morbidities completed 
one sCPET and one SPV, although only thirty of those patients when ahead with surgery. 
Post-surgery, patients were monitored for incidence of morbidity on postoperative days 
3 and 5, length of hospital stay, and incidence of mortality in the 30 days after surgery. 
3DWLHQWVDFKLHYHGDVLJQLILFDQWO\KLJKHU9%c22peak, HR, 9%cE, peak PO and TTE in the SPV 
compared to the sCPET (P < 0.05). Logistic regression analysis demonstrated that for the 
thirty patients who had surgery, none of the CPET variables were associated with 
postoperative morbidity at either day 3 or 5 (P > 0.05). Although when combining 
postoperative morbidity at days 3 and 5, logistic regression analysis showed that oxygen 
pulse at AT obtained from the SPV was significantly related to postoperative 
complications (P < 0.05). ROC curve analysis demonstrated oxygen pulse at AT to 
provide an AUC of 0.72 a.u. (95%CI 0.51 to 0.92), with an optimal cut-off point of 8.5 
ml/beat-1 which provided 72.7% sensitivity and 71.4% specificity. It was concluded that 
the SPV was able to assess preoperative fitness comparable to the sCPET. Although none 
of the CPET variable from either test were associated with postoperative morbidity, 
which is likely a result of the small sample size. 
 
The conclusion for this thesis is that a self-paced CPET test is able to reliably assess 
cardiovasFXODUSDWLHQW¶VILWQHVVFRPSDUDEOHWRWUDGLWLRQDOPHWKRGV7KLVW\SHRIWest may 
be seen as advantageous, this is because the SPV takes away the need of clinicians having 
to choose the most appropriate work rate increments, it allows patients to have full control 
vi 
 
over the test, and it ensures that regardless of fitness all patients will be exercise for the 
recommended test time. The fixed test duration of 10 minutes may also help to improve 
the efficiency of running busy CPET clinics. There are clear benefits to using the SPV, 
although further research is required first to assess its ability of predicting postoperative 
outcome in a much larger sample, and to determine if it can be used to the same 














Table of Contents  
Acknowledgements                ii 
Abstract                iii-vi 
List of Figures                x-xi 
List of Tables                xii 
Abbreviations                xiii-xv 
Ethical Approval Reference Numbers              xvi 
Chapter 1 ± Introduction 
1.1.Introduction               2-8 
Chapter 2 ± Literature Review 
2.1. Physiological demands of CPET             10-14  
2.2. CPET vs. the demands of surgery            14-16 
2.3. The CPET procedure              16-18 
2.4. CPET derived parameters and risk stratification           18-30 
2.5. The use of CPET for patient optimisation strategies          30-31 
2.6. CPET protocols               31-34 
2.7. Problems associated with current CPET protocols          35-39 
6HOISDFHG9%c22peak protocol             39-50 
2.9. Summary                50-51 
2.10. Thesis aims and hypotheses             51-54 
Chapter 3 ± General Methods 
3.1. Ethics approval and recruitment             56 
3.2. Experimental procedure              56-59 
3.3. General Statistical Analysis             62 
Chapter 4 - The reliability of a self-paced 9ࡆ 22peak test in a healthy population 
4.1. Abstract                62 
viii 
 
4.2. Introduction                           63 
4.3. Method                63-64 
4.4. Results                64-69 
4.5. Discussion                          69-73 
4.6 Conclusion               73-74 
&KDSWHU'LIIHUHQFHVLQWKHSK\VLRORJLFDOUHVSRQVHVEHWZHHQDVHOISDFHGDQGD
VWDQGDUGLQFUHPHQWDOUDPS9ࡆ 22peak test 
5.1. Abstract                76 
5.2. Introduction                77-80 
5.3. Method                80-85 
5.4. Results                 85-91 
5.5. Discussion               91-100 
5.6 Conclusion               100-101 
&KDSWHU5HOLDELOLW\DQGYDOLGLW\RIDVHOISDFHG9ࡆ 22peak test in post-MI patients 
6.1. Abstract                103 
6.2. Introduction                104 
6.3. Method                104-107 
6.4. Results                107-111 
6.5. Discussion               111-118 
6.6 Conclusion               119-120 
Chapter 7 - The use of self-paced CPET protocol in preoperative assessment and 
its ability to predict postoperative outcome in patients undergoing major elective 
surgery 
7.1. Abstract                122 
7.2. Introduction                123-124 
7.3. Method                124-128 
7.4. Results                128-135 
7.5. Discussion               135-143 
ix 
 
7.6 Conclusion               143-145 
Chapter 8 ± General discussion 
8.1. General discussion              147-153 
8.2. General Limitations               153-155 
8.3. Future directions               155-156 
8.4. Conclusions               157 
References                158-189 
Appendices                  
Appendix A                191-193 
Appendix B                194 
Appendix C                195 











List of Figures 
&KDSWHU7KHUHOLDELOLW\RIDVHOISDFHG9ࡆ 22peak test in a healthy population 
Figure 4.1 %ODQG$OWPDQSORWVRIWKHDJUHHPHQWEHWZHHQ9%c22peak          66 
from the three repeated SPV tests 
Figure 4.2 %ODQG$OWPDQSORWVRIWKHDJUHHPHQWEHWZHHQ9%c22 at          67 
the
 
anaerobic threshold from the three repeated SPV tests 
Figure 4.3 Bland-Altman plots of the agreement between peak power          68 
output from the three repeated SPV tests 
Figure 4.4 Power output profiles over the duration of each SPV test         69 
Chapter 5 - Differences in the physioloJLFDOUHVSRQVHVEHWZHHQDVHOISDFHGDQGD
VWDQGDUGLQFUHPHQWDOUDPS9ࡆ 22peak test 
Figure 5.1 9%c2UHVSRQVHRYHUWLPHLQWKHV&3(7DQG639LQD   
UHSUHVHQWDWLYH\RXQJDQGROGSDUWLFLSDQW 
Figure 5.2 5HODWLYHFKDQJHLQPXVFOHR[\JHQGHVDWXUDWLRQRYHUWLPH  
LQWKHV&3(7DQG639 
Figure 5.3 5HODWLYHFKDQJHLQ(0*RYHUWLPHLQWKHV&3(7DQG639  
Figure 5.4 Cardiac output and stroke volume response over timeLQ  
WKHV&3(7DQG639 
Figure 5.5 Power outputSURILOHIURPWKH639LQWKH\RXQJDQGROG 
  JURXS 
&KDSWHU5HOLDELOLW\DQGYDOLGLW\RIDVHOISDFHG9ࡆ 22peak test in post-MI patients 
Figure 6.1 %ODQG$OWPDQSORWVRIWKHDJUHHPHQWEHWZHHQ9%c22peak and          108 
AT from the two SPV tests 




Chapter 7 - The use of self-paced CPET protocol in preoperative assessment and 
its ability to predict postoperative outcome in patients undergoing major elective 
surgery 
Figure 7.1 Receiver operating characteristic (ROC) curve for oxygen           133 
















List of Tables 
Table i  Ethical approval reference numbers for research chapters         xvi 
Chapter 2 ± Literature review 
Table 2.1  Summary of studies that have investigated the use of the          41 
639IRUGHWHUPLQLQJ9%c22peak 
&KDSWHU7KHUHOLDELOLW\RIDVHOISDFHG9ࡆ 22peak test in a healthy population 
Figure 4.1 Physiological values recorded from each repeated SPV          65 
tests in the healthy population 
Chapter 5 - Differences in the SK\VLRORJLFDOUHVSRQVHVEHWZHHQDVHOISDFHGDQGD
VWDQGDUGLQFUHPHQWDOUDPS9ࡆ 22peak test 
Table 5.1 Physiological values recorded from the SPV and sCPET         86 
test in the healthy young and old population 
Chapter 6 - Reliability and validity of a selISDFHG9ࡆ 22peak test in post-MI patients 
Table 6.1 Physiological values recorded from the sCPET, SPV1          109 
and SPV2 in post-MI patients 
Table 6.2 Mean PO and the variability within each stage of SPV1         111 
and SPV2 in post-MI patients 
Chapter 7 - The use of self-paced CPET protocol in preoperative assessment and 
its ability to predict postoperative outcome in patients undergoing major elective 
surgery 
Table 7.1 Patient demographics and postoperative morbidity at          130 
day 3 and day 5 
Table 7.2 Physiological values recorded from the sCPET and SPV         131 
Table 7.3 Physiological values between patients with and without          134 





AAA     Abdominal aortic aneurysm 
ANOVA   Analysis of variance 
AT    Anaerobic threshold 
ATP    Adenosine triphosphate 
AUC    Area under the curve 
a-vO2 diff   Arteriovenous oxygen difference 
BMI    Body mass index 
BP    Blood pressure 
bpm    Beats per minute 
Cao2    Arterial oxygen content 
CI    Confidence interval 
Cvo2    Mixed venous oxygen content 
CMD     Central motor drive 
CNS     Central nervous system 
CPET    Cardiopulmonary exercise testing 
CV    Coefficient of variation 
deoxyHB   Deoxyhaemoglobin  
DO2    Global oxygen delivery 
ECG    Electrocardiogram 
EMG    Electromyography  
FEV1    Forced expiratory volume in 1 second 
FVC    Forced vital capacity 
h    Hours 
HCO3-    Bicarbinate 
HDU    High dependency unit 
xiv 
 
HR    Heart rate 
ICC    Intraclass correlation coefficient  
ICU    Intensive care unit 
L·min-1   Litres per minute 
LOA    Limits of agreement 
LOS    Length of stay 
MET    Metabolic equivalent 
min    Minutes 
MIVC     Maximal isometric voluntary contractions 
Ml    Millilitres 
mL·min-1   Millilitres per minute 
ml·kg-1·min-1   Millilitres, per Kilogram of body weight, per minute 
mmHg    Millilitres of mercury 
mmol/L   Millimoles per litre  
MVV    Maximal voluntary ventilation 
n    Number 
NIRS     Near-Infrared Spectroscopy 
OER     Oxygen extraction ratio 
OR    Odds ratio 
OUES    Oxygen update efficiency slope 
P    Significance level 
PaO2    Oxygen saturation 
PETO2     Partial end-tidal 
PETCO2   Partial end-tidal 
PO    Power output 
POMS    Postoperative morbidity survey 
xv 
 
POSSUM Physiological and Operative Severity Score for the 
enUmeration of Mortality and Morbidity 
4%c    Cardiac output 
RAMP    Standard incremental ramp test 
RER    Respiratory exchange ratio 
ROC    Receiver operator characteristic 
RPE    Ratings of perceived exertion 
rpm    Rates per minute 
sCPET    Standard cardiopulmonary exercise test 
SD    Standard deviation 
secs    Seconds 
SPV    6HOISDFHG9%c22peak test 
SV    Stroke volume 
TTE    Time to exhaustion 
VD    Dead space volume 
9%cE    Minute ventilation 
9%cE9%c&22   Minute ventilation for carbon dioxide production 
9%cE9%c22   Minute ventilation for oxygen consumption 
9%c&22      Carbon dioxide production 
VL    Vastus lateralis 
9%c22    Oxygen consumption 
9%c22/HR   Oxygen pulse 
9%c22max    Maximal oxygen consumption 
9%c22peak   Peak oxygen consumption 
W    Watts 




Ethical Approval Reference Numbers 
All of the individual research studies within this thesis were ethically approved by either 
WKH8QLYHUVLW\RI.HQW¶V6FKRRORI6SRUWDQG([HUFLVH6FLHQFHV5HVHDUFK(WKLFVDQGf 
Governance Committee (Chapter 4 & 5), or the South East Coast, Brighton and Sussex, 
National Research and Ethics Committee (Chapters 6 & 7). 
 
Table i. Ethical approval reference numbers for all research chapters.  
 Ethical Reference Number 
Chapter 4 Prop79_2012_13 
Chapter 5 Prop123_2013_14 


















The health benefits of regular physical activity are indisputable, with exercise being 
strongly linked to general health, well-being, and reduced risk of disease (Cooper & 
Storer 2001)([HUFLVHLWVHOILVFRQVLGHUHGDVWKHWUXHVWWHVWRIDQLQGLYLGXDO¶VKHDOWKDVLW
is the most common everyday stress that we undertake (Froelicher & Stahr 2005). 
Maximal exercise testing, in particular, has become a standard procedure in exercise 
physiology for assessing cardiovascular function (Andreacci, Lemura, Cohen, Urbansky, 
Chelland et al., 2002) and exercise capacity. In sport and fitness, exercise capacity is 
linked to performance outcomes and achievements, whereas exercise performance in a 
clinical setting is related to functional capacity and quality of life (Cooper & Storer 2001). 
The key values derived from the test can be used as a starting point for exercise 
prescription (Andreacci et al., 2002), with follow up tests being used to help determine 
the success of a specific training plan (Bassett & Howley 2000). Exercise testing in a 
clinical setting, also known at cardiopulmonary exercise testing (CPET), can provide 
valuable diagnostic and prognostic information for both cardiovascular and pulmonary 
patients (Balady, Arena, Sietsema, Myers, Coke et al., 2010). This is because CPET 
provides an assessment of the integrative responses to exercise involving the pulmonary, 
cardiovascular, respiratory, neuropsychological, and skeletal muscle systems (West, Jack 
& Grocott 2011). This non-invasive method represents a physiological overview of both 
submaximal and maximal exercise responses (Albouaini, Egred, Alahmar & Wright 
2007) and caQSURYLGHDQREMHFWLYHDVVHVVPHQWRIWKHERG\¶VUHVSRQVHWRVWUHVV(Hopker, 




CPET is increasingly being used in a clinical setting for the evaluation of exercise 
tolerance and for the detection of functional capacity and impairment (Albouaini et al., 
2007). Exercise tolerance is suggested to be the ability to complete a required physical 
task successfully. Everyone who exercises will have a particular level of exercise 
intolerance, but from a clinical perspective, the issue is whether a patient demonstrates an 
intolerance that is not representative of the norms (Palange, Ward, Carlsen, Casaburi, 
Gallagher et al., 2007). Exercise tolerance is dependent on the efficiency of pulmonary 
gas exchange, cardiovascular performance and skeletal muscle metabolism (Albouaini et 
al., 2007). Previous work has suggested that exercise tolerance correlates better with 
overall health status compared to resting measurements (Albouaini et al., 2007). In 
addition, exercise capacity has been shown to be one of the best predictors of mortality 
(Myers, Prakash, Froelicher, Partington & Atwood 2002), With these benefits, CPET is 
therefore considered a gold standard method for evaluating the response of the 
cardiopulmonary system when placed under stress, and is based on the principle that 
system failure usually occurs while the system (e.g. cardiovascular or pulmonary) is under 
stress (Palange et al., 2007).  
 
There are a number of benefits to CPET, for example it can be used for the development 
of an exercise programme, determining functional capacity, evaluation of exertional 
dyspnea, risk stratification and heart failure prognosis, assess the effectiveness of medical 
and surgical therapies, and even determine the need for surgical repair in congenital heart 
disease (Milani, Lavie, Mehra & Ventura 2006). Among these many benefits of CPET, it 
is also proposed to pURYLGHDQLQGLFDWLRQRIDSDWLHQW¶VDELOLW\WRFRSHZLWKWKHPHWDEROLF
demands associated with major surgery (Hopker, Jobson & Pandit 2011; Smith, Stonell, 
Purkayastha & Paraskevas 2009). Major surgery is considered as any procedure which 
4 
 
places DKLJKDPRXQWRIVWUHVVRQDSDWLHQW¶VFDUGLRSXOPRQDU\V\VWHP (Reilly, McNeely, 
Doerner, Greenberg, Staiger et al., 1999), for example vascular and intra-abdominal 
surgery are deemed as high risk due to the extent, invasiveness and complexity of such 
procedures (Lee, Hamilton & Rhodes 2009). As such surgeries place a high amount of 
stress on the cardiopulmonary system, using a dynamic WHVWZKLFKHYDOXDWHVDSDWLHQW¶V
ability to deal with such stresses is seen as a useful predictor of postoperative morbidity 
and mortality. The benefit of CPET is that this objective assessment of the integrated 
body systems, during exercise, has the ability to determine cardiorespiratory reserve, 
diagnose diseases and identify underlying causes of exercise limitations (Burnside & 
Snowden 2014).  
 
Whilst the use of CPET is increasing, it is acknowledged that this method is still relatively 
rare across the UK. Indeed, a recent survey investigated the use of preoperative CPET 
services in England (Huddart, Young, Smith, Holt & Prabhu 2013), and from this survey, 
32% of all adult anaesthesia departments in England had a preoperative CPET service 
available, with 4% of these in the process of setting a service up. Whilst this number 
seems relatively low, in 2008 only 17% of the 115 NHS Acute Trusts contacted had CPET 
services available, with 7% of these in the process of being set up (Simpson, Sutton and 
Grocott, 2009). This is reassuring as it demonstrates a continuing increase in the use of 
preoperative CPET. The survey results also report that the main reason for the lack of 
services is predominantly related to the financial cost and lack of available resources. 
However, other reasons stated were a perceived lack of clinical need and insufficient 
evidence of the clinical benefit. There are however alternative, more simple and 
inexpensive methods available which are commonly used to assess the functional 
capacity of patient populations. For example, the submaximal six-minute walk test 
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(6MWT) and the incremental shuttle walk test (SWT), have both been shown to be  
moderate predictors of peak oxygen uptake and thus functional capacity (Fletcher, Ades, 
Kligfield, Arena et al., 2013; Miyamoto, Nagaya, Satoh, Kyotani et al., 2000; Morales, 
Montemayor & Martinez 2000; Wise & Brown 2005). However, unlike CPET, they do 
not provide a direct assessment of the cardiopulmonary response to exercise. These 
methods and others will be discussed in greater detail later on in this thesis. 
 
When CPET is not used or is unavailable for preoperative assessment, assessing a 
SDWLHQW¶VFDUGLRSXOPRQDU\KHDOWKSULRUWRVXUJHU\LVXVXDOO\EDVHGRQVWDWLF, individual 
organ measures (e.g. echocardiography, spirometry etc.) (Forshaw, Strauss, Davies, 
Wilson, Lams et al., 2008). Surgical risk is then usually calculated based on the use of 
various scoring systems, for example, the American Society of Anesthesiologists (ASA) 
physical status classification (Wolters, Wolf, Stutzer & Schroder 1996), the Physiological 
and Operative Severity Score for the enUmeration of Mortality and Morbidity 
(POSSUM) system (Copeland 2002) DQG/HH¶VUHYLVHGFDUGLDFLQGH[(Lee, Marcantonio, 
Mangione, Thomas, Polanczyk et al., 1999) have all been used in preoperative 
assessment. Physical activity history is also integrated with these methods to help with 
the risk stratifications (Bhagwat & Paramesh 2010)$SDWLHQW¶VZDONLQJGLVWDQFHRUWKHLU
ability to climb stairs is often used as a subjective measure of exercise tolerance to help 
with the prediction of postoperative complications (Forshaw et al., 2008). However such 
methods are deemed as unreliable and fail to provide any specific detail of how the 
integrated systems work together under stress, making it difficult to gain a true 
representation of fitness from these type of tests. As previously mentioned, CPET is 
proposed to mimic the metabolic demands associated with major surgery (Hopker et al., 
2011) giving a more objective risk assessment, which is not adequately reflected through 
6 
 
individual organ system measurements and by acquiring information on previous physical 
activity history (Bhagwat & Paramesh 2010). As a result patients may be wrongly 
allocated for their postoperative care when being assessed using these traditional 
PHWKRGV )RU H[DPSOH DQ RYHUHVWLPDWLRQ RI D SDWLHQW¶V KHDOWK PD\ FDXVH WKHP WR EH
referred to ward care postoperatively, where they could deteriorate, develop organ failure, 
and have WKHLU KRVSLWDO VWD\ SURORQJHG &RQYHUVHO\ VRPH SDWLHQW¶V KHDOWK PD\ EH
underestimated in the pre-assessment, which could result in them being referred to the 
intensive care unit (ICU) postoperatively, which would place unnecessary demand on, 
what are already, limited resources (Bhagwat & Paramesh 2010).  
 
Practitioners who already use CPET in preoperative assessment in England successfully 
use the information obtained from the test to help allocate appropriate level of post-
operative care (ICU, ward etc), determine the level of intraoperative monitoring, modify 
surgical procedure (if possible) and in some cases even cancel or advise against the 
surgical procedure (Huddart, Young, Smith, Holt & Prabhu 2013). If this preoperative 
method is truly capable of providing a reliable indicator of post-operative morbidity and 
mortality, it could have a significant impact on the care of patients. By identifying those 
at a high risk the appropriate care and additional resources can be planned prior to surgery 
to reduce morbidity and mortality (Smith, Stonell, Purkayastha & Paraskevas 2009).  
 
It is clear that CPET has the potential to be a useful tool in preoperative assessment and 
therefore it is of great importance for the protocol to be both valid and reliable. One of 
the key values obtained from CPET is peak oxygen uptake (9%cO2peak), which is defined as 
the highest amount of oxygen a person consumes during dynamic exercise (Bassett & 
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Howley 2000). As 9%cO2peak measures maximal aerobic capacity, it is considered a strong 
indicator of cardiovascular fitness (Smith et al., 2009). Current practice is to use a CPET 
protocol that encompasses an incremental exercise test, whereby the SDWLHQW¶VUHTXLUHG
work rate gradually increases until volitional exhaustion is reached, and thus 9%cO2peak 
(Albouaini et al., 2007; Balady et al., 2010; Chaitman, Moinuddin & Sano 2007). It is 
suggested that in order to gain a true representation of fitness, the CPET protocol needs 
to ensure that the patient reaches volitional exhaustion between 8-12 minutes (min) 
(Buchfuhrer, Hansen, Robinson, Sue, Wasserman et al., 1983), therefore it is the 
responsibility of the person conducting the test to decide on the most appropriate starting 
work rate and stage increments that ensure exhaustion in this time period. This can 
sometimes be problematic as it is often difficult to judge how an individual is likely to 
tolerate the protocol until they actually commence the test:  a test which lasts for too long, 
or is too short, reduces the validity of the results. It is suggested that a test which is short 
in duration (< 8 min) may underestimate 9%cO2peak due to increased glycolytic contribution 
to energy and enhanced fast-twitch muscle fibre recruitment (Astorino, Rietschel, Tam, 
Taylor, Johnson et al., 2004). Also a short test may only acquire limited information 
making it difficult to confidently assess fitness. Conversely, if a test lasts too long patients 
may stop due to such factors as boredom or increased local muscle fatigue (Astorino et 
al., 2004), rather than a result of their actual cardiopulmonary limit. There have also been 
a number of other limitations that have been brought to light regarding the general nature 
of the current CPET protocol (Noakes 2008), for example, the patient is unaware of the 
test duration and it is known that knowledge of exercise duration can facilitate 
performance (Mauger, Jones & Williams 2009), the test does not replicate any normal 
exercise behaviour, and finally the patient only has control over when they stop which 
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adds a psychological aspect to the test i.e. low motivation. These ideas will be discussed 
in greater detail later on.  
 
Recent research has demonstrated the use of an alternative CPET protocol based on the 
use of perception of effort (Mauger & Sculthorpe 2012). This novel protocol, WHUPHGWKH
VHOISDFHG 9%cO2peak (SPV) test, allows participants to self-regulate their work rate 
according to prescribed ratings of perceived exertion (RPE), whilst still maintaining an 
incremental test format. The SPV consists of 5 × 2 minute stages, so regardless of a 
SHUVRQ¶V fitness everyone exercises for the recommended time period of 10 min. This 
novel protocol has been previously used with both healthy (Mauger & Sculthorpe 2012) 
and trained (Mauger, Metcalfe, Taylor & Castle 2013) individuals, where it has been 
shown to produce higher 9%cO2peak values than the standard CPET (sCPET) protocol in 
both cycling and running. The SPV takes away the need for practitioners to decide on the 
most appropriate work rate increments to ensure a valid test, it also ensures all participants 
to exercise for the recommended duration of 10 min and provides participants with a clear 
end point to work towards. These factors provide a test that solves some of the issues 
associated with the current CPET protocols, therefore it would be advantageous to 
investigate if the SPV could be used on a clinical population in order to establish a more 
valid method for determining cardiorespiratory fitness prior to elective surgery. This 
thesis aims to identify if a self-paced CPET protocol can be used to identify preoperative 

































2.1. Physiological demands of CPET 
 
The ability to perform physical exercise is related to both the cardiovascular and 
pulmonary system to supply oxygen to the working muscles (Balady, Arena, Sietsema, 
Myers, Coke et al., 2010). There are a series of processes that occur to allow this supply 
in oxygen, these include; pulmonary ventilation, pulmonary diffusion, transportation of 
oxygen and carbon dioxide in the blood, and capillary gas exchange (Balady et al., 2010). 
In CPET, this physiological pathway of oxygen can be effectively assessed (Burnside & 
Snowden 2014). Any limitations in this process will limit the delivery of oxygen and 
therefore exercise capacity. As oxygen cannot be stored, a continuous and endless supply 
is required. It is the cardiovascular system¶s primary role to deliver this continuous supply 
of oxygen to tissue around the body to sustain aerobic metabolism. The oxygen supply 
available must match the metabolic demands, otherwise inflammation and organ 
dysfunction can occur (Lee, Hamilton & Rhodes 2009). This process must be energy 
efficient so that unnecessary cardiorespiratory work is avoided, but it must also be 
sensitive to the inconsistent demands of cellular metabolism (Leach & Treacher 1992). 
 
Oxygen consumption (9%cO2) is the total amount of oxygen consumed per minute. This can 
be measured directly by breath by breath analysis (Leach & Treacher 2002). 9%cO2 can be 
described using the Fick equation, at rest it is shown as:  
9%cO2 = (SV x HR) X (CaO2 - CvO2) 
SV is stroke volume, HR is heart rate, CaO2 is the arterial oxygen content and CvO2 is 
mixed venous oxygen content. Oxygen uptake is usually normalised to body weight and 
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expressed in ml·kg-1·min-1. One metabolic equivalent (MET), which is resting oxygen 
uptake, is equal to 3.5 ml·kg-1·min-1. At peak exercise the Fick equation is expressed as: 
9%cO2max = (SVmax x HRmax) x (CaO2max - CvO2max) 
This demonstrates the ability of the body to maximally transport and use up oxygen, 
ZKLFK GHILQHV DQ LQGLYLGXDO¶V DHURELF FDSDFLW\ (Albouaini, Egred, Alahmar & Wright 
2007). During increasing work rate, the body will increase oxygen delivery in attempt to 
maintain efficient energy production, this can been seen by an increase in minute 
ventilation (9%cE) and cardiac output 4%c(Burnside & Snowden 2014). If during a maximal 
test the 9%cO2 curve (9%cO2/work rate) represents a plateau, regardless of a continuous 
increase in work rate, then this can be referred to as 9%cO2max (Milani, Lavie, Mehra & 
Ventura 2006). Otherwise the term 9%cO2peak is commonly used as this defines the highest 
9%cO2 reached during a test and does not assume that a maximal physiological response 
has been reached, which is very uncommon in a clinical setting particularly in patients 
with cardiovascular and pulmonary disease (Albouaini et al., 2007; Balady et al., 2010). 
During exercise, the increase in oxygen uptake is mRVWO\DLGHGE\DQLQFUHDVHLQ4%c (HR 
x SV). Additionally, to facilitate this greater oxygen delivery to the working muscles, 
blood is redistributed away from the tissues which are not in use. There is also an increase 
in blood flow to the lungs, which is supported by an increase in 4%c and by vasodilation of 
the pulmonary vessels. As the blood perfuses the muscles, there is also a widening of the 
arteriovenous oxygen difference (a-vO2 diff) which also results in a greater oxygen 
extraction from the blood (Balady, Arena, Sietsema, Myers, Coke et al., 2010). All of 





Global oxygen delivery (DO2) is the total amount of oxygen delivered to the tissues per 
minute which is defined by both 4%c and CaO2DQGLVFRQVLGHUHGWREHLQGHSHQGHQWRI9%c22 
(Leach & Treacher 2002; Lee, Hamilton & Rhodes 2009)7KHR[\JHQH[WUDFWLRQUDWLR
2(5LVGHILQHGE\9%c22 as a fraction of DO2 (Leach & Treacher 2002). During resting 
conditions, it is suggested that DO2 H[FHHGV 9%c22 (Lee et al., 2009), wLWK WKH QRUPDO
GLVWULEXWLRQ RI 4%c adequately meeting the oxygen demand and ensuring that aerobic 
metabolism is maintained (Leach & Treacher 2002). AV9%cO2 increases or DO2 decreases, 
OER will increase to maintain aerobic metabolism, this will continue to rise up to 
maximum OER where critical DO2 is reached (Leach & Treacher 2002), at this point 9%c22 
becomes supply dependent and anaerobic metabolism will occur (Lee et al., 2009). 
)XUWKHULQFUHDVHVLQ9%c22 or decreases in DO2, beyond critical DO2, will lead to tissue 
hypoxia (Leach & Treacher 2002), which can lead to cellular dysfunction and eventually 
organ dysfunction, failure and possibly death (Lee et al., 2009). Optimal level of DO2 will 
depend on the metabolic demands but it is suggested that an inadequate DO2 is confirmed 
by a very high OER, which is demonstrated by mixed venous oxygen saturations (SvO2) 
of < 70% (Lee et al., 2009). It is suggested that the ability of tissues to increase OER is 
less efficient in the critically ill (Lee et al., 2009), indeed DO2 has been shown to be an 
early and better predictor of multiple organ dysfunction after ruptured Abdominal Aortic 
Aneurysm (AAA) in comparison to previously identified risk factors. The inability to 
attain a normal DO2 within 8 hours after AAA repair is strongly correlated with multiple 
organ dysfunction and mortality (Peerless, Alexander, Pinchak, Piotrowski & Malangoni 
1998). Previous research has also demonstrated that complications and mortality post-
surgery have been strongly linked to reduced DO2DQG9%c22 (Kusano, Baba, Takao, Sane, 
Shimada et al., 1997; Russel, Ronco, Lockhat, Belzberg, Kiess et al., 1990). Therefore, 
with this knowledge, objectively assessing a SDWLHQW¶V ability to cope with increased 
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metabolic demands via CPET is seen as a valid test for risk stratifying SDWLHQW¶V prior 
surgery. 
 
To sustain a given level of exercise, the cardiorespiratory response must be adequate to 
supply the oxygen needed to regenerate all the adenosine triphosphates (ATP) required 
for the working muscles (Wasserman, Hansen, Sue, Stringer & Whipp 2005a). As an 
individual progresses through an incremental exercise test their 9%cE, 9%cO2 and CO2 
production per minute (9%cCO2) all increase linearly in relation to work rate or time in order 
to supply all of the oxygen needed. However a point is reached when 9%cCO2 increases 
disproportionately to 9%cO2. This sudden change is attributed to bicarbonate (HCO3-) 
buffering the lactate accumulation and consequently producing excess CO2 (Smith, 
Stonell, Purkayastha & Paraskevas 2009). The increase in lactate production is caused by 
the onset of anaerobic glycolysis, in order to meet the ever increasing energy demands of 
the incremental exercise test (Wasserman, Whipp, Koyal & Beaver 1973). The increase 
in CO2 output is sensed by chemoreceptors in the carotid bodies, which causes an increase 
in 9%cE (Milani, Lavie, Mehra & Ventura 2006). This metabolic transition is termed the 
anaerobic threshold (AT) (Smith, Stonell, Purkayastha & Paraskevas 2009), and is 
commonly defined as the work rate or oxygen consumption just below the point where 
metabolic acidosis and changes in gas exchange occur (Hopker, Jobson & Pandit 2011). 
This physiological point is also referred to as the ventilatory threshold (Gaskill, Ruby, 
Walker, Sanchez, Serfass et al., 2001), gas exchange threshold (Inbar, Oren, Scheinowitz, 
Rotstein, Dlin et al., 1994), and if determined via blood lactate analysis, the lactate 
threshold (Binder, Wonisch, Corra, Cohen-Solal, Vanhees et al., 2008). In the current 





As well as 9%cO2peak and AT, there are other important parameter which are obtained from 
CPET to assist in the evaluation of cardiopulmonary fitness, these include the relationship 
between 9%cE and 9%cCO2 (9%cE/9%cCO2) (Arena, Myers, Aslam, Varughese & Peberdy 2004) 
and the relationship between 9%cO2 and heart rate, known as oxygen pulse (9%cO2/HR) 
(Vassaux, Torre-Bouscoulet, Zeineldine, Cortopassi, Paz-Díaz et al., 2008). All of the 
key CPET derived variables will be discussed in greater detail in chapter 2.4 with regards 
to their predictive ability of postoperative outcome.  
 
2.2. CPET vs. the demands of surgery 
 
Major surgery is associated with a systemic inflammatory response (Tolchard, Angell, 
Pyke, Lewis, Dodds et al., 2014) and is suggested to place severe stress on a paWLHQW¶V
cardiopulmonary reserve (Forshaw, Strauss, Davies, Wilson, Lams et al., 2008). The 
stress response to surgery is suggested to result in an increased secretion of stress 
hormones (Gutierrez, Hornigold & Pearce 2011) and activation of the sympathetic 
nervous system (Desborough 2000). In particular, the large endocrine response to surgery 
increases the secretion of catabolic hormones, which can result in the breakdown of 
muscle and fat causing patient weight loss and muscle wasting (Gutierrez et al., 2011). 
Increased activation of the sympathetic nervous system is known to have various 
cardiovascular effects including tachycardia and hypertension (Desborough 2000), and 
also influences renal, hepatic and pancreatic functions (Gutierrez et al., 2011). This 
significant systemic inflammatory response is directly associated with an increase in 
oxygen demand (Lees et al., 2009), usually requiring about 40% (or greater in some 
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instances) increase in oxygen delivery. This increase requires a concurrent increase in 4%c 
or oxygen extraction in order to meet this demand (Forshaw, Strauss, Davies, Wilson, 
Lams et al., 2008; Older & Hall 2004). For example, AAA repair surgery can result in an 
oxygen consumption of 4.5 to 5 ml·kg-1·min-1, which in older patients could be 50% or 
more over their resting values (Older, Smith, Courtney & Hone 1993). Cardiopulmonary 
exercise is said to closely mimic the postoperative situation and essentially assess how 
well a patient copes with oxygen demands at > 50% of their resting values. The inability 
to keep up with the increased oxygen demand results in an accumulatLYHµR[\JHQGHEW¶
and thus tissue hypoxia (Lees et al., 2009). Tissue hypoxia is known to contribute to 
inflammation and microcirculatory failure, which can result in organ dysfunction and/or 
failure and ultimately death (Lees et al., 2009). Therefore, those patients whose oxygen 
delivery is compromised during exercise will be therefore at an increased risk following 
surgery (Older, Hall & Hader 1999), particularly of myocardial infarction (MI) and death 
(Tolchard et al., 2014).  
 
Determining risk for surgery is dependent on two main components, the type of surgical 
procedure and the functional capacity of the patient. Actual surgical risk relates to the 
extent, invasiveness, complexity and duration of the procedure (Lees et al., 2009). All of 
these factors have a direct influence to the oxygen demand required (Older & Hall 2004) 
and the stress response (Lees et al., 2009). For example laparoscopic surgery is deemed 
µOHVVLQYDVLYH¶DQGWKerefore causes less pain, leads to a faster recovery, and consequently 
shorter hospital stay, compared to those open surgical procedures (Reza, Blasco, 
Andradas, Cantero & Mayol 2006; Scott, Shohag, Kam, Jelinek & Khadem 2013). This 
may suggest that CPET is more important for patients undertaking those µKLJKHU¶ ULVN
procedures, indeed previous research has suggested that CPET is not a useful predictor 
16 
 
of risk in all surgery types (e.g. oesophagectomy) (Forshaw et al., 2008). The functional 
capacity of the patient also has a direct influence on surgical risk. It is suggested that 
patients with limited physiological reserve, and therefore unable to meet the increased 
oxygen demands, are more likely to suffer complications or death (Lees et al., 2009). 
Therefore determining a SDWLHQW¶V functional capacity, via CPET, prior to surgery will 
contribute in the risk stratification and thus decision making process for patients. If 
surgery is agreed, then the right care can be assured during the perioperative period in the 
attempt to minimise any risks that there may be. When assessing a patients risk for surgery 
it is important to take both components into consideration, for example, a lower risk 
surgery may still treated as high risk if a patient has a reduced functional capacity.  
 
2.3. The CPET Procedure 
 
Despite CPET requiring a moderate to high level of exertion, it is well tolerated by the 
patient population, and is regarded as a safe procedure to conduct, even in older 
individuals with multiple co-morbidities (Older, Smith, Courtney & Hone 1993, West, 
Jack & Grocott 2011). CPET testing can be completed on either a cycle ergometer, 
treadmill or an arm ergometer (Bhagwat & Paramesh 2010). It is known that treadmill 
testing produces a 5 to 10% higher 9%cO2peak compared to cycle ergometry, primarily due 
to the recruitment of more muscle groups (Albouaini et al., 2007). Although, cycling is 
perceived as the preferred exercise modality for clinical testing due to greater upper body 
stability, making falls from equipment less likely (Smith, Stonell, Purkayastha & 
Paraskevas 2009), and electrocardiogram (ECG) and blood pressure (BP) measurements 
more reliable (Takken, Blank, Hulzebos, Brussel, Groen et al., 2009). Regardless of the 
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method of exercise used, a CPET test usually consists of incremental work stages where 
the patient is required to continue exercise until they can no longer do so. On a treadmill, 
work rate can be increased by speed and/or gradient, whereas on a cycle ergometer, work 
rate is incremented by increasing the resistance to cycling (Smith et al., 2009). The 
common cycling CPET protocol commences with a 2-5 minute rest period where the 
patient is required to remain stationary on the cycle ergometer to allow time for them to 
become accustomed to the equipment (Burnside & Snowden 2014). This stage also allows 
practitioners to gain some resting measurements and to ensure all the equipment is 
working correctly. Following the initial stage there is usually a 3 minute period of cycling 
against no resistance, often known as unloaded pedalling, to allow stabilization of any 
adverse baseline measures i.e. anxiety driven hyperventilation (Burnside & Snowden 
2014). Following the unloading pedalling phase the main exercise test encompasses a 
continual ramped increase in cycling resistance whilst cadence is consistently maintained 
at a predetermined rate by the patient (Burnside & Snowden 2014). The work rate 
increment is chosen to allow patients to reach exhaustion at the recommended optimal 
duration of 10 min, these increments usually range between 5-25 W.min-1 (American 
Thoracic Society & American College of Chest Physicians 2003). Buchfuhrer et al., 
(1983) demonstrated that 9%cO2peak is significantly higher in tests lasting between 8-12 min 
compared to tests of longer and shorter duration, with 10 min being optimal.  
 
Following volitional exhaustion resistance is removed from the cycle ergometer and the 
patient is required to complete a gentle cool down until their HR has returned within 10 
beats.min-1 (bpm) of their resting value. During the test a range of physiological variables 
are commonly measured including, breath-by-breath expired gas analysis (Grocott & 
Pearse 2010), BP, and ECG (Smith, Stonell, Purkayastha & Paraskevas 2009). Breath-
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by-breath gas analysis enables the determination of 9%cO2, 9%cCO2 and 9%cE (Milani, Lavie, 
Mehra & Ventura 2006). The continuous ECG readings assist in identification of 
ischaemic changes during the test, a signal for immediate test termination (Bhagwat & 
Paramesh 2010). Key physiological CPET derived variables often used by clinicians in 
risk stratification are 9%cO2peak, AT, 9%cE/9%cCO2 at the AT and VO2/HR (West, Jack & 
Grocott 2011). 
 
2.4. CPET derived parameters and risk stratification 
 
2.4.1. Peak Oxygen Consumption 
The 9%cO2peak is the highest 9%cO2 achieved during the CPET and generally occurs at or near 
maximal exercise capacity. As previously mentioned, 9%cO2peak is defined by the Fick 
equation: 9%cO2peak = (HR x SV) x (CaO2 ± (CvO2), which represents the 4%c and a-vO2 diff 
at peak exercise (Balady, Arena, Sietsema, Myers, Coke et al., 2010). If the 9%cO2 curve 
represents a plateau, where the 9%cO2 no longer increases regardless of an increase in work 
rate, this can be referred to as 9%cO2max (Milani, Lavie, Mehra & Ventura 2006). As 9%cO2peak 
measures maximal aerobic capacity, it is a useful indicator of cardiovascular fitness 
(Smith, Stonell, Purkayastha & Paraskevas 2009).  
 
9%cO2peak has previously been shown to be a consistent parameter when obtaining risk of 
patients going into major surgery. Walsh, Morice, Putnam, Nesbitt, McMurtrey et al., 
(1994) identified how those patients, considered for lung resection, who achieved a 
9%cO2peak > 15 ml·kg-1·min-1 survived their operation with what they deemed as 
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µsatisfactory¶ morbidity, whereas those patients with a 9%cO2peak of < 15 ml·kg-1·min-1 had 
higher rates of morbidity and mortality. Further to this, Beckles, Spiro, Colice and Rudd 
(2003) concluded that a 9%cO2peak of > 20 ml·kg-1·min-1 is perceived as no increased risk of 
complications or death after surgery, < 15 ml·kg-1·min-1 is perceived as an increased risk 
of post-operative complications, and < 10 ml·kg-1·min-1 is perceived as a very high risk 
for post-operative complications. Berchard & Wetsein (1987) also demonstrated that for 
a group of lung resection patients, those who had no complications post-surgery had a 
9%cO2peak 17.01 ± 0.77 ml·kg-1·min-1 (mean ± SD), whereas those who had complications 
post-surgery had a 9%cO2peak of 9.95 ± 1.52 ml·kg-1·min-1. These findings are supported by 
McCullough and colleagues (2006), who showed that from a group of patients undergoing 
bariatric surgery, those who achieved a 9%cO2peak of < 15.8 ml·kg-1·min-1 had a 16.7% 
incidence rate of complications post-surgery. By contrast the authors only found 2.8% of 
those patients who achieved a 9%cO2peak > 15.8 ml·kg-1·min-1 to experience post-surgical 
complications. Those factors that where classed as complications in this study where 
death, unstable angina, MI, venous thromboembolism, renal failure, stroke, length of 
hospital stay (LOS) and readmissions in the hospital (McCullough, Gallagher, deJong, 
Sandberg, Trivax et al., 2006). Mancini et al., (1991) also used CPET to determine 
whether measurements of peak 9%cO2 can be used to identify patients in whom cardiac 
transplantation can be safely deferred, by comparing heart failure patients who were not 
accepted for cardiac transplantation with those who received a transplant. For all those 
not accepted for transplantation, a 9%cO2peak > 14 ml·kg-1·min-1 produced higher survival 
rates compared to those after transplantation who had a 9%cO2peak < 10 ml·kg-1·min-1.  
 
9%cO2peak has not always been shown to significantly predict postoperative complications. 
Indeed, Nugent, Riley, MegaUU\ 2¶5HLOO\ 0DF0DKRQ HW DO (1998) failed to find a 
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significant relationship with postoperative complications in patients undergoing elective 
AAA repair. However, an underlying trend was observed in the data of Nugent and 
colleagues (1998), suggestive of higher complication rates in those patients with a 9%cO2peak 
of < 20 ml·kg-1·min-1. The authors propose that their results could have been influenced 
by the small sample size, and the reduced tendency of clinicians to operate clinically 
µERUGHUOLQH¶SDWLHQWVZLWK$$$, compared with lung cancer patients. It has also been 
concluded by Forshaw et al., (2008) that 9%cO2peak does not strongly predict postoperative 
cardiopulmonary complications in patients undergoing oesophagectomy, which questions 
the need for CPET in such surgeries. Although, they did still find that 9%cO2peak was 
significantly lower in those patients who did develop cardiopulmonary complications 
postoperatively. It is also worth mentioning that for various reasons not all patients may 
be able to reach near maximal values (e.g. orthopaedic or muscular discomfort, low 
motivation etc.). In particular if incorrect work rates are selected then a patient may not 
achieve the recommended test time (8-12 min; Buchfuhrer et al., 1983) and thus fail to 
achieve near oSWLPDO9%c22 values. This will ultimately lead to incorrect values which will 
reduce the validLW\RI9%c22peak to accurately risk stratify patients prior to surgery. Therefore 
a test which may help patients achieve values closer to maximum would be advantageous.  
 
2.4.2. Anaerobic Threshold 
During CPET, there becomes a point where the oxygen supply cannot meet the increasing 
oxygen requirements at the exercising muscles, at this point anaerobic metabolism occurs 
(Albouaini et al., 2007). This metabolic transition results in 9%cCO2 increasing 
disproportionately to 9%cO2, which is a result of the buffering processes of  lactic acid to 
lactate and consequently producing excess CO2 (Smith, Stonell, Purkayastha & 
Paraskevas 2009), this physiological change in gas exchange is the AT (as previously 
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described). The AT is a more preferable parameter used by some physiologists in 
preoperative assessment compared to 9%cO2peak, this is because it is an accurate objective 
assessment of cardiac function which does not require the patients to work to their 
maximum capacity, therefore not putting high physical stress on the patient (Older, Hall 
& Hader 1999). Additionally, surgery does not maximally stress the cardiopulmonary 
system, in fact the oxygen demand is said to be up to around 50% above their resting 
values (Older et al., 1993) so it raises questions as to whether peak exercise capacity is 
necessary. Although a number of studies have now provided evidence that both 9%c22peak 
and AT are able predict postoperative outcome to the same effect as each other (Junejo, 
Mason, Sheen, Moore, Foster et al., 2012, West, Parry, Lythgoe, Barben, Kemp et al., 
2014, West, Asher, Browning, Minto, Swart et al., 2016). 
 
Older et al., (1993) studied 187 preoperative patients who were over the age of 60 years. 
Each patient completed a CPET prior to their major intra-abdominal surgery. It was 
concluded that patients with an AT of < 11 ml·kg-1·min-1 and where myocardial ischemia 
was present, their risk of postoperative complications almost doubled. To mitigate the 
risk they suggested that all those patients scheduled for major intra-abdominal surgery 
with an AT of < 11 ml·kg-1·min-1 should be admitted to ICU after surgery. These findings 
have been further supported by Older et al., (1999) and Wilson, Davies, Yates, Redman 
and Stone (2010) as both studies identified that an AT < 11 ml·kg-1·min-1 is a strong 
predictor of mortality after major abdominal surgery. The use of the AT has additionally 
been used in the prediction of both short-term (6 months) and long-term (2 years) survival 
of patients with chronic heart failure, showing high prognostic strength (Gitt, Wasserman, 
Kilkowski, Kleemann, Kilkowski et al., 2002). It is suggested that the average oxygen 
consumption following major surgery is 4.5 to 5 ml·kg-1·min-1, but it is not uncommon to 
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see levels rise by 6 to 7 ml·kg-1·min-1, therefore patients incapable of achieving an AT of 
> 8.5 ml·kg-1·min-1 would result in them being unable to meet the increased oxygen 
demands and 4%c associated with major surgery (Older, Smith, Courtney & Hone 1993). It 
is clear that AT is a strong predictor of post-operative complications, however, some 
studies suggest that AT is not a consistently strong predictor across all surgical procedures 
such as oesophagectomy (Junejo, Mason, Sheen, Moore, Foster et al., 2012). A further 
issue is that the reproducibility of AT on a test-retest basis is lower than parameters such 
as 9%cO2peak. Specifically, previous studies have demonstrated AT to have a coefficient of 
variation (CV) 9.3% (Scott, Haykowsky, Eggebeen, Morgan, Brubaker et al., 2012) to 
10% (Kothmann, Danjoux, Owen, Parry, Turley et al., 2009) compared to the CV for 
9%cO2peak being 4.9% (Scott, Haykowsky, Eggebeen, Morgan, Brubaker et al., 2012) to 6% 
(Elborn, Stanford & Nicholls 1990). With this in mind using a maximal CPET, rather 
than submaximal, allows measurements of both variables which can be used in 
combination to predict risk, indeed previous research has demonstrated that assessing 
CPET derived variables in combination is beneficial when predicting postoperative 
outcomes (West et al., 2014). 
 
2.4.3. Ventilatory Equivalents for Carbon Dioxide 
The ventilatory equivalents for carbon dioxide production (9%cE/ 9%cCO2) at the AT has also 
been used as a predictor of post-operative outcomes. In healthy individuals, 9%cE increases 
linearly with increasing work rate. As an individual inhales air into their lungs, only some 
of the tidal volume actually reaches the alveoli. The remaining air that is not included 
within the gas exchange is known as the dead space volume (VD) (Balady, Arena, 
Sietsema, Myers, Coke et al., 2010). During exercise, dilation of the respiratory passages 
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causes the VD to increase, but due to an increase in tidal volume, adequate gas exchange 
can be maintained. This can be referred to as normal ventilation-perfusion matching 
(Balady et al., 2010). During exercise, the 9%cE/9%cCO2 ratio decreases as work rate 
increases. When AT is reached there is an increase in the 9%cE for 9%cO2 (9%cE/9%cO2) ratio and 
a levelling of 9%cE/9%cCO2, this point is used as a confirmatory point when determining AT 
(Burnside & Snowden 2014). Larger values for 9%cE/9%cCO2 (> 34) are suggestive of a large 
dead space and a ventilation-perfusion mismatch, and are particularly linked with 
conditions such as cardiac failure or respiratory disease (Burnside & Snowden 2014). For 
example, in pulmonary disease, there is a higher dead space as there are fewer healthy 
tissues in the lungs where gas exchange can take place, which ultimately limits exercise 
capacity (Balady et al., 2010). Carlisle and Swart (2007) demonstrated that patients who 
had a 9%cE/9%cCO2 < 43 were found to have improved 30 day and mid-term survival post-
operatively, following elective AAA repair, compared to those with a higher 9%cE/9%cCO2. 
A few years later it was then concluded by Wilson et al., (Wilson, Davies, Yates, Redman 
& Stone 2010) that a 9%cE/9%cCO2 > 34 is associated with an increased risk of hospital 
mortality following major intra-abdominal non-vascular surgery. A few studies have also 
used 9%cE/9%cCO2 to help determine cardiac mortality and hospitalization in patients who 
were diagnosed with heart failure. It has been shown that in those patients with a 
9%cE/9%cCO2 of KLJKHU UDWHVRIPRUWDOLW\DQGKRVSLWDOL]DWLRQZHUH seen compared to 
those with a 9%cE/9%cCO2 < 34 (Arena, Myers, Aslam, Varughese & Peberdy 2004; Nanas, 
Nanas, Sakellariou, Dimopoulos, Drakos et al., 2006).  
 
2.4.4. Oxygen Uptake Efficiency Slope 
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The oxygen uptake efficiency slope (OUES) was first recognised by Baba and colleagues 
(1996) who revealed that it could provide an objective estimation of cardiorespiratory 
function, related to pulmonary dead space and metabolic acidosis. The OUES is derived 
from the logarithmic relationship between 9%cO2 and 9%cE during incremental exercise, and 
theoretically represents how effectively the oxygen is extracted by the lungs and then 
taken into the body (Akkerman, van Brussel, Hulzebos, Vanhees, Helders et al., 2010; 
Baba, Nagashima, Goto, Nagano, Yokota et al., 1996; Van Laethem, Bartunek, Goethals, 
Nellens, Andries et al., 2005). A correlation between 9%cO2peak and OUES has also been 
shown in previous research, with OUES being shown to not be greatly affected by 
whether or not the CPET was maximal or not (Baba et al., 1996). This was evidenced by 
there being no differences in OUES from the first 90% of the exercise data compared to 
100% of the data. This suggests that OUES can be determined from submaximal exercise, 
although OUES was slightly lower from the data accumulated from the first 75% of the 
test (Baba et al., 1996). Kasikcioglu Toker, Tanju, Arzuman, Kayserilioglu et al., (2009) 
evaluated the ability of the OUES to predict postoperative cardiorespiratory morbidity in 
patients following lung resection. The authors discovered that patients who had 
postoperative complications possessed an OUES that was significantly lower (11.1 ± 1.2) 
than those who had no postoperative complications (13.3 ± 2.1). Furthermore, Davies 
Wensel, Georgiadou, Cicoira, Coats et al., (2006) also demonstrated strong prognostic 
value of the OUES in patients with chronic heart failure. Specifically, the OUES was 
significantly lower in patients with left ventricular (LV) dysfunction, compared to those 
patients with normal LV function (Van Laethem et al., 2005). Arena, Myers, Hsu, 
Peberdy, Pinkstaff et al., (2007) also provide support for the use of OUES as a predictor 
of mortality in patients with heart failure. Study results demonstrated that patients with a 
lower OUES had a significantly higher incidence of major cardiac events within a 3 year 
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period following surgery. Interestingly, even though the OUES was a strong predictor of 
morbidity, the 9%cE/9%cCO2 slope was shown to have better prognostic value (Arena et al., 
2007).  
 
2.4.5. Oxygen Pulse 
The oxygen pulse is a measure of the amount of oxygen consumed per heart beat 
(9%cO2/HR), and provides an indication of SV and a-vO2 diff (Vassaux, Torre-Bouscoulet, 
Zeineldine, Cortopassi, Paz-Díaz et al., 2008). Oxygen pulse is suggested be more 
dependent of cardiac function as it incorporates HR response which is not reflected in 
other measures such as 9%cO2peak (Lavie, Milani & Mehra 2004). During incremental 
exercise oxygen pulse increases due to linear rises in 9%cO2 and HR, and eventually 
plateaus during maximal exercise. Patients with conditions such as chronic obstructive 
pulmonary disease (COPD) and chronic heart failure demonstrate a flattened oxygen 
pulse response (Burnside & Snowden 2014). This flattened response is a result of a 
reduced stroke volume and/or an inability to adequately increase oxygen extraction 
(American Thoracic Society & American College of Chest Physicians 2003). The oxygen 
pulse response to exercise has therefore been shown to be a strong indicator of exercise 
induced myocardial ischaemia (Belardinelli, Lacalaprice, Carle, Minnucci, Cianci et al., 
2003). Very few studies have identified the prognostic value of oxygen pulse regardless 
of its strong diagnosis of cardiac function. One previously published study found that 
peak oxygen pulse has the capability to risk stratify patients, but suggests that peak 
oxygen pulse should be recorded for those patients who are unable to reach a peak 
respiratory exchange ratio (RER) of > 1.0 (Ingle, Witte, Cleland & Clark 2008). However, 
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other research has shown oxygen pulse to have no significant prognostic value (Cohen-
Solal, Barnier, Pessione, Seknadji, Logeart et al., 1997).  
 
2.4.6. Pulmonary Function Testing  
Resting pulmonary function testing (spirometry) is a standard procedure done prior to a 
&3(7WKLVLVEHFDXVHLWSURYLGHVDQDVVHVVPHQWRIDSDWLHQW¶VOXQJPHFKDQLFVDQGZKHWKHU
or not they are likely to be limited during exercise (Balady et al., 2010). This test is 
typically performed to determine two key values, forced vital capacity (FVC), which is 
the total volume of air exhaled during a maximally forced expiration, and the other is the 
forced expiratory volume in 1 second (FEV1), which is the volume delivered in the first 
second of the FVC (Miller, Hankinson, Brusasco, Burgos, Casaburi et al., 2005). Testing 
for resting lung function can help determine if a patient has a respiratory disorder and 
particularly if it is obstructive and/or restrictive dysfunction (Pellegrino, Viegi, Brusasco, 
Crapo, Burgos et al., 2005). Lung function values expressed as a percentage of the 
predicted values have been shown to predict postoperative outcome in patients 
undergoing lung cancer surgery (Win, Jackson, Sharples, Groves, Wells et al., 2005). 
From the resting spirometry, maximum voluntary ventilation (MVV) can be indirectly 
calculated (MVV = FEV1 x 40) (Balady et al., 2010). The MVV represents respiratory 
muscle strength (Datta & Lahiri 2003) and can be used during CPET to help determine a 
SDWLHQW¶VH[HUFLVHEUHDWKLQJUHVHUYHWKLVFDQEHLGHQWLILHGby assessing how closely 9%cE is 
in relation to MVV by the end of exercise (maximum 9%cE/MVV) (Balady et al., 2010). If 
9%cE exceeds 85% of MVV and the patient is evidently not trained, then confirmation of 
an obstructive or even a restrictive lung disease can be assumed (Palange, Ward, Carlsen, 




2.4.7. Oxygen Saturation  
Oxygen saturation (PaO2) is a parameter that is often continuously monitored throughout 
a CPET. Observation of desaturation during the test has been linked with an increased 
risk of postoperative complications (Beckles, Spiro, Colice & Rudd 2003; Markos, 
Mullan, Hillman, Musk, Antico et al., 1989). Ribas Diaz, Barbera, Mateu, Canalis et al., 
(1998) discovered that those patients who did not survive after lung resection surgery, 
had a greater decrease in PaO2 during exercise when compared to those who survived the 
procedure. Ninan et al., (1997) also concluded that exercise oximetry was highly 
predictive of risk for lung resection surgery. Those patients with a resting PaO2 of less 
than 90%, or those who demonstrated desaturation greater or equal to 4% during exercise, 
had a heightened risks of morbidity and prolonged ICU (Ninan, Sommers, Landreneau, 
Weyant, Tobias et al., 1997). However, as with oxygen pulse, there is limited literature 
concerning the predictive nature of PaO2 from CPET.  
 
2.4.8. Electrocardiogram 
The use of an ECG is standard practice in clinical CPET, primarily to ensure patient 
safety. Due to exercise causing an increase in HR and a reduction in diastolic time, the 
time for coronary perfusion is reduced, therefore coronary artery disease is more likely to 
be identified during exercise, when HR is elevated (Wasserman, Hansen, Sue, Stringer & 
Whipp 2005b). Conditions like stress induced myocardial ischemia can also be confirmed 
on the basis of ST segment changes (depression/elevation), angina, ventricular 
arrhythmias, and a drop in systolic blood pressure whilst a continued increase in exercise 
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intensity (Belardinelli, Lacalaprice, Carle, Minnucci, Cianci et al., 2003). Myocardial 
ischemia is attributed to an inadequate oxygen supply to the myocardium and the inability 
to support the increased cardiac work (Wasserman et al., 2005b). Previous literature has 
used the presence of myocardial ischemia during CPET, combined with AT, to help triage 
patients post-operative location in the attempt to minimise risk of complications (Older, 
Smith, Courtney & Hone 1993). Therefore it is essential to monitor ECG during exercise 
in order to determine any cardiac limitation and also to ensure the patient is safe. 
 
2.4.9. Blood Pressure 
Blood Pressure is dependent on 4%c and peripheral resistance (Chaitman et al., 2007) and 
monitoring blood pressure response during exercise is seen as important for assessing 
cardiovascular function (Robinson, Sue, Huszczuk, Weiler-Ravell & Hansen 1988). 
During incremental exercise, systolic blood pressure will increase progressively whilst 
diastolic blood pressure remains fairly constant, although a slight decline may occur in 
the diastolic blood pressure if the heart function continues to keep up with the increases 
in 4%c. An abnormal blood pressure responses can include an excessive rise, or a fall. An 
excessive rise in blood pressure is commonly seen in patient with resting hypertension, 
but an abnormal rise with exercise, when resting blood pressure is normal, may be 
suggestive of abnormal blood pressure control (American Thoracic Society & American 
College of Chest Physicians 2003). A reduction in blood pressure during exercise is a 
sign of an inability of 4%c to compensate for the exercise-induced systemic vasodilation 
(Albouaini, Egred, Alahmar & Wright 2007) which could be suggestive of a cardiac 
limitation or abnormality in blood pressure control. The exercise test should be 
immediately stopped if blood pressure falls whilst exercise intensity increases, this 
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response could indicate heart failure, ischemia, aortic stenosis, pulmonary vascular 
disease, or venous obstruction (American Thoracic Society & American College of Chest 
Physicians 2003). During CPET it is noted that the test should be stopped if there is a fall 
in systolic blood pressure > 20 millilitres of mercury (mmHg) or if blood pressure is > 
250 mmHg for systolic and > 120 mmHg for diastolic (Albouaini, Egred, Alahmar & 
Wright 2007).  
 
2.4.10. Recovery Heart Rate 
The rise in HR during CPET is said to be a result of vagal withdrawal and sympathetic 
activation, therefore it is suggested that the fall in HR seen after exercise is a result of 
vagal reactivation (Cole, Blackstone, Pashkow, Snader & Lauer 1999; Imai, Sato, Hori, 
Kusuoka, Ozaki et al., 1994). This rapid recovery in HR is deemed important so that 
excessive cardiac work is avoided after exercise (Imai et al., 1994). Patients with 
cardiovascular disease have been shown to have a decreased vagal activity (Imai et al., 
1994). With this information recovery HR after graded exercise has previously been 
shown to be a strong predictor of mortality (Cole et al., 1999), although it is not highly 
documented as a fundamental measure in CPET. Further research is required to determine 
if recovery HR is predictive of post-operative mortality and morbidity like other CPET 
variables 9%c22peak$79%cE9%c&22 at AT) have been shown to do (West et al., 2014).  
  
To summarise, it is clear from the above section that there is an extensive amount of 
evidence supporting the association of key CPET derived variables on postoperative 
outcome, in a range of major elective surgeries. It seems that majority of the research is 
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primarily focused around the predictability of 9%c22peak and AT DOWKRXJK WKHUH LV
LQFUHDVLQJUHVHDUFKVXSSRUWLQJRWKHU&3(7GHULYHGYDULDEOHV9%cE9%c&22 at AT).  
 
2.5. The use of CPET for patient optimisation strategies 
 
Using CPET as part of the preoperative assessment has the scope to determine those 
patients with a low cardiorespiratory reserve who can then be provided with right 
interventions in the attempt to improve their risk and reduce their hospital LOS. One 
preoperative optimisation strategy which has recently been considered to improve a 
SDWLHQW¶VSRVWRSHUDWLYHRXWFRPH is preoperative exercise training (Jones, Peddle, Eves, 
Haykowsky, Courneya et al., 2007), although there is very limited research to support this 
notion.  Changes in various lifestyle factors such as alcohol consumption (Tonnesen & 
Kehlet 1999), smoking (Bluman, Mosca, Newman & Simon 1998) and dietary factors 
(Bozzetti, Gianotti, Braga, Di Carlo & Mariani 2007) have all been linked with increasing 
post-operative complications. As a consequence preoperative lifestyle modifications have 
been suggested to reduce patient risk and improve surgical outcome (Kehlet & Wilmore 
2002). Research studies have also shown that the use of blood transfusions in anaemic 
adults leads to significantly higher exercise capacityLQFOXGLQJDQLQFUHDVHLQ$79%c22peak, 
peak power output (PO), OUES and a lower 9%cE9%c&22 at AT (Wright, Pearce, Snowdon, 
Anderson & Wallis 2014), which should therefore improve their risk going into elective 
surgery. Perioperative beta-blocker treatment has also been associated with a reduced risk 
of in-hospital mortality (Lindenauer, Pekow, Wang, Mamidi, Gutierrez et al., 2005) and 
30-day mortality (Wijeysundera, Beattie, Wijeysundera, Yun, Austin et al., 2014) in high 
risk patients undergoing major non-cardiac surgery. Again there is still limited research 
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to support these ideas, but if CPET can be used to initially identify those patients at an 
increased risk for elective surgery, then strategies can be implemented with the right 
patients in the attempt to optimise them preoperatively, and thus reducing the risk of 
postoperative morbidity and mortality.  
 
Obtaining a vDOLGDQGUHOLDEOHUHSUHVHQWDWLRQRIDSDWLHQW¶VFDUGLRSXOPRQDU\ILWQHVVDQG
their associated level of preoperative risk has been shown to provide better allocation of 
post-operative destination and care (Khan, Amoroso & Gulati 2013). Older and 
colleagues (1999) were the first group to use the information from CPET (AT and 
evidence of myocardial ischemia) to aid their decision making on post-operative triage 
(ICU, high dependency unit (HDU), or ward). Moreover, Prentis Trenell, Vasdev, French, 
Dines et al., (2013) also used AT to triage their patients to a level of post-operative care, 
demonstrating that AT strongly correlated with postoperative outcome and LOS. 
Allocating patients to the most appropriate level of care post-surgery has potential to 
reduce the number of patients deteriorating postoperatively in the ward (Hoyland, 
Vasdev, Adshead & Thorpe 2014). These patients commonly end up needing to be 
admitted to ICU, which could have been prevented if the right level of care was provided 
immediately after surgery (Bhagwat & Paramesh 2010). Appropriate triage and post-
operative care also has the potential to reduce costs by ensuring patients admitted to ICU 
postoperatively are only those who truly need this level of care (Bhagwat & Paramesh 
2010; Hoyland et al., 2014).  
 




Since the work of A.V. Hill, various CPET protocols have been designed for determining 
and predicting 9%cO2peak (Takken, Blank, Hulzebos, Brussel, Groen et al., 2009). It was 
initially common to use discontinuous protocols (Taylor, Buskirk & Henschel 1955), 
where exercise stages were performed on consecutive days until a subject had reached 
their 9%cO2 plateau. For obvious reasons, these protocols were very impractical in clinical 
settings due to the time constraints. Thus more realistic exercise protocols were designed 
with much shorter times between stages, and now it is common for practitioners to use 
continuous exercise protocols where stages can vary from a couple of seconds (secs) up 
to 5 min (Takken et al., 2009).  
 
The Bruce protocol, which was developed in the 1960s, is known to be one of the most 
popular protocols used when measuring 9%cO2peak, particularly in the clinical setting. The 
test involves a change of speed and elevation every three min. In the modified version of 
the Bruce protocol, the speed stays constant for the first three stages and after this, work 
rate increase every three min (Takken et al., 2009). However, the large increments in 
work rate (3 min) is suggested to reduce the accuracy of 9%cO2peak, mainly due to this type 
of test creating a nonlinear relation between oxygen uptake and work rate (Fletcher, 
Balady, Amsterdam, Chaitman, Eckel et al., 2001). This nonlinear increase in oxygen 
uptake may also make the identification of the AT difficult to interpret (Myers & Bellin 
2000).  The large increments within the Bruce protocol have also been suggested to cause 
patients to terminate the test earlier than expected due to musculoskeletal discomfort 
and/or the inability to tolerate the large increments, potentially causing an 
underestimation of a paWLHQWV³WUXH´PD[LPDOH[HUFLVHFDSDFLW\ (Fletcher et al., 2001). 
Despite the extensive popularity of the Bruce protocol, it has been recognised that there 
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is a need for more gradual and individualised approaches to testing (Myers & Bellin 
2000).  
 
Another common CPET protocol is the ramped Bruce exercise test, which involves work 
rate to be systematically increased as a function of time until the participant is unable to 
continue (Poole, Wilkerson & Jones 2008). An advantage of the ramp protocol is that the 
test can be individualised to the particular patient, this is because the increases in work 
UDWHDUHFRQWLQXRXVDQGFRQVWDQWDQGWKHUDWHRILQFUHDVHFDQEHDGDSWHGWRWKHSDWLHQW¶s 
own capabilities (Myers & Bellin 2000). The test has also been shown to have an 
improved ability to predict 9%cO2peak compared against those protocols that have larger 
increments in both patient and healthy populations (Myers, Buchanan, Walsh, Kraemer, 
McAuley et al., 1991), this is a primary result of the constant linear increase in work rate 
over 9%cO2 (Myers, Buchanan, Smith, Neutel, Bowes et al., 1992). The ramped designed 
exercise test involves a continuous and gradual increase in work rate, which avoids 
sudden changes in neuromuscular motor unit recruitment or metabolic changes, which is 
associated with other incremental protocols which involve larger step increments (3-5 
min), such as the traditional Bruce protocol (Myers et al., 1991; Takken et al., 2009). 
Research has demonstrated that ramped like protocols provide an improved 
haemodynamic and gas exchange response in comparison to protocols with longer 
exercise stages, therefore it is suggested that identification of the anaerobic threshold is 
easier to determine in more ramp like protocols, primarily a result of the constant linear 
increase in 9%cO2 (Myers et al., 1991; Takken, 2009). The ramp protocol appears to be a 
popular method for clinical testing, with many studies using the ramp protocol when 
testing exercise capacity in patients prior to surgery (Brutsche, Spiliopoulos, Bolliger, 
Licker, Frey et al., 2000; Brunelli, Belardinelli, Refai, Salati, Socci et al., 2009; Gitt, 
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Wasserman, Kilkowski, Kleemann, Kilkowski et al., 2002; Older, Hall & Hader 1999, 
Older, Smith, Courtney & Hone 1993; Walsh, Morice, Putnam, Nesbitt, McMurtrey et 
al., 1994; Wilson, Davies, Yates, Redman & Stone 2010). 
 
&3(7UHTXLUHVPD[LPDOHIIRUWDQGSURYLGHVDGLUHFWPHDVXUHRI9%c22peak, although this 
direct method of assessing functional capacity can be perceived as fairly complex and 
expensive (Morales et al., 2000). More simple and inexpensive indirect methods have 
been developed and are commonly used for the assessment of functional capacity. A 
specific example of an indirect method for assessing function capacity is the 6MWT, this 
is a submaximal exercise test which measures the distance walked in 6 min and has been 
shown to modestly correlate with 9%c22peak (Fletcher et al., 2013; Miyamoto et al., 2000). 
The 6MWT has also been shown to be a predictor of mortality in chronic heart failure 
patients (Ingle, Cleland & Clark 2014; Ian, Rigby, Carroll, Buttery et al., 2007). An 
alternative method is the SWT, which involves patients walking back and forth between 
two cones placed 10 meters apart with walking pace increased by 0.17 m/sec every 
minute, for a maximum of 12 stages. The patient is required to continue until they can no 
longer keep with the pace (Wise & Brown 2005). The SWTKDVEHHQVKRZQWRVWURQJO\
DQGLQGHSHQGHQWO\SUHGLFW9%c22peak in patients with chronic heart failure (Morales et al., 
2000) and COPD (Singh, Morgan, Hardman, Rowe & Bardley 1994). Out of these two 
methods, the SWT has been shown to predict outcome better than the 6MWT in patients 
with moderate to severe chronic heart failure (Morales et al., 2000). Even though there 
are clear benefits associated with these types of methods (simple, safe, inexpensive etc.), 
these do not provide a direct assessment of exercise capacity and are therefore less reliable 
than CPET. In addition, other important CP(7GHULYHGYDULDEOHVVXFKDV$79%cE9%c&22 




2.7. Problems Associated with Current CPET Protocols   
 
Most current CPET protocols involves a maximal incremental exercise test to exhaustion, 
whereby the intensity (usually treadmill speed/incline or cycling PO) increases by a set 
amount, at set given periods of time during the test (e.g every minute), until volitional 
exhaustion is reached (Albouaini et al., 2007). Even though this type of CPET is widely 
used in the fields of clinical exercise testing, and more widely in exercise physiology, a 
number of concerns have been raised in regard to the general nature of the protocol 
(Noakes 2008). Firstly, there is no clear test endpoint, and therefore the participant is 
unaware of the expected exercise duration (Noakes 2008). Knowledge of the exercise 
duration is known to optimise exercise performance as the subject can accurately regulate 
their work rate (Mauger, Jones & Williams 2009).  Secondly, the fixed progressive 
intensity of the protocol does not replicate normal exercise behaviour, which questions 
the validity of the test (Mauger & Sculthorpe 2012). Thirdly, the only part of the test the 
patient has control over is when they stop exercising, which adds a more subjective 
component to the test. Many patients may terminate the test earlier than expected as a 
result of various psychological factors (e.g. low motivation, low self-efficacy etc.) 
(Noakes 2008), potentially resulting in a submaximal effort. Fourthly, the recommended 
duration of an MIE is 8-12 min in order to achieve peak 9%cO2 values (Buchfuhrer et al., 
1983). The experimenter must therefore estimate the most appropriate starting intensity, 
and work rate increments, in order to achieve volitional exhaustion within the 8-12 min 
time period. Appropriately setting the work rate therefore requires a good level of 
experience of CPET, and prior knowledge of the patient. Incorrect estimation of starting 
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intensity and work rate increment can result in a test which lasts too long, or is too short, 
thus limiting the validity of the test.  
 
It has been demonstrated that enforced paced exercise causes a significantly greater 
physiological and thermoregulatory challenge to homeostasis when compared to self-
paced exercise, despite there being no difference in performance (Lander, Butterly & 
Edwards 2009). Lander et al., (2009) found reductions in blood lactate, core temperature 
and integrated electromyography in the self-paced compared to the enforced paced 
exercise. They concluded that these different responses, between the self-paced and fixed 
paced exercise, are most likely a result of the self-SDFHH[HUFLVHHQDEOLQJLQGLYLGXDO¶VWR
self-manage their effort in response to subconscious physiological feedback in order to 
protect homeostasis. It is suggested that physiological variables (i.e. blood lactate, core 
temperature, arterial saturation, ventilatory rates and HR) are used as peripheral afferent 
signallers to the brain to regulate exercise intensity (Tucker 2009), therefore having the 
ability to make slight adjustments in PO is suggested to be an important regulatory 
process in order to prevent a catastrophic system failure occurring (Lambert, St Clair 
Gibson & Noakes 2005; Lander, Butterly & Edwards 2009). During sCPET protocols, 
the test is driven by progressive increases in work rate requirements which is dictated by 
the treadmill or cycle ergometer. No alterations in intensity can be made by the individual, 
therefore the increasing afferent signallers can only be attenuated by volitional exhaustion 
(Mauger & Sculthorpe 2012), with this the participant only has two options, continue to 
match the increasing exercise requirements, or to stop. Unless the individual has high 
levels of motivation, which may be lacking particularly in patient populations, they are 
likely to choose to stop which may lead to early termination of the test and an 




It is proposed that exercise intensity is regulated through the conscious perception of 
effort to protect the athlete and to ensure that optimal performance is achieved (Tucker 
2009). This exercise performance model is termed the anticipatory feedback model, as it 
utilises physiological and psychological inputs prior to exercise to establish initial pace 
(Noakes 2011), and regulate pacing strategy during (Tucker 2009).  The model allows 
exercise intensity to be pre-set before exercise actually begins which is based on previous 
experience (Mauger, Jones & Williams 2010). Pre-setting exercise intensity is beneficial 
to ensure that initial high work rates are avoided to prevent premature fatigue (Tucker 
2009). Other factors that are likely to influence the pre-set pace usually consist of the 
VXEMHFW¶VSK\VLRORJLFDOVWDWe at the start of exercise, the expected exercise duration, and 
the individuals level of motivation (Noakes 2011). The model also allows the regulation 
of pacing strategy during exercise, which as previously mentioned, is achieved via 
continuous subconscious physiological feedback from afferent signals that in turn allow 
exercise behaviour to be continuously regulated and protect the body from a catastrophic 
physiological failure (Noakes 2011). Although, pre-setting exercise intensity and self-
regulation during exercise is not possible in the sCPET protocols due to the predetermined 
work rates and fixed intensities, which could lead to a premature termination of the test 
in order to protect homeostasis from the continuous increase in the afferent signallers. 
 
As previously mentioned, knowledge of exercise duration has been proven to facilitate 
exercising performance in trained populations (Baden, McLean, Tucker, Noakes & St 
Clair Gibson 2005; Eston, Stansfield, Westoby & Parfitt 2012; Mauger, Jones & Williams 
2009), although this has not shown to be the case in a group of healthy, untrained 
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individuals (Williams, Bailey & Mauger 2012). Williams et al., (2012) demonstrated that 
untrained populations were able to complete a 4 km time trial (TT) in similar times, 
regardless of whether distance knowledge, distance feedback or prior experience is 
provided. These findings challenge the notion that anticipatory feedback is crucial for a 
successful pacing strategy to be adopted. Williams et al., (2012) also concluded that this 
result demonstrated that participants relied more on afferent feedback when pacing the 4 
km TT, rather than the distance information they received. This suggests that untrained 
individuals do not rely on these pieces of information in order to successfully complete 
an exercise test, this is likely a result of the unfamiliarity of such tasks, which questions 
whether the same would apply in a more clinical populations. It must also be 
acknowledged that factors such as prior experience would not be applicable in clinical 
populations as many patients tend to be inactive who live sedentary lifestyles, and 
therefore would lack in previous exercise experience. 
 
The ability to tolerate exercise induced pain or discomfort is recognised as a critical 
influence of a successful performance (Anshel & Russell, 1994). During exercise the 
development of peripheral fatigue is monitored by the central nervous system (CNS) via 
sensory feedback from the locomotor muscles (Amann et al., 2009). This feedback adjusts 
central motor drive (CMD) to limit the level of peripheral fatigue development, and 
consequently avoid intolerable levels of effort/pain, and excessive muscle dysfunction 
(Amann et al., 2009). If these neuromuscular signals are consciously interpreted as pain 
or discomfort, then those individuals with a higher pain tolerance may be more capable 
to push their selves further compared to those with a lower pain tolerance (Mauger et al., 
2010). Based on this, patient populations who are unaccustomed to the feelings associated 
with maximal exercise may interpret higher levels of discomfort or pain mainly due to 
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the unfamiliarity of the task (Mitros, Gabriel, Ainsworth, Lee, Herrmann et al., 2011). As 
the sCPET protocol involves gradual increases of an enforced pace, individuals are unable 
to adjust their effort to attenuate any muscle pain or discomfort that they might be 
experiencing. Thus, as pain tolerance is suggested to be an important determinant of 
successful performance (Anshel & Russell, 1994), termination of the exercise test could 
be a result of WKHLQGLYLGXDO¶VSDLQintolerance rather than their actual cardiorespiratory 
limit. Consequently, if self-regulating pace can reduce these premature responses and 
FRQWURODQLQGLYLGXDO¶VGLVFRPIRUWGXULQJWKHWHVWLWFRXOGEHSODXVLEOH that a higher and 
more representative 9%cO2peak is attainable in a self-paced based protocol.  
 
2.8. Self-paced 9ࡆ O2peak protocol (SPV) 
 
Mauger and Sculthorpe (2012) recently developed a novel maximal incremental exercise 
test design to assess 9%cO2peak. The novel protocol allows subjects to self-pace their work 
rate according to a given end point, whilst maintaining the usual incremental format used 
in sCPET. In their study, Mauger and Sculthorpe (2012), recruited sixteen untrained 
subjects who were required to complete two tests, one being the proposed self-paced 
9%cO2peak (SPV) protocol and the other being the traditional 9%cO2peak test. The SPV design 
consisted of 5 × 2 minute stages equalling a total test time of 10 min, whereby each stage 
was fixed to a level on the RPE scale (11, 13, 15, 17 & 20). Participants were able to 
continuously self-manage their work rate according to the specific RPE for each stage. 
The traditional 9%cO2peak test compromised of the standard incremental design, where 
subjects started at a PO of 60 watts (W), which was increased by 30 W every two min, 
until the subject reached volitional exhaustion, or the cadence dropped below 60 rate per 
minute (rpm). Results from Mauger and Sculthorpe (2012) demonstrated a significant 
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difference in 9%cO2peak, with participants achieving an 8% higher 9%cO2peak in the SPV when 
compared to the traditional test. A significant difference was also observed in PO between 
the tests, with participants achieving a higher peak PO in the SPV (273 ± 58 W) than in 
the traditional test (238 ± 55 W). Similar observations have been demonstrated in more 
recent studies in both cycling (Astorino, McMillan, Edmunds & Sanchez 2015) and 
treadmill running (Faulkner, Mauger, Woolley & Lambrick 2015; Hogg, Hopker & 
Mauger 2014; Mauger, Metcalfe, Taylor & Castle 2013)DOWKRXJKQRWDOOVWXGLHVKDYH
IRXQG WKH 639 WR SURGXFH D VLJQLILFDQWO\ KLJKHU 9%c22peak values (Chidnok, DiMenna, 
Bailey, Burnley, Wilkerson et al., 2013; Straub, Midgley, Zarvorsky & Hillman 2014). 
Table 2.SUHVHQWVVWXGLHVZKLFKKDYHXVHGWKH639SURWRFRO$OOVWXGLHVWRGDWHKDYH












Table 2.1 Summary of studies that have used RPE-clamped maximal exercise test protocols for 
the determination of 9%cO2peak. The studies are organised in descending order of publication date. 
9%cO2peak data is displayed at mean ± SD.  










Cycling SPV. RPE clamped, 5 × 2-min  48 ± 8 mL·kg-1·min-1* 
Treadmill SPV. RPE clamped, 5 × 2-min  56 ± 5 mL·kg-1·min-1 









SPV. RPE clamped, 5 × 2-min stages 50 ± 10 mL·kg-1·min-1* 
RAMP 1. Start 50-80 W, increased 25-40 
W min-1 
47 ± 10 mL·kg-1·min-1 
RAMP 2. Start 50-80 W, increased 25-40 
W min-1 






Treadmill SPV. RPE clamped, 5 × 2-min stages 64 ± 3 mL·kg-1·min-1* 
GXT. Speed increased 1 km.h-1 every 2 
min 







Treadmill SPV incline-based. RPE clamped, 5 × 2-
min stages 
71 ± 4 mL·kg-1·min-1* 
SPV speed-based. RPE clamped, 5 × 2-
min stages 
68 ± 4 mL·kg-1·min-1 
 
GXT. Speed increased 1 km.h-1 every 2 
min 









SPV. RPE clamped, 5 × 2-min stages 3.87 ± 0.72 L·min-1 
Ramp. Start at 80 W, increased by 30 W 
min-1 for men and 20 W min-1 for 
women. Repeated twice 






Treadmill SPV. RPE clamped, 5 × 2-min stages 64 ± 8 mL·kg-1·min-1* 
GXT. Speed increased by 1 km.h-1 every 
2 min 










SPV. RPE clamped, 5 × 2-min stages 4.33 ± 0.60 L·min-1 
RAMP 1. 3 min unloaded, 30 W min-1 4.31 ± 0.62 L·min-1 











SPV. RPE clamped, 5 × 2-min stages 40 ± 10 mL·kg-1·min-1* 
GXT. Started at 60 W, 30W increase 
every 2 min. 
37 ± 8 mL·kg-1·min-1 




It has been acknowledged, by Mauger and Sculthorpe (2012), that in their first study on 
the SPV protocol the mean test duration (13 ± 3 min) for the traditional test was longer 
than the self-paced test, and that recommended for achieving optimal 9%cO2peak values (8-
12 min) (Buchfuhrer et al., 1983). Test durations have been demonstrated to be of great 
importance in achieving 9%cO2peak, suggesting that too long or too short tests may result in 
the subject reaching their limit of exercise tolerance or experiencing peripheral fatigue 
before maximum 9%cO2 values are reached (Midgley, Bentley, Luttikholt, McNaughton & 
Millet 2008). Therefore, it is possible that the higher 9%cO2 values achieved in the self-
paced test in the study by Mauger and Sculthorpe (2012) was due to the standard 
incremental test lasting too long, and as a result participants being unable to achieve 
µRSWLPXP¶YDOXHVLQWKe test. Although, there was no significant difference between test 
duration in the later study (Mauger et al., 2013) where significantly higher values where 
achieved in the SPV. The differences in test time highlights one of the suggested 
drawbacks associated with sCPET protocols. Unless repeated tests are able to be 
completed, which is unlikely in a clinical setting, then an ³optimal´ test cannot be 
guaranteed. If an alternative test is available that can increase the likelihood of individuals 
reaching their peak effort within the recommended time period, it warrants further 
investigation. 
 
The recommended test duration of 8-12 min originated from an early study by Buchfuhrer 
et al., (1983). In this study five healthy males each performed five treadmill and three 
cycle ergometer incremental exercise tests, each test had different test durations, with the 
mean times ranging from 5.8 - 26.4 min. It is not denied that the work from Buchfuhrer 
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et al. (1983) had a great influence on WRGD\¶VNQRZOHGJHDQGSUDFWLFHRIPD[LPDOH[HUFLVH
testing, although when under scrutiny a number of flaws can be identified, which limit 
the dependability of the conclusions drawn out from their study. The first being the very 
small sample size, which therefore causes the results to be underpowered. Secondly, 
9%cO2peak was only significantly lower in the shortest test times (7 min for treadmill; 5.8 
min for cycling) which raises questions as to why the authors suggest the upper boundary 
of 12 min. Although, Buchfuhrer et al., (1983) did conclude that tests lasting more than 
12 min do not provide any additional information which is the main reason they used this 
as the upper cut off limit for test duration. Finally, all participants were healthy males, so 
there is no evidence to prove that the same results would be representative in various 
other populations. Aside from these limitations a few recent studies have supported the 
ILQGLQJVIURP%XFKIXKUHU¶VHDUO\VWXG\)RUH[DPSOHRQHVWXG\required 12 male 
cyclists/triathletes to each complete a slow, medium and fast ramp cycling protocol 
(Weston, Gray, Schneider & Gass 2002). The three mean test durations were 7.2, 11.1 
and 27.9 min. The results demonstrated that there were no differences in 9%cO2peak between 
7.2 and 11.1 min, but the mean 9%cO2peak value achieved in a test lasting 27.9 min was 
significantly lower (Weston et al., 2002). Whereas, some studies have disputed the 
ILQGLQJVIURP%XFKIXKUHU¶VHDUO\ZRUNfinding no differences in 9%cO2peak between 
various test durations ranging from 9.1 to 25.9 min (Bentley & McNaughton 2003; 
Bishop, Jenkins & Mackinnon 1998).  
 
It is clear that there is limited and mixed evidence to support the optimal test duration for 
CPET. Nevertheless, regardless of the limitations mentioned above, it seems that the 
original work by Buchfuhrer (1983) has become the accepted reference for test duration. 
In this regard, it seems irrational to rely on one single study, conducted on a small sample 
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size, to guide current practice. In a recent review article, Midgley et al., (2008) concluded 
WKDW WR REWDLQ D µWUXH¶ 9%cO2max in healthy individuals, a cycling protocol should last 
between 7 and 26 min, and treadmill tests should last between 5-26 min, but the authors 
acknowledge that further research is required. Indeed, it is likely that optimal test time 
will vary dependant on populations; for example, shorter incremental test times may be 
more suitable for trained individuals due to theLUDFFHOHUDWHG9%c22 kinetics compared to 
untrained individuals (Caputo, Mello & Denadai 2003). Conversely, shorter protocols 
may not be suitable for patient populations with impaired cardiorespiratory function 
(Midgley et al., 2008). Indeed, Agostoni, Bianchi, Moraschi, Palermo et al. (2005) report 
that when HF patients completed a CPETLQPLQWKH\DFKLHYHGDVLJQLILFDQWO\ORZHU
9%c22peak compared to when the test was completed in 10 and 15 min. They suggested that 
hard work rates early on in exercise forces the patient to stop exercising because of limited 
O2 transport, and consequently, early muscle fatigue. It appears that even though there is 
still limited evidence, optimal CPET time may vary from person to person, although it 
does seem that there is at least a minimum test time requirement of 5 minutes.  
 
There are conflicting findings from previous studies investigating differences LQ9%c22peak 
between  SPV and sCPET protocols (Astorino et al., 2015; Faulkner et al., 2015; Hogg et 
al., 2014; Mauger & Sculthorpe 2012; Mauger et al., 2013; Chidnok et al., 2013; Hansen 
et al., 2016; Hogg et al. 2014; Straub et al., 2014). A possible reason for these conflicting 
findings are due to methodological differences in the SPV protocol used. For example, 
research by Chidnok and colleagues (2013) does not support the original findings of 
Mauger and Sculthorpe (2012) that a self-paced exercise test UHVXOWVLQDKLJKHU9%c22peak 
than a sCPET protocol.  However, key differences between the protocols and instructions 
provided to participants about the final maximal stage of the test are likely to explain the 
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discrepancy in the findings. Specifically, Chidnok et al., (2013) asked participants to 
interpret RPE 20 as the highest work rate that they could sustain for the duration of the 
final stage, whereas Mauger and Sculthorpe (2012) asked individuals to rate their 
maximal effort on a moment to moment basis. The subtle differences in test protocol 
instructions are borne out by PO profiles from the two studies. IQ &KLGQRN¶V VWXG\
participants maintained a fairly even PO during the final stage of the test, dropping by 
less than 20W in the entire 2 min stage (Chidnok et al., 2013). By contrast, Mauger and 
Sculthorpe (2012) demonstrated a drop in PO of more than 70 W in the final stage, 
indicating that their participants used an all-out pacing strategy, rather than an a more 
evenly paced effort as evident in ChidQRN¶Vstudy. Therefore, it is possible that the lack 
of difference between SPV and sCPET SURWRFROVLQ&KLGQRN¶Vstudy is likely due to the 
participants not exerting themselves to an RPE 20 on a moment to moment basis. Similar 
reasoning could also be used to explain a lack of differences between SPV and traditional 
protocols in the studies of Straub et al. (2014) and Hansen et al. (2016), although this 
cannot be confirmed as they did not provide the PO profile for the final stage in their 
manuscripts, or state how they described the final stage to their participants. 
 
Mauger et al., (2013) propose that the all-out effort produced at the start of the final RPE 
20 stage, with a subsequent drop off in POFRXOGEHWKHUHDVRQIRUWKHKLJKHU9%c22peak 
attainment in the SPV compared to a traditional ramp or step protocol. Specifically, 
Mauger et al. (2013) state that the large increase in PO at the start of the stage significantly 
increases the oxygen demand of the working muscles, with the subsequent reduction in 
PO creating the optimal physiological conditions to meet this demand. This theory can be 
supported by recent findings demonstrating that during a high intensity work bout where 
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VO2peak is obtained, a subsequent reduction in work rate FDQVWLOOFDSDEOHRIPDLQWDLQLQJ
9%c22 at the 9%c22peak (Billat, Petot, Karp, Sarre, Morton et al., 2013).  
 
Interestingly, Straub et al., (2014) identified a significantly higher 9%cO2peak in their 
SDUWLFLSDQW¶V preferred test protocol, being either the SPV or traditional test, with there 
being a 4% higher 9%cO2peak being achieved in comparison to their non-preferred test. 
Although, the authors acknowledge that this difference may be due the participants stating 
their preferred test as the one that they perceived they did better in, or the test they felt 
less mentally or physically fatigued on the day of the test. They also recognised that the 
4% higher 9%cO2peak may not actually be physiologically meaningful, as this 4% increase 
in 9%cO2peak (140 mL·min-1) was less than the smallest measureable difference of 180 
mL·min-1 and only slightly higher than the measurement error of 130 mL·min-1 for the 
self-paced protocol. Nonetheless, Straub et al., (2014) concluded that having an 
alternative option and the choice between protocols may act as advantageous to both the 
individual being tested and the person conducting the test. These findings were also 
replicated in the study by Hanson, Scheadler, Lee, Neuenfeldt, Michael et al., (2016)ZKR
IRXQG WKDWRI WKHLUSDUWLFLSDQWVDFKLHYHG WKHLUKLJKHVW9%c22 in their preferred test. 
Choosing the most appropriate test on an individual basis may help optimize the results 
(as shown in the study by Straub et al., 2014 and Hanson et al., 2016), it may improve 
adherence if repeated/follow up tests are needed, and it may also improve the general 
feelings towards maximal exercise testing (Straub et al., 2014). Although, it must be 
acknowledged that having a choice between protocols could be problematic for research 





Research has also demonstrated the use of submaximal RPE clamped protocols in the 
attempt to predict 9%cO2peak in cycling (Eston, Lambrick, Sheppard & Parfitt 2008; Eston, 
Faulker, Mason & Parfitt 2006; Eston, Lamb, Parfitt & King 2005; Faulkner & Eston 
2007), running (Eston, Evans, Faulkner, Lambrick, Al-Rahamneh et al., 2012; Evans, 
Parfitt & Eston 2013; Morris, Lamb, Hayton, Cotterrell & Buckley 2010; Smith, Eston, 
Norton & Parfitt 2015), and even arm ergometery (Al-Rahamneh & Eston 2011c). The 
above studies used a protocol similar to Mauger and Sculthorpe (2012), although in these 
studies stages started at a lower RPE (9) and ended at either 15 or 17 on the scale, with 
each stage lasting between 2-4 min. Coquart, Tabben, Farooq, Tourny and Eston (2016) 
completed a meta-analysis on the 10 studies cited above which had looked at the 
predictive ability of determining 9%cO2peak from a submaximal RPE clamped protocol. It 
was concluded that 9%cO2peak can adequately be predicted in various populations (i.e. 
young, old, active, and sedentary) when using the linear relationship of RPE (9-15) and 
9%cO2 (Coquart et al., 2016). In addition to the above studies, the ability of submaximal 
RPE values to predict 9%cO2peak in paraplegic and poliomyelitis participants has also been 
tested (Al-Rahamneh & Eston 2011a; Al-Rahamneh & Eston 2011b; Al-Rahamneh, 
Faulkner, Byrne & Eston 2011). Results from these studies suggested that for those higher 
RPE values (15 and 17), there is acceptable predictability of 9%cO2peak (Al-Rahamneh & 
Eston 2011a; Al-Rahamneh & Eston 2011b). Although one study concluded that there is 
considerable variability in the consistency when predicting 9%cO2peak (Al-Rahamneh, 
Faulkner, Byrne & Eston 2011). Submaximal exercise testing has been suggested to be 
advantageous particularly as the risk of an adverse event is reduced, also these tests do 
not require high amounts of motivation (Coquart et al., 2016). It is reassuring to see that 
this type of exercise testing can also be used in the form of a submaximal protocol, 
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although there are obvious disadvantages to measuring 9%cO2peak indirectly, with direct 
assessment being considered the most accurate way to determine exercise capacity 
(Beekley, Brechue, Dehoyos, Garzarella, Werber-Zion et al., 2004). Additionally the 
submaximal RPE clamped protocol has not been tested on any other clinical population, 
and it is evident that the physiological responses to exercise can differ depending on 
disease state (Palange et al., 2007), so it is unclear as to whether you could accurately 
predict 9%cO2peak in other patient populations.  
 
7KHSK\VLRORJLFDOUHVSRQVHVWRWKH639DQGZK\DKLJKHU9%c22peak is achievable is still 
unclear. One study investigated the 4%c response to the SPV in comparison to a sCPET 
protocol, in the attempt to identify the undeUOLQLQJPHFKDQLVPV$VWRULQRHWDO
$VWRULQRHWDOFRQFOXGHGWKDWWKHKLJKHU9%c22peak values achieved in the SPV was 
a result of a greater oxygen delivery available, which is evident from the higher maximal 
4%c and HR achieved in the SPV vs. a sCPET. $GGLWLRQDOO\DFKDQJHLQR[\JHQH[WUDFWLRQ
DW WKHZRUNLQJPXVFOHVKDVDOVREHHQVXJJHVWHG WREHWKHPDLQFDXVHRIWKHLQFUHDVHG
9%c22peak seen in the SPV (Mauger et al., 2013). This hypothesis was based on their 
participants achieving a lower peak HR in the SPV and theUHEHLQJQRGLIIHUHQFHVLQ9%cE 
(Mauger et al., 2013). These findings would suggest that oxygen intake and delivery is 
not in fact enhanced by the SPV, which goes against those findings by Astorino et al., 
(2015). Although, no study KDVORRNHGLQWRWKHSK\VLRORJLFDOUHVSRQVHWRWKH639DWD
PXVFXODUOHYHOWRFRQILUPWKLVWKHUHIRUHIXUWKHUUHVHDUFKLVQHHGHGWRIXOO\XQGHUVWDQGWKH
SK\VLRORJLFDOPHFKDQLVPVEHKLQGWKH639VRZHFDQJDLQPRUHRIDQXQGHUVWDQGLQJDV




In the studies mentioned in this review the primary focus was the validity of determining 
9%cO2peak. There is limited evidence to show that this protocol has the capability to reliably 
determine other important variables such as AT, which as previously mentioned, has 
become a vital measure in clinical CPET. The SPV has also only been tested on younger, 
healthy populations so it is unclear as to whether it can be effectively used in an older and 
clinical population. Finally, it is unclear if the SPV can be effectively used as a diagnostic 
and prognostic tool to aid important clinical decisions, like the sCPET protocol has been 
shown to do (Balady et al., 2010; Palange et al., 2007). Therefore, further research is 
necessary in order to determine if the SPV can be used to the same effect and extent as a 
sCPET.  
 
Overall the SPV protocol has, on a number of occasions, been demonstrated to provide 
higher (Mauger & Sculthorpe 2012, Mauger et al., 2013)RUDWOHDVWVLPLODU9%cO2peak values 
(Chidnok et al., 2013; Straub et al., 2014), when compared to a sCPET protocol, and 
should be considered as a viable alternative. The nature in which the SPV is conducted 
could be deemed as advantageous, especially in a clinical setting. Specifically, the SPV 
may be a more µSDWLHQW-IULHQGO\¶ test, primarily as a result of the self-administered work 
rates with individuals having control over their own exercise intensity. The fixed test 
duration may also enable patients to provide a true maximal effort during the final stage 
of the SPV. In this regard, knowing the test will soon come to an end may make any 
muscular discomfort they are experiencing more tolerable. In addition, the defined test 
length (10 min) ensures that regardless of ability and fitness, and assuming the test is not 
symptom limited, all patients will be exercising for the µORRVHO\¶recommended time of 
10 min (Buchfuhrer et al., 1983). This prevents the risk of obtaining unreliable data from 
a test that does not last long enough to elicit optimal peak values (> 5 min; suggested by 
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Midgley et al., 2008). If an unreliable test data is obtained from a given protocol it 
represents a waste of valuable clinician time, effort and resources. Moreover, this would 
be problematic in some surgical pathways with strict time frames (e.g. cancer pathway), 
as there will not be enough time to repeat the test. In a more practical sense, the defined 
test length may also help to improve the general running and efficiency of a CPET clinic, 
because the length of time needed for each patient will be more consistent due to the 
defined test duration. However, it is clear that further research is necessary to determine 
if the SPV be used in clinical populations, and whether important physiological values 





Overall, the use of CPET in pre-operative assessment is a valuable method for identifying 
risk in patients going in to elective surgery. Research has demonstrated how the use of 
CPET is a reliable indicator of risk, which aids in the decision making process of surgery, 
and planning of appropriate post-operative care (ICU, HDU and ward based care). 
However, limitations are evident in the traditional incremental CPET protocol, and 
consequently questions have been asked about its¶ DELOLW\WRGHWHUPLQHDµWUXH¶reflection 
of exercise capacity. With this in mind, the self-paced protocol has been developed, and 
shown to produce higher (Mauger & Sculthorpe 2012; Mauger, Metcalfe, Taylor & Castle 
2013), or similar (Chidnok et al., 2013; Straub et al., 2014), 9%cO2peak values when 
compared to a sCPET protocol. The self-paced protocol may indeed provide patients with 
the feeling of control over their effort, and eliminates the need for practitioners to choose 
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suitable starting intensities. In this regard, the test will enable patients to provide a true 
maximal effort, as well as ensure that they exercise for the recommended duration of 10 
min. With all of these factors in mind, it is plausible to suggest that the SPV may be a 
more valid and reliable way for determining exercise capacity in clinical patients, and 
therefore in preoperative assessment. Any test which can improve the efficacy of CPET 
should be of interest, as there is now a large body of evidence showing that CPET is 
valuable in the perioperative care of patients. If the most accurate representation of a 
patients risk can be provide before surgery, then the right decisions and care can be 
assured in the attempt to minimise the risk of postoperative morbidity and mortality, and 
also ensure that the expensive and limited intensive care facilities are used for those 
patients who truly need it. To date the SPV has only been used with healthy populations, 
so it is unclear whether it will elicit the same responses in clinical patients but due to the 
potential benefits of this type of test in clinical CPET, further investigation in warranted. 
 
2.10. Thesis Aims and hypotheses 
 
The overall aim of this thesis was to assess the ability of a novel self-paced CPET to 
assess cardiopulmonary exercise fitness prior to major elective surgery and its ability to 
predict postoperative outcomes. Although before this was assessed, a greater 
understanding of the SPV was required in the attempt to support and build on the current 
body of literature. Therefore, the following chapters presents a series of studies which 
contribute to the overall aim of the thesis. The aims and hypotheses of each experimental 




1. As current literature lacked information on the reliability, the first experimental chapter 
aimed to assess the general reliability of the SPV in a healthy population (chapter 4).  
x Aim: To assess the test re-test reliability of key CPET variables obtained from 
three repeated SPVs.  
x H10: The SPV will not produce reliable values of the key exercise parameters 
when compared against previous research using sCPET protocols. 
x H11: The SPV will produce reliable values of the key exercise parameters when 
compared against previous research using sCPET protocols.  
 
 2. Due to the lack of research, a greater understanding of the physiological responses 
associated with the SPV was needed. Additionally, because the test had only previously 
been used in younger populations it was unclear as to whether or not the SPV could be 
used to the same effect in an older aged population and whether the physiological 
responses to the test would differ with age. This is particularly important as the older aged 
group is more reflective of the type of patients needing to undertake preoperative CPET, 
and so this provides a safer initial assessment of the use of the SPV before testing in a 
clinical population.  
x Aims: To assess the SPV in a middle aged to older adult healthy population, and 
to assess the physiological responses between both young and the older to 
middle aged participants. The older aged group was used to reflect the general 
age seen in preoperative CPET (chapter 5). 
x H20: The SPV will not be shown to be a valid determinate of exercise capacity in 
an older healthy population. 
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x H21: The SPV will be shown to be a valid determinate of exercise capacity in an 
older healthy population.  
x H30: The SPV will not demonstrate DKLJKHU9%c22peak in both the young and middle 
to older aged group when compared against a sCPET. 
x H317KH639ZLOOGHPRQVWUDWHDKLJKHU9%c22peak in both the young and middle to 
older aged group when compared against a sCPET. 
x H40: The SPV will not demonstrate an enhanced oxygen delivery and oxygen 
muscle extraction in both group when compared against a sCPET. 
x H41: The SPV will demonstrate an enhanced oxygen delivery and oxygen muscle 
extraction in both groups when compared against a sCPET. 
 
3. The SPV had only been tested on healthy and trained groups of individuals, therefore 
there was a lack in evidence as to whether or not the SPV could effectively be used in a 
clinical population.  
x Aim: To determine both the validity and reliability of the key exercise 
pDUDPHWHUVREWDLQHGYLDWKH639LQDµVWDEOH¶FOLQLFDOSRSXODWLRQSRVW-MI 
patients) when compared against a sCPET. 
x H50: The SPV will not be shown to be a valid and reliable determinant of exercise 
capacity in post-MI patients. 
x H51: The SPV will be shown to be a valid and reliable determinant of exercise 
capacity in post-MI patients.  
 
4. As previously discussed in the literature review, preoperative CPET is of great 
importance for assessing surgical risk. Therefore ensuring the test provides the 
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opportunity for all patients to demonstrate a true reflection of their fitness is essential, and 
with the SPV overcoming some of the drawbacks associated with sCPET methods, this 
should be at the very least considered as a means of testing. 
x Aim: To determine if the S39FDQDFFXUDWHO\DVVHVVSDWLHQW¶VSUHRSHUDWLYHILWQHVV
and whether important CPET variables obtained from the test can predict 
postoperative outcomes (LOS, 30-day morbidity and mortality), like previous 
research has shown the sCPET protocol to do.  
x H60: 7KH639SURWRFROZLOOQRWSURYLGHDQDFFXUDWHUHSUHVHQWDWLRQRIDSDWLHQW¶V
cardiovascular fitness, and therefore not be a reliable predictor of post-operative 
outcome. 
x H61: 7KH 639 SURWRFRO ZLOO SURYLGH DQ DFFXUDWH UHSUHVHQWDWLRQ RI D SDWLHQW¶V
































3.1. Ethics Approval and Recruitment 
 
All hospital based studies (Chapters 6 & 7 / studies 3 & 4) were approved by the South 
East Coast, Brighton and Sussex, National Research and Ethics Committee (see Appendix 
A for ethical approval document). All other studies (Chapters 4 & 5 / studies 1 & 2) were 
approved by the University of Kent Ethics Committee prior to the recruitment of any 
participants (see Appendix B & C for ethical approval documents). After being provided 
with all the necessary information about the experimental procedures, requirements and 
potential risks, participants provided their written consent. Prior to testing, all participants 
were required to complete a health questionnaire to ensure they were safe to exercise. For 
all clinical testing, patients deemed suitable and safe to test were referred by either 
consultants or nurses following an initial health screening. The absolute and relative 
contraindications used for the clinical based studies were those defined by Chaitman et 
al. (2007). All participants were free from cold, coughs etc., during the preceding 2 weeks. 
Participants were also encouraged not to exercise the day prior to each visits, and they 
were also asked to refrain from consuming food, caffeine or smoking 2 hours before 
testing. 
 
3.2. Experimental Procedure 
 
3.2.1. Equipment and calibration methods 
Every participant had their stature and weight measured. Throughout the duration of all 
exercise tests expired gases were measured with the use of an online breath-by-breath 
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analysis system (Cortex Metalyzer, Cortex, NL). Before each test the gas analyser was 
fully calibrated in accordance to the manufactures guidelines, using a calibration gas and 
3-litre syringe. A two-point gas calibration was completed using a measurement of 
ambient air and a measurement of standard compressed gas of 17% O2 and 5% CO2. The 
3-litre syringe (Hans Rudolph Inc. Kansas, USA) was used to calibrate the flow sensor 
and turbine, which was moved in time with a set flow rate. Heart rate was measured using 
a Polar Heart Rate Chest Strap T31 (New York, USA). When testing the clinical 
populations (study 3 & 4), on the first visit, each patient completed a resting lung function 
test in order to determine their FEV1 and FVC (MircoLab, CareFusion, Germany). 
Resting lung function was conducted in accordance to the recommendations (Miller et 
al., 2005), they were completed in a seated position and repeated at least 3 times. A 12 
lead ECG trace (Meta Control 3000), blood pressure and oxygen saturation were all also 
measured throughout the duration of all tests, this was to ensure the safety of the patient 
population.  
 
3.2.2. Self-paced 9լ O2peak Protocol (all studies) 
The test design was replicated from the initial study by Mauger and Sculthorpe (2012) on 
the self-SDFHG 9%cO2peak protocol (SPV). The test was completed on a cycle ergometer 
Wattbike, UK), the handlebars and saddle height were adjusted for participant comfort. 
The test consists of 5 × 2 minute stages, to total a test time of 10 min. For each stage the 
SDUWLFLSDQWVZHUHDEOH WRFRQWLQXRXVO\YDU\ WKHLU32EXWZLWK%RUJ¶V53(-20 scale 
(Borg, 1982) anchored to a fixed level for each stage. Prior to starting the test, all 
participants were provided with an A4 page description of the RPE scale, this description 
provided guidance and examples of using RPE scale to regulate work rate (see Appendix 
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D). Following this, participants were also given a verbal explanation where relative 
H[DPSOHVZHUHXVHGLQWKHDWWHPSWWRIDFLOLWDWHWKHLUXQGHUVWDQGLQJLH³53(VKRXOG
feel like an intensity that you could maintain for a long period of time with a small amount 
RIHIIRUWLQYROYHG´WKLVDOVRJDYHWKHPWKHRSSRUWXQLW\WRDVNTXHVWLRQVLIWKH\ZHUHVWLOO
unsure. PO adjustments were facilitated by the participants manually adjusting the cycle 
ergometer air brake in order to produce a level of resistance that allows them to match the 
target RPE required for each stage. Stage 1 (0-2 min) of the SPV was fixed at an RPE of 
11, stage 2 (2-4 min) fixed to an RPE of 13, stage 3 (4-6 min) fixed at an RPE of 15, stage 
4 (6-8 min) fixed to an RPE of 17 and stage 5 (8-10 min) fixed to an RPE of 20. 
Throughout each stage participants were continually reminded of the required RPE that 
they needed to be working at for that particular stage, the RPE scale was always in view. 
Participants were reminded to vary their PO to match the RPE for each given moment, 
rather than to pace themselves according to the projected end-point of the test. Using this 
design allows participants to vary their work rate according to the RPE required at each 
stage, but the progressive RPE clamps allowed the test to retain an incremental format. 
Changes in PO were facilitated by the patients manually adjusting the cycle ergometer air 
brake in order to produce a level of resistance that allowed them to match the target RPE 
for each stage of the SPV. Verbal encouragement was also used in the later stages of the 
test to ensure maximal effort. 
 
3.2.3. Standard CPET Protocol (study 2, 3 & 4) 
The incremental ramp protocol was used for the sCPET protocol, the test was completed 
on an electronically braked cycle ergometer (Lode Corival), the handlebars and saddle 
height were adjusted for participant comfort. The ramped design involves a continuous 
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and gradual increase in work rate (Myers, Buchanan, Walsh, Kraemer, McAuley et al., 
1991) and is a popular test used in preoperative assessment (Brutsche, Spiliopoulos, 
Bolliger, Licker, Frey et al., 2000, Brunelli, Belardinelli, Refai, Salati, Socci et al., 2009, 
Gitt, Wasserman, Kilkowski, Kleemann, Kilkowski et al., 2002, Older, Hall & Hader 
1999, Older, Smith, Courtney & Hone 1993, Walsh, Morice, Putnam, Nesbitt, McMurtrey 
et al., 1994, Wilson, Davies, Yates, Redman & Stone 2010). The sCPET protocol 
commenced with a 3-5 min baseline cycling, the intensity was dependent on the 
SDUWLFLSDQW¶V ILWQHVV IRU H[DPSOH FOLQLFDO SDWLHQWV VWDUWHG ZLWK XQORDGHG SHGDOOLQJ
whereas healthy populations either started at 20 W or 50 W. The baseline cycling was 
followed by an incremental ramp of either 5, 10, 15 or 20 W.min-1. Participants were 
instructed to cycle at the minimum of 60 rpm and were asked to maintain this cadence 
until they felt like they reached volitional exhaustion. The test was terminated when the 
participant could no longer keep above 60 rpm for more than 5 s. Participants were asked 
to rate their RPE every 1-2 min. Verbal encouragement was given in the latter stages of 
the test to ensure maximal effort.  
 
3.2.4. Physiological measures (all studies) 
For each participant 9%cO2peak (L·min-1 and ml.kg-1.min-1) was determined by the highest 
30 s average value during the entire test. The term 9%cO2peak was used as a 9%cO2 plateau was 
not determined (Milani, Lavie, Mehra & Ventura 2006). Anaerobic threshold (AT), 
determined by ventilatory measures, was determined using the V-slope method with 
confirmation of the ventilatory equivalents (9%cE/9%cO2 and 9%cE/9%cCO2) and the partial end-
tidal (PETO2 and PETCO2) methods (Hopker, Jobson & Pandit 2011). The decided AT was 
secondary checked either by a clinician or another researcher. Minute ventilation (9%cE), 
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RER and maximal cycling PO (W) were all calculated as the highest 30 second average 
value during the entire test. 
 
3.3. General Statistical Analysis 
 
3.3.1. Statistical differences analysis  
All data was analysed using IBM SPSS Statistics version 21. Descriptive data is presented 
as mean ± standard deviation (SD) throughout unless stated otherwise. Statistical 
significance was set at 95% (P < 0.05). Normality of each variable as checked through 
the Shapiro-Wilk test. Differences in CPET derived variables were assessed either using 
a paired sample T-Test (chapters 5, 6 & 7 / studies 2, 3 & 4) or, a one-way repeated 
measures analysis of variance (ANOVA) if comparisons were made with more than two 
trials (Chapter 4 / study 1). 
 
3.3.2. Reliability analysis  
Limits of agreement (Bland & Altman 1986), coefficient of variation (CV) and intraclass 
correlation coefficients (ICC) (Hopkins 2001) were calculated to assess the reliability of 
the SPV in Chapters 4 and 6 (studies 1 & 3). It has been suggested that a CV of < 5% 
(Hopkins 2000), and an ICC close to 1 both indicate good test-retest reliability (Atkinson 
& Nevill 1998)ZLWKFODVVLILFDWLRQVIRU,&&UDQJLQJIURPµTXHVWLRQDEOH¶WRWR




Chapter 4. The reliability of a self-paced 9ࡆ O2peak 
test in a healthy population 
 
Aspects of the following chapter have been included within the following manuscript: 
Jenkins LA., Mauger A., Fisher, J. and Hopker JG. (2017). Reliability and validity of a 
self-paced cardiopulmonary exercise test in post-MI patients. International Journal of 

























The SPV has been shown to produce higher 9%cO2peak values when compared to sCPET 
protocols. This study aimed to assess the reliability of the maximal exercise test 
parameters obtained from the SPV. Twenty-five (12 females, 13 males) healthy 
participants (age = 26 ± 6 yrs, weight = 68 ± 10 kg, stature = 172 ± 9 cm, BMI = 23.0) 
completed three SPV tests on three separate occasions, with at least 24 hours rest between 
each test. Results demonstrated a CV for 9%cO2peak (ml·kg-1·min-1) of 4.2% (95% 
confidence interval (CI): 3.4-5.6%) for trials 2-1, and 5.1% (95% CI: 4.2-6.8%) for trials 
3-2. Repeated measures ANOVA analysis demonstrated no significant difference in 
9%cO2peak across the repeated tests (P > 0.05). The LOA were ± 5.59 ml·kg-1·min-1 for trials 
2-1, and ± 5.86 ml·kg-1·min-1 for trials 3-2. The mean ICC was 0.95, which represents 
good reproducibility. The current study results demonstrate that the SPV is a reliable 

















The SPV has been shown to produce either the same (Chidnok et al., 2013; Straub et al., 
2014) RU KLJKHU 0DXJHU 	 6FXOWKRUSH  0DXJHU HW DO  9%c22peak values in 
comparison to traditional MIE protocols, although for it to be accepted as a viable test for 
assessing exercise capacity it must have good test-retest reliability. To date the reliability 
of the SPV has not been tested, one study did report some reliability findings that 
demonstrated the SPV to have a day-to-day variability of 3% (Straub et al., 2014), 
although this was not the main aim of the study and the variability was only assessed 
between the familiarisation trial and the main trial. Therefore, the purpose of the current 
study was to determine the test-retest reliability of maximal exercise test parameters 
obtained from the SPV.  
 
4.3. Methods  
 
4.3.1. Participants 
Twenty-five (12 females, 13 males) healthy participants (age = 26 ± 6 yrs, weight = 68 ± 
10 kg, stature = 172 ± 9 cm, BMI = 23.0) volunteered to participate in this study. Written 
informed consent was given from each participant once they had received all the required 
information.  
 
4.3.2. Experimental Procedure 
Each participant visited the exercise testing laboratory on three separate occasions to 
complete an SPV. Tests were separated by at least 24 hours to allow full recovery and 
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were completed at the same time of the day (± 2 hours). Participants were required to 
complete a 10-min warm-up at a self-selected intensity, where participants were also 
familiarised with the process of freely adjusting their PO on the cycle ergometer 
(Wattbike Pro, UK).  
 
4.3.3. SPV protocol 
For each visit participants were asked to complete an SPV, which was described in the 
general methods chapter (Chapter 3).  
 
4.3.4. Physiological Measures 
Expired gases (9%cO2, 9%cCO2, 9%cE), HR and PO were continuously recorded for the duration 
of all three tests. The anaerobic threshold (AT) was determined using the methods stated 
in Chapter 3, all AT were secondary checked by an additional researcher.  
 
4.3.5. Statistical analysis 
Differences in 9%cO2peak, maximal 30 second PO, AT, HR and 9%cE were all assessed using 
one-way repeated measures ANOVA. LOA (Bland & Altman 1986), CV and ICC 
(Hopkins 2001) were calculated to assess the reliability of SPV across the three repeated 
tests.  
 
4.4. Results  
 
The mean and SD of the physiological variables recorded over the three repeated SPVs 
are displayed in table 4.1. When separating the data into gender groups there were no -
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significant differences in 9%cO2peak, AT, HR, 9%cE and PO between the three repeated SPV 
tests in both males and females (P > 0.05).  
 
4.4.1. 9լ O2peak (ml·kg-1·min-1) 
There was a mean group typical error, expressed as a CV, of 4.2% (95% CI: 3.4-5.6%) 
for trials 2-1 and 5.1% (95% CI: 4.2-6.8%) for trials 3-2. The total mean CV for all three 
tests was 4.7% (95% CI: 3.8-6.2%). A high level of agreement was found between trials 
2-1 (ICC = 0.95) and trials 3-2 (ICC = 0.94). The LOA were ± 5.59 ml·kg-1·min-1 for 
trials 2-1 and ± 5.86 ml·kg-1·min-1 for trials 3-2 (Figure 4.1). A repeated measures 
ANOVA demonstrated WKDW9%cO2peak was not significantly different across each trial (F (2, 
48) = 0.849, p= 0.43). When separating the data based on gender, the results demonstrated 
that for the male group the mean CV was 4.5% (95% CI: 3.4-6.8%) and the ICC was 0.95. 
For the female group the CV was 5.0% (95% CI: 3.7-7.9%) and the ICC was 0.85. 
 
Table 4.1: Peak values for physiological variables recorded during repeated SPV tests in 
the healthy population. 
  SPV1 SPV2 SPV3 
9ࡆ 22peak (L·min-1)  3.30 ± 0.86 3.23 ± 0.90 3.25 ± 0.92 
9ࡆ 22peak (ml·kg-1·min-1) 48.56 ± 8.93 47.87 ± 9.28 47.85 ± 9.40 
AT (ml·kg-1·min-1) 27.00 ± 6.83 26.67 ± 7.26 26.95 ± 7.34 
HR (bpm) 184 ± 10 183 ± 11 182 ± 11 
9ࡆ E (L·min-1) 137.8 ± 38.9 133.3 ± 41.0 128.4 ± 39.1* 
Peak PO (W) 312 ± 93 299 ± 109 304 ± 101 





Figure 4.%ODQG$OWPDQSORWVRI9%c22peak (ml·kg-1·min-1) differences between trials 1 
and 2 (left) and 2 and 3 (right). The solid horizontal line represents mean difference, 
whilst the dashed lines represent the 95% limits of agreement. 
 
4.4.2. Anaerobic Threshold (AT) 
The 9%cO2 (ml·kg-1·min-1) at the anaerobic threshold was assessed. Data demonstrated 
there was a mean CV of 5.2% (95% CL: 4.2-6.9%) for trials 2-1 and a mean CV of 5.8% 
(95% CL: 4.7-7.7%) for trials 3-2. The ICC was 0.96 for trials 2-1 and trials 3-2 which 
represents a high level of agreement. The limits of agreement were ± 3.99 ml·kg-1·min-1 
for the measure of trials 2-1 and ± 4.57 ml·kg-1·min-1 for the measure of trials 3-2 (figure 
4.2). A repeated measures ANOVA demonstrated that AT in ml·kg-1·min-1 was not 
significantly different between each trial (F (2, 48) = 0.328, p= 0.72). When separating 
the data based on gender, the results demonstrated that for the male group the mean CV 
was 7.4% (95% CI: 5.6-11.4%) and the ICC was 0.95. For the female group the CV was 





Figure 4.2: Bland-Altman plots of the AT (ml·kg-1·min-1) differences between trials 1 and 
2 (left) and 2 and 3 (right). The solid horizontal line represents mean difference, whilst 
the dashed lines represent the 95% limits of agreement. 
  
4.4.3. HR, VլE and RER 
For HR there was a CV of 1.7% (95% CL: 1.4-2.3%) and an ICC of 0.93. For 9%cE, the CV 
was 7.2% (95% CL: 5.8-9.6%) with an ICC of 0.95, and for RER the CV was 3.1% (95% 
CL: 2.5-4.1%) with an ICC of 0.82. When separating the data based on gender, tKHUHVXOWV
GHPRQVWUDWHGWKDWIRU+5LQWKHPDOHJURXSWKHPHDQ&9ZDV&,
DQGWKH,&&ZDV)RUWKHIHPDOHJURXSWKH&9ZDV&,DQG
WKH,&&ZDV)RU9%cE in the male group the CV was 6.3% (95% CI: 4.8-9.7%) with 
an ICC of 0.94, and for the female group the CV was 8.4% (95% CI: 6.2-13.3%) with an 
ICC of 0.85.  
 
4.4.4. Power Output  
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There was a mean group typical error expressed as a CV of 8.9% (95% CL: 7.1-11.9%) 
for trials 2-1 and 6.8% (95% CL: 5.5-9.2%) for trials 3-2. The ICC was 0.94 for trials 2-
1 and 0.97 for trials 3-2, representing a high level of agreement. The limits of agreement 
were + 81 W for the measure of trials 2-1 and ± 51 W for the measure of trials 3-2 (Figure 
4.3). When separating the data based on gender, the results demonstrated that for the male 
group the mean CV was 8.8% (95% CI: 6.6-13.8%) and the ICC was 0.88. For the female 
group the CV was 6.4% (95% CI: 4.7-10%) and the ICC was 0.94. Figure 4.4 represents 
the average PO throughout the duration of the test for the three trials. Although peak PO 
was significanlty different across the three repeated trials, the overall patterns of response 




Figure 4.3: Bland-Altman plots of the PO (W) differences between trials 1 and 2 (left) 
and 2 and 3 (right). The solid horizontal line represents mean difference, whilst the dashed 





Figure 4.4: Mean PO for every 30 secs for the duration of the test for all three repeated 
tests.  
 
4.5. Discussion  
 
The results of the current study demonstrate that the 9%cO2peak values obtained via the use 
of the SPV protocol are reliable. The mean CV of 4.7% for 9%cO2peak (ml·kg-1·min-1) is 
lower than the accepted upper limit of 5% suggested by Hopkins (Hopkins 2000). The 
limits of agreement analysis suggest that there is 95% probability that test-retest 
differences, would at worst lie between ± 5.73 ml·kg-1·min-1. Furthermore, repeated 
measures ANOVA found no significant differences in 9%cO2peak across the repeated trials 




An interesting finding was that the CV in 9%cO2peak increased from trials 2-1 to trials 3-2, 
this would suggest WKDWWKHUHZDVQRµOHDUQLQJHIIHFW¶UHODWHGWRWKH639SURWRFRO%DVHG
on these findings the SPV is considered to be a reliable test for 9%cO2peak. However, it is 
interesting that the highest 9%c22peak, HR, 9%cE and PO were obtained in the first SPV 
compared to the following two. This may be a result of potential behavioural changes that 
may negatively influence the results, individuals may change pacing strategy to avoid the 
high levels of discomfort they experienced in first test. Figure 4.4 supports this suggestion 
as PO appears to be higher throughout the final two stages, with a larger reduction in PO 
during the final stage of SPV1 (102 W), compared to SPV2 (60 W) and SPV3 (61 W). 
This would suggest that for optimal results, just one SPV test is needed and that a 
familiarisation session may negatively affect the result. Interestingly, previous studies 
reporting VLJQLILFDQWO\ KLJKHU 9%c22peak values in SPV protocols (Astorino et al., 2015; 
Faulkner et al., 2015; Mauger et al., 2013; Mauger & Sculthorpe 2012) do not report that 
a familiarisation was used. In contrast some of the studies that failed to find differenFHV
LQ9%c22peak between SPV and traditional protocols (Chidnok et al., 2013; Straub et al., 
2013) did incorporate a familiarisation session into their study design.  
 
Previous literature has demonstrated the reproducibility of maximal exercise parameters 
when using standard MIE protocols. Mauger et al. (2013) most recently presented data 
on a subset of participants that they used to determine the test-retest reliability of a MIE 
protocol. They discovered a low CV of 3.7% for 9%cO2peak. Froelicher et al. (1974) found 
that for three maximal treadmill exercise protocols, the Bruce, Balke and Taylor protocol, 
the CV for 9%cO2peak ranged from 4.1-5.8%. A succession of MIE tests have also been 
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completed on patients with cardiac failure in order to determine long-term reproducibility 
of gas exchange measurements during maximal exercise, with the average CV for 9%cO2peak 
being 5.7% (Janicki, Gupta, Ferris & McElroy 1990). Some studies have also considered 
the reproducibility of a cycling MIE test in patients with various respiratory conditions, 
where the coefficient of variation ranged from 3.5-6.9% (Cox, Hendrink, Binkhorst, 
Folgering & van Herwaarden 1989; Marciniuk, Watts & Gallagher 1993; McKone, Barry, 
FitzGerald & Gallagher 1999). It was concluded that all of these tests had good test-retest 
reliability. Whether the SPV would demonstrate similar level of test-retest reliability in 
clinical patients is yet to be investigated.  
 
In addition, one study had already investigated the reliability of the physiological 
variables obtained from the SPV (Straub et al., 2014), although this was not the main aim 
of their study. Straub and colleagues (2014) wanted to determine the efficacy of the SPV 
in comparison to a standard ramp test in trained cyclists, but as each participant completed 
both test twice, the first of each test being a familiarisation trial, they also reported some 
reliability findings. They concluded the SPV to have similar day-to-day variability (CV 
= 3%) as the ramp test (CV = 4%), and suggested that no familiarisation session is needed 
to obtain valid test results. These findings are similar to that of the current study. 
 
The intraclass correlation coefficient (ICC) is an increasingly popular method used for 
reliability studies, and it is suggested that an ICC close to 1 indicates excellent reliability 
(Atkinson & Nevill 1998). In the current study, the ICC for 9%cO2peak in trials 2-1 was 0.95 
and 0.94 for trials 3-2, suggesting very good reproducibility. Previous research has 
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demonstrated similar ICC of 0.93 for 9%cO2peak when determining test-retest reliability on 
cycling maximal incremental exercise tests (Eng, Dawson & Chu 2004).  
 
Even though there was high variance in peak PO across the repeated trials in the current 
study, individual participant PO profiles demonstrated a relatively similar pacing profile 
across the three tests (see figure 4.4). Indeed, previous research has demonstrated that 
pacing strategies in self-paced cycling time trials are broadly similar (Albertus, Tucker, 
Gibson, Lambert, Hampson et al., 2005; Thomas, Stone, Thompson, Gibson & Ansley 
2012), although with a higher degree of variability at the start and the end of trials 
(Thomas et al., 2012). The findings of this study demonstrate that irrespective of the self-
paced nature of the SPV, participants generally showed consistency in the way that they 
performed the test. Differences between trials seemed to lie at the end of the test where 
potentially, as previously mentioned, behavioural changes may have influenced the 
variation. Interestingly, the CV for peak PO decreased from trials 2-1 (8.9%) to trials 3-
2 (6.8%), with peak PO being highest in SPV1. However, it is interesting to see that this 
high variability in PO seems to have very little effect on the variability RI9%c22peak between 
the repeated tests; 4.2% (95% CI: 3.4-5.6%) for trials 2-1 and 5.1% (95% CI: 4.2-6.8%) 
for trials 3-2.  
 
An unexpected finding was the significant differences in 9%cE (P < 0.05) between repeated 
tests, with pairwise comparison demonstrating that the main difference was between 
SPV1 and SPV3, with 9%cE being significantly lower in SPV3. This variability in 9%cE may 
explain some of the discrepancy of the findings in 9%cE between the previous studies using 
the SPV (Chidnok et al., 2013; Mauger & Sculthorpe 2012; Mauger et al., 2013; Straub 
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et al., 2014). Mauger et al., (2013) recently stated that because HR was significantly lower 
in the SPV and there were no changes in 9%cE, this indicates that oxygen intake and delivery 
were not enhanced during the SPV and that the higher peak 9%cO2 was likely to be due to 
a change in oxygen extraction at the working muscles. The observation in the current 
study that 9%cE differed across repeated tests, yet 9%cO2peak remained unchanged, suggests 
that the mechanisms underpinning 9%cO2peak in this protocol are multifactorial, and may 
occur at any point down the oxygen cascade.  Further research is essential in order to fully 
understand the mechanisms behind the SPV protocol and why participants are able to 
achieve a higher 9%cO2peak in some studies (Mauger & Sculthorpe 2012; Mauger et al., 
2013). 
 
4.6. Conclusion  
 
The results of the current study demonstrate that the SPV is a reliable method for 
determining exercise capacity in healthy populations; therefore, the null hypothesis (H10) 
stated in chapter 2.10 can be rejected. Combined with earlier studies, this work suggests 
that the SPV is a valid and reliable measure of 9%cO2peak in healthy populations, and should 
be considered as an accepted means of testing for maximal oxygen uptake. Finally, these 
findings demonstrate that well-instructed participants, who are familiarised with the RPE 
scale and ergometer work rate changes, do not require an SPV familiarisation bout for 





What is already known about this topic 
 
x There are problems associated with sCPET methods, the SPV was 
produced to overcome some of these. Previous research has 
demonstrated the SPV to be a valid test of exercise capacity, with 
some studies showing it to produce higher sȩK2peak values. No 
studies had looked the reliability of the SPV. 
 
What this study adds 
 
x This study shows that the SPV is a reliable test for ĚĞƚĞƌŵŝŶŝŶŐ
sȩK2peak in a healthy population. Other important CPET variables 
such as AT via gas exchange can be determined from the SPV, with 












Chapter 5. Differences in the physiological 
responses between a self-paced and a standard 
incremental ramp 9ࡆ O2peak test 
 
Aspects of the following chapter have been included within the following manuscript, 
Jenkins, L.A., Mauger, A.R. & Hopker, J.G. (2016). Age differences in physiological 
responses to self-paced and incremental VO2max testing. European Journal of 























A self-paced maximal exercise protocol has demonstrated higher 9%cO2peak values when 
compared against traditional tests. The aim of the study was to assess the physiological 
response to the SPV protocol in comparison to a sCPET in young adults and middle aged 
to older adults. Forty-four participants (22 = 18-30 yrs; 22 = 50-75 yrs) completed both 
tests in a randomised, counter-balanced, crossover design. The SPV included 5 × 2 minute 
stages where participants were able to self-regulate their PO by using incremental 
µFODPSV¶LQRPE. The sCPET consisted of either a 15 or 20 W min-1 ramp, depending on 
training status. Expired gases, Q, SV, muscular deoxyhaemoglobin (deoxyHb) and 
electromyography (EMG) at the vastus lateralis (VL) were recorded throughout. Results 
demonstrated a significantly higher 9%cO2peak in the SPV ( ml·kg-1·min-1) vs. 
the sCPET ( ml·kg-1·min-1) in the young, but no differences in the middle to 
older aged group (P > 0.05). Q and SV were significantly higher in the SPV vs. the sCPET 
in the young (P < 0.05) but no differences in the middle to older aged group (P > 0.05). 
No differences were seen in both age groups in the deoxyHb and EMG response (P > 
0.05). FLQGLQJVVXJJHVWWKDWLQWKH\RXQJJURXSWKH639SURGXFHVKLJKHU9%c22peak values 
as a result of an increase in oxygen delivery (enhanced Q). However, likely due to age-
related differences, particularly in the cardiovascular response to exercise, the middle to 
older aged participants achieved VLPLODU9%c22peak values regardless of them reaching a 








The SPV has been shown to allow young participants to achieve a higher 9%c22peak when 
compared against a standard incremental exercise test in both cycling and running 
exercise (Mauger & Sculthorpe 2012; Mauger et al., 2013). Although, not all studies have 
found differences in 9%cO2peak when comparing the SPV vs. standard exercise protocols 
(Chidnok et al., 2013; Faulkner et al., 2015; Straub et al., 2014), but for those studies who 
have found differences (Astorino et al., 2015; Mauger & Sculthorpe 2012; Mauger et al., 
2013) a mechanistic explanation is yet to be identified.  
 
Maximal oxygen consumption is suggested to be limited by factors such as: pulmonary 
diffusion capacity, maximal cardiac output, oxygen carrying capacity of the blood, or 
skeletal muscle characteristics (Bassett & Howley 2000). Mauger et al. (2013) suggested 
that a higher 9%cO2peak may be achieved during an SPV protocol due to changes in oxygen 
extraction at the working muscles, rather than any increase in oxygen delivery. The 
authors based this hypothesis on the observation that participants achieved a lower HR in 
the SPV without differences in peak 9%cE; they suggested that if the higher 9%cO2peak were a 
result of an increase in the oxygen delivery it would be expected that both HR and VE 
would be increased by the SPV (Mauger & Sculthorpe 2012; Mauger et al., 2013). 
Although it is also possible that increases in SV, which was not measured in either study 
(Mauger & Sculthorpe 2012; Mauger et al., 2013), may have compensated for the lower 
HR achieved which would mean an increase in oxygen delivery and thus 9%cO2peak (Bassett 
& Howley 2000). Nevertheless an increased oxygen extraction in the SPV may still arise 
from the participant being able to adjust work rate, potentially creating optimal conditions 
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that allow enhanced rates of muscle oxygen extraction and allows higher work rates to be 
achieved. Indeed, previous research demonstrates that muscle blood flow, and thus 
oxygen extraction, is reduced when both muscle force and duration of contractions 
increase (Bjorklund, Stoggl & Holmberg 2010, Hoelting, Scheuermann & Bartow 2001). 
Research has also suggested that decreased blood transit time is associated with reduced 
rates of oxygen extraction (Bassett & Howley 2000; Kalliokoski, Oikonen, Takala, Sipila, 
Knuuti et al., 2001). In traditional tests, this continuous increase in force and consistent 
duration of each contraction cannot be adjusted, this may therefore result in a constriction 
in the amount of blood flow available at the muscle and reduced time for extraction to 
take place. Both force and duration of muscle contractions are free to vary by the 
participant in the SPV, which may contribute in optimising the muscle blood flow at the 
working muscles. Additionally, it has been suggested that the self-regulation of work rate 
during the SPV may improve the efficiency of muscle recruitment, i.e. affording greater 
reliance on more oxygen efficient muscle fibres (Type I) particularly in the earlier stages 
(Mauger & Sculthorpe 2012; Mauger et al., 2013). This self-regulation may help to 
conserve more Type II fibres for the final stage (RPE 20) which ultimately allows high 
work rates to be achieved. Although this is very speculative with no evidence to support 
this concept.  
 
A more recent study has demonstrated that the SPV may elicit a greater Q and peak HR 
when compared against a standard incremental ramp protocol (Astorino, McMillan, 
Edmunds & Sanchez 2015). This was the first study to assess 4%c and suggests that the 
higher 9%cO2peak may be explained by an increase in oxygen delivery (Mortensen, Dawson, 
Yoshiga, Dalsgaard, Damsgaard et al., 2005), rather than an increase in the oxygen 
extraction as previously suggested. Astorino and colleagues (2015) suggested the increase 
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in Q during the SPV protocol is likely the result of participants adequately pacing their 
effort to minimise fatigue in the early stages of the test. This leads to a greater work rate 
being achieved in the final stage of the SPV, potentially because they have preserved the 
use of type II fibres in the earlier stages, resulting in a greater HR, Q and 9%cO2peak.  
 
In a clinical setting, those patients who require preoperative CPET are generally middle 
aged to older adults. It is well accepted that there is a decline in 9%cO2peak with aging, this 
is suggested to be predominantly the result of reductions in maximal Q and muscle blood 
flow (Betik & Hepple 2008). Cardiac function (Lakatta & Levy 2003), lung performance 
(Chaunchaiyakul, Groeller, Clarke & Taylor 2004; Janssens, Pache & Nicod 1999) and 
muscle oxidative capacity (Betik & Hepple 2008; Russ & Kent-Braun 2004) have all been 
shown to reduce with age, which contribute to the deterioration in 9%cO2peak. 7KLV
GHWHULRUDWLRQLQ9%c22peak will be more pronounced in those patient groups where cardiac 
and respiratory function is further reduced. Therefore, the limiting factors to 9%cO2peak may 
differ between young and older populations. Consequently, selecting a protocol which 
adequately stresses the limiting physiological system may be an important decision when 
testing different age groups. Indeed, a previous study has demonstrated that the SPV 
producesKLJKHU4DQG9%c22peak values vs. traditional methods (Astorino et al., 2015). It 
could therefore be speculated that a self-paced exercise test provides a better assessment 
of the cardiorespiratory system, which may be particularly beneficial in those patient 
groups where cardiac function is already limited. Furthermore, examining the 
cardiopulmonary and muscular response to an SPV (compared with a standard test), may 
help explain why a higher 9%cO2peak is often seen from this test. Therefore, the aim of the 
current study was to assess the physiological responses to the SPV in comparison to a 
sCPET in healthy younger adults (18-30) and middle aged to older adults (50-75), and to 
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objectively test whether responses differ between the two groups. The ages chosen for the 
middle to older adult group were selected to reflect the age of typical patient groups 





Forty-four male and female healthy participants, comprising of twenty two 18-30 year 
olds (age = 25 ± 4 years; stature = 174 ± 11 cm; weight = 69 ± 9 kg, BMI = 22.8) and 
twenty two 50-75 year olds (age = 59 ± 6 years; stature = 171 ± 8 cm; weight = 73 ± 13 
kg, BMI = 25.0), volunteered to take part in the current study. All participants were 
apparently healthy, free of disease, free of any risk factors associated with cardiovascular 
disease and were all physically active (> 90 min of moderate activity per week). This 
information was obtained via a health questionnaire. For the middle aged to older adult 
participants a resting blood pressure measurement was taken on their first visit to ensure 
they were not hypertensive. All participants who volunteered gave their written informed 
consent.  
 
5.3.2. Experimental procedure 
Each participant visited the laboratory on two separate occasions, where they were asked 
to complete either an SPV, or a traditional ramp 9%cO2peak  test in a randomised order and 
counter-balanced, crossover design. Tests were separated by at least 24 hours to allow 
full recovery and were completed at the same time of the day (± 2 hours). Participants 
were asked to refrain from drinking alcohol (24 h abstinence), eating (2 h abstinence), 
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and not to perform any exercise in the 24 h prior to each test. Prior to each test participants 
were required to complete a 5 minute warm-up at approximately 50W. In the SPV 
condition during the warm-up, participants were familiarised with the process of freely 
adjusting their PO, this could be achieved by participants making adjustments in both the 
resistance and/or cadence on the cycle ergometer.  
 
SPV protocol 
The SPV was completed on an air-braked cycle ergometer (Wattbike Ltd, Nottingham, 
UK), which allowed participants to continually vary their PO throughout the test. The 
SPV was conducted in accordance with the procedures previously outlined in the general 
methods chapter (Chapter 3). Participants were able to view their cadence and PO 
throughout the test, they also received feedback on elapsed time particularly when 
approaching the end of a stage.  
  
RAMP protocol 
The sCPET was completed on an electro-magnetically braked cycle ergometer (Corival, 
Lode, Groningen, Netherlands), so that for each stage PO could be fixed according to the 
test requirements. The test followed a standard incremental ramp design. The cycle 
ergometer was set in hyperbolic mode to ensure that any changes in cadence did not 
influence PO. Participants were instructed to keep their cadence above 60 rev.min-1. The 
ramp commenced with a 3 minute period of baseline cycling where a various range of 
work rate starting points were selected for each participant (20, 50 and 100 W), according 
to self-reported fitness levels. This 3 min period was then followed by ramp increments 
of either 15 or 20 W min-1. The starting point and the rate of increase in work rate was 
selected on an individual basis in the attempt to optimise the protocol for each participant. 
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The test was stopped when the participant could no longer continue or if they were unable 
to maintain a cadence of more than 60 rev.min-1, despite verbal encouragement.  
 
5.3.3. Physiological measures 
Expired gases 
Expired gases, HR and PO were measured throughout both tests. 9%cO2peak and AT were 
determined using the those methods stated in Chapter 3. 
 
Near-Infrared Spectroscopy  
Muscle deoxyhaemoglobin (deoxyHb) was measured using a Near-Infrared Spectroscopy 
(NIRS) device (Portamon, Artinis Medical Systems, Elst, Netherlands). The device uses 
small skin surface lasers to measure light absorbance, operating at wavelengths between 
760 and 850 nm with an average optode distance of 35 mm and a sampling rate of 10 Hz. 
The device was placed longitudinally on the VL of the left leg, and was situated 10 cm 
above the patella (Wang, Xu, Tian, Sun, Sun et al., 2012). Before placement of the NIRS 
device, the NIRS system was calibrated and the skin was carefully shaved. The device 
was secured to the site using adhesive tape, which covered the whole device to reduce 
light loss.  Afterwards, the deoxyHb data were exported into 1 s values and then averaged 
into 30 s at 10 time points over both tests. A baseline deoxyHb from the NIRS was 
averaged from the final 30 s of the first stage, and the peak was determined from the 
average of the final 15 s of each test. The deoxyHb for each time point was then 
normalized to the total amplitude of response (peak ± baseline) (Boone, Koppo, Bartow 






Surface EMG was recorded using a wireless BioPac MP150 (Biopac Sytems Inc, CA, 
USA), two surface electrodes were placed on the VL of the right leg and a reference 
electrode was placed on the patella of the same leg. The skin was prepared by carefully 
shaving and cleaning the area with skin preparation alcohol wipes. EMG was recorded at 
a sampling frequency of 1000 Hz. Prior to each maximal test, participants performed three 
maximal isometric voluntary contractions (MIVC) of the VL muscle in order to determine 
the EMG signal at maximal contraction. The MIVCs were completed on a Cybex 
Isokinetic Dynamometer (HUMAC Norm, CSMi, Stoughton, MA, USA). Before the 
MIVCs a series of submaximal contractions were completed as a preparatory warm-up. 
Each MIVC lasted 5 s, with 1 min rest between each. Participants were also required to 
complete one MIVC directly after both maximal tests to determine the level of muscle 
fatigue, this occurred 1 min after the test or as close to 1 min as possible; depending on 
how quickly the participant was safely able to move off the bike and onto the 
dynamometer. The time was kept consistent between tests for each individual. Maximum 
EMG was calculated by averaging the highest 1 s EMG value from each MIVC trial. The 
30 s average EMG signals from each stage of the SPV and sCPET was then normalized 
to the maximum EMG from the MIVC. Data were plotted as a function of %TTE from 
each maximal test. It was decided to include the whole 30 s of the EMG signal within the 
average, thus the inactive periods were included. The authors are aware that including the 
inactive periods between each contraction may been seen as a limitation, as variations in 
cadence would influence the average of EMG (e.g. higher cadence would results in a 
higher EMG average), although for the nature of the study it was felt that excluding the 
inactive periods would not be necessary as we purely wanted to get an idea of the overall 




Cardiac Output and Stroke Volume 
A non-invasive thoracic impedance device (PhysioFlow, Manatec Biomedical, France) 
was used to measure stoke volume (SV) and Q throughout the duration of both exercise 
tests. Electrodes were positioned in the following areas; above the supraclavicular fossa 
SDUWLFLSDQWV¶ OHIW VLGH, xiphoid process and two additional electrodes were placed to 
determine a single ECG signal at V1 and V6 positions. Prior to electrode placement, all 
skin sites were carefully cleaned, and shaved where necessary. In accordance with the 
manufacturer recommendations, the equipment was auto-calibrated prior to each test by 
establishing impedance waveforms over 30 heart beats. Peak Q and SV were determined 
by the highest 30 s average value over the entire duration of the test. A 30 s average of 
SV and Q was plotted, for every 2 min, as a function of percentage of time to exhaustion 
(%TTE) from each exercise test.  
 
Blood Lactate 
A finger-tip capillary blood sample was taken directly at the end of each test to determine 
end-exercise blood lactate concentrations (Biosen C-Line, EKF Diagnostic, London, 
UK).  
 
5.3.4. Statistical analysis 
ThePHDQPD[LPXPYDOXHVIRU9%c22peak$732+59%cE, blood lactate, Q and SV were 
all compared between the protocols using a paired sample t-test. The percentage 
difference between the pre and post MIVC (highest 1 s EMG and torque) from the SPV 
and sCPET was also compared using a paired sample t-test. Differences (P < 0.05) 
between Q, SV, deoxyHb and EMG for the last 30 s of each stage, in both the SPV and 
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sCPET test were assessed using a repeated measured ANOVA (2 x 10 for NIRS and 
EMG; 2 x 6 for Q and SV). Violation of the assumptions were assessed using the 
0DXFKO\¶VWHVWRIVSKHULFLW\LISZDV!WKHQVSKHULFLW\ZDVDVVXPHGEXWLf p was < 
0.05 then Greenhouse-Geisser corrections were used. If an interaction was present then 
pairwise comparisons with a Bonferroni correction was used to identify where the 
interaction occurred. The two defined group, 18-30 years (young) and 50-75 years 




Table 5.1 presents data fromWKHSK\VLRORJLFDOSDUDPHWHUVPHDVXUHGGXULQJWKHWZRWHVWV
IRUERWK DJHJURXSV ,Q WKH \RXQJSRSXODWLRQ WKHUHZDV D VLJQLILFDQWO\KLJKHU9%cO2SHDN
L·min-1 and ml·kg-1·min-1), peak 9%cE, peak RER, peak Q, peak SV and peak PO achieved 
in the SPV when compared to the sCPET protocol (P < 0.05). There were no differences 
in AT, peak HR, end-exercise lactate and TTE. (P > 0.05). In the middle to older aged 
population there was only significant differences in peak RER, peak PO and TTE (P < 
0.05). Figure 5.1 shows the 9%cO2 response over time, in the SPV and sCPET, of a 
representative participant from each group. These participant¶VZere selected as those 
who were representative of the mean 9%cO2peak values and the average differences between 







 Young (18-30 yrs) Middle Aged and Older Adults (50-75 yrs) 
  sCPET SPV P-Value sCPET SPV P-Value 
9ࡆ 22peak (L·min-1) 3.34 ± 0.88 3.45 ± 0.87* 0.02 2.74 ± 0.76 2.78 ± 0.74 0.79 
9ࡆ 22peak (ml·kg-1·min-1) 47.70 ± 9.98 49.68 ± 10.26* < 0.01 38.99 ± 9.54 39.12 ± 8.61 0.84 
AT (ml·kg-1·min-1) 25.36 ± 6.71 24.55 ± 5.18 0.32 21.69 ± 6.17 22.34 ± 6.36 0.23 
HR (bpm) 181 ± 10 183 ± 9 0.19 164 ± 12 164 ± 12 0.93 
9ࡆ E (L·min-1) 130.7 ± 32.9 147.7 ± 37.4* < 0.01 122.8 ± 31.4 129.4 ± 29.6 0.08 
RER 1.24 ± 0.05 1.31 ± 0.08* < 0.01 1.22 ± 0.09 1.32 ± 0.12* < 0.01 
Peak Q (L·min-1) 23.1 ± 5.5 26.7 ± 4.1* < 0.01 24.5 ± 5.1 26.0 ± 5.0 0.24 
Peak SV (ml) 132.1 ± 34.8 154.5 ± 28.7*  < 0.01 158.5 ± 29.7 167.6 ± 28.4 0.24 
End-exercise Lactate 
(mmol/L) 8.06 ± 1.74 9.52 ± 2.85 0.06 6.15 ± 1.88 7.21 ± 2.89 0.05 
Peak PO (W) 265 ± 69 336 ± 122* < 0.01 226 ± 63 245 ± 74* < 0.01 
TTE (secs) 637 ± 153 600 ± 0 0.26 695 ± 149 600 ± 0* < 0.01 








Prior to analysis, data from three participants in the young and six in the older group were 
excluded due to a poor quality NIRS signal. There was no interaction effect, as there were 
no differences between the protocol and increase in deoxyHB (P > 0.05). Figure 5.2 
demonstrates the relative change in deoxyHb over the duration of both the sCPET and 
SPV, in both the age groups. There was a main effect of time, as deoxyHB increased 
significantly over %TTE in both age groups (P < 0.01), post hoc testing was used to 
determine differences between each successive time point. Results demonstrated that for 
the young group in the sCPET there were no differences between 70-80%, 80-90% and 
90-100% of TTE (P > 005), in the SPV there were differences between 30-40%, 40-50% 
and 60-70% of TTE (P < 005). For the middle to older aged group in the sCPET there 
were differences between 20-30%, 30-40% and 40-50% of TTE (P < 0.05), in the SPV 
there were differences between 30-40%, 40-50%, 50-60% and 60-70% of TTE (P < 0.05).  
 







There was no interaction effect in the young group as there were no differences in the 
increase of relative EMG between the protocols. However in the middle to older aged 
population there was an interaction effect, with post hoc testing demonstrating a 
significantly higher EMG at 70% of TTE in the SPV compared to the sCPET (P < 0.05). 
There was a main effect of time as the relative EMG increased significantly in relation to 
%TTE in both age groups (P < 0.01; Figure 5.3), although, for the young group, post hoc 
analysis showed there to only be a significant difference between 80-90% of TTE for the 
sCPET, and only between 20-30% TTE for the SPV. For the middle to older aged group, 
post hoc analysis only showed a significant difference between 90-100% of TTE from 
the sCPET, and no significant differences between the successive stages in the SPV. 
There were no differences for the percentage difference of the pre and post MIVC in EMG 











5.4.3. Cardiac Output and Stroke Volume 
Prior to analysis, data from four participants in the middle to older aged group (total n = 
18) were excluded due to a poor quality signal. In figure 5.4, the mean and SD for Q and 
SV is presented over time. For the young population there was an interaction effect of the 
protocol in both Q and SV over time, with post hoc testing demonstrating differences 
between the two tests at 6 min, 8 min and the final 30 s for Q, and 6 min and the final 30 
s of the test for SV (P < 0.05). There was a main effect of time, as both Q and SV increased 
significantly over time, although post hoc testing demonstrated that over both tests 
differences specifically occurred between baseline to 8 min for CO, and only between 
baseline and 2 min for SV (P < 0.05). For the middle to older aged population there was 
no interaction effect as there were no differences between the protocol and the increase 
in Q and SV (P > 0.05). There was an overall main effect of time (P < 0.05), although 
post hoc testing showed that for the sCPET there were differences from baseline to 8 min 
for CO and from baseline to 4 min for SV. For the SPV there were differences from 
baseline to 6 min for CO and for SV differences occurred between baseline to 2 min, and 








5.4.3. Power output profile 
Figure 5.5 displays the mean PO values for each stage of the SPV for both the young and 
middle to older aged group. Further analysis demonstrated that within stage PO variability 
in the young group was consistent through the first three stages of the SPV (CV = 3.68%, 
2.95%, 2.95%), but increased in stage 4 (CV = 5.79%), with variability being highest in 
the final stage (CV = 7.72%). In the older age group, the variability of PO was consisted 
through the first four stages (CV = 3.59%, 3.31%, 2.43%, 3.84%), and increased for the 











5.4.4. Gender differences   
Some sub-analysis was completed which investigated sex differences, in the young group 
there was twelve male and ten females. For the male participants there was a 2.22 ml·kg-
1
·min-1 KLJKHU9%c22peak achieved in the SPV vs. the sCPET (P = 0.02), and a 1.69 ml·kg-
1
·min-1 higher 9%c22peak achieved in the SPV vs. the sCPET in the female participants (P = 
0.06). In the older age group there were seventeen males and five females :KHQ
VHSDUDWLQJEHWZHHQPDOHVDQGIHPDOHVWKHUHZHUHQRGLIIHUHQFHVLQ9%c22peak between the 






In support of previous literature (Astorino et al., 2015; Mauger & Sculthorpe 2012; 
Mauger et al., 2013), the results of the current study demonstrate that younger participants 
were able to achieve a significantly higher 9%cO2peak in the SPV when compared to the 
sCPET. However, this was not evident in the middle aged to older adult population where 
there were no differences in 9%cO2peak between the two protocols.  The results also 
demonstrate that the SPV produced a higher peak Q and peak SV in the young group, 
which was statistically different between the SPV and sCPET at the latter stages of the 
test. No differences for these parameters between tests were seen in the older aged group. 
The SPV also allowed a higher physiological work rate in both age groups, evidenced by 
the significantly higher RER and peak PO. These findings suggest that even though both 
populations achieved a higher work rate in the SPV, this only led to a higher 9%cO2peak in 
the young group. In turn this suggests that the limiting factor to 9%cO2peak and the 
mechanisms behind the SPV may differ between young and older aged populations. 
Although this may also suggest that PO is not responsible for the differences seen in 
9%cO2peak, in fact previous research has demonstrated that once 9%cO2peak has been achieved 
further increases or even decreases in exercise intensity do not effect these values (Billat, 
Petot, Karp, Sarre, Morton et al., 2013; Milani, Lavie, Mehra & Ventura 2006). 
Additionally, the current study also demonstrated a lack of protocol specific patterns of 
deoxyHB and muscle recruitment of the VL, suggesting that oxygen extraction was not 
enhanced by the SPV. Mauger et al. (2013) did not measure SV therefore it is possible 
that the lower HR values seen in their study may have be compensated by a higher SV, 
which would explain a higher 9%cO2peak being achieved, even if HR was lower. This is the 
first study to assess both the cardiovascular and muscular response to the SPV in 





In support of the current study, Astorino et al. (2015IRXQGDVLJQLILFDQWO\KLJKHU4%cDQG
9%c22peak in the SPV when compared against a standard test. The autKRUVVXJJHVWHGWKDWWKH
KLJKHU 4%c GXULQJ WKH 639 LV UHVSRQVLEOH IRU WKH KLJKHU 9%c22peak observed due to an 
increased oxygen delivery to the working muscles. It is well accepted that there is a stroQJ
OLQHDU UHODWLRQVKLS EHWZHHQ 4%c DQG 9%c22 ZLWK 4%c EHLQJ D SULQFLSDO OLPLWLQJ IDFWRU IRU
9%c22peak during whole-body exercise (Bassett & Howley 2000). Therefore, it wRXOGEH
H[SHFWHGWKDWDKLJKHU4%cZRXOGUHVXOWLQDJUHDWHU9%c22peak being achieved. Results from 
the current study demoQVWUDWHDVLJQLILFDQWO\KLJKHU4%c achieved in the SPV vs. the sCPET 
in the young, but not in the old aged SRSXODWLRQ,QWHUHVWLQJO\ZLWK9%c22peak only being 
significantly higher in SPV in the yRXQJJURXSWKLVVXJJHVWVWKDW4%c is the primary limiter. 
The same maximal HR achieved from both protocROVVXJJHVWVWKDWWKHHQKDQFHG4%c seen 
in the young group is predominantly the result of the higher SV achieved in the SPV vs. 
sCPET, although this cannot be confirmed as peak SV and peak HR may not have 
necessarily occurred at the same time point. Indeed, previous literature has suggested that 
differences in 9%c22peak between individuals are primarily a result of the differences in 
maximal SV, as less inter-individual variation is seen in maximal HR (Bassett & Howley 
2000) ,Q WUDGLWLRQDO 9%c22peak tests it is known that SV bHJLQV WR SODWHDXIDOO SULRU WR
9%c22peak being reached, whilst HR continues to increase to maximal level, thus causing a 
plateau in Q (Mortensen, Dawson, Yoshiga, Dalsgaard, Damsgaard et al., 2005). This 
demonstrates an impairment of the circulatory system to continue supplying a linear 
increase in oxygen delivery at higher exercise intensities (Mortensen et al., 2005). The 
main cause for the plateau/fall in SV is suggested to be predominately attributed to a 
decrease in diastolic filling time as a result of the increasing HR (Higginbotham, Morris, 
Williams, McHale, Coleman et al., 1986; Vella & Robergs 2005). From the data presented 
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in Figure 5.4 it is evident that SV in the young group increases to a greater extent in SPV 
than the sCPET. A plateau in SV is also evident between the final two time points in the 
sCPET, which does not seem to occur in the SPV (although there were no significant 
differences between these two time points). As a result, the increase in Q during the final 
stage of the SPV test is greater than in the sCPET protocol. In the middle to older aged 
group a SV plateau is evident in both tests, although in the SPV this appears to be delayed 
until the fourth time point (6 min), compared to a plateau occurring at approximately 4 
min in the sCPET (no significant increase between each successive time point after 4 min; 
P > 0.05). It may be that the self-paced nature of the SPV, particularly in the younger 
populations, contributes in preventing this early plateauing in SV. This may be a result of 
participants making self-adjustments in work rate and potentially creating optimal 
physiological conditions to maintain adequate oxygen delivery. Although at this stage the 
underlining reasons why this may occur are still unclear, therefore further research is 
required to understand this.  
 
The middle to older agedSDUWLFLSDQWVGHPRQVWUDWHGQRVLJQLILFDQWGLIIHUHQFHVLQ9%c22peak 
between the SPV and sCPET protocols. It is likely that the effect of the protocol is reduced 
in the older group due to their inability to increase Q in response to the increased work 
rates, as seen in the young group. Indeed, previous research has suggested that Q plateaus 
at around ~80% of peak PO (Mortensen et al., 2005), and even though in the young group 
there were no significant differences in Q between the final two stages of the SPV (P > 
0.05), the pattern of response is not the same as in the sCPET. It is not clear why this 
differential response has been observed between test protocols. However, interestingly 
the Q response is similar between protocols in the older group. It is suggested that there 
are age-related changes which occur in relation to cardiac function in healthy individuals, 
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in particular these include increased left ventricular wall thickness, changes in diastolic 
filling, impaired left ventricular ejection fraction, and changes in HR (Lakatta & Levy 
2003). All of these changes are known to influence cardiac function (Lakatta & Levy 
2003). In particular, diastolic filling time is suggested to be the primary cause of the 
plateauing that occurs in SV above a certain exercise level (Higginbotham et al., 1986; 
Vella & Robergs 2005), and with diastolic filling rate progressively slowing with age 
(Lakatta & Levy 2003), this could be the key reason why the middle to older aged group 
did not achieve a significantly higher Q and therefore 9%cO2peak as seen in the young group. 
Even though there were no differences in Q in the old group between the two tests, the 
middle to older aged participants still achieved a higher PO in the SPV vs. the sCPET.  
 
Previous literature has shown the SPV to produce higher 9%cEYDOXHVZKHQFRPSDUHGWRD
VWDQGDUG 9%c22peak protocol in young population (Astorino et al., 2015; Faulkner et al., 
2015; Hogg et al., 2014; Mauger et al., 2013). Interestingly, studies that demonstrate no 
difference in 9%c22peak between the SPV and sCPETSURWRFROVDOVRIDLOHGWRILQGGLIIHUHQFHV
LQ9%cE (Chidnok et al., 2013; Straub et al., 2014). The greater 9%cE in the young group seen 
in the current, and previous studies (Astorino et al., 2015; Hogg et al., 2014; Faulkner et 
al., 2015; Mauger et al., 2013)LVOLNHO\GXHWRWKH³DOO-RXW´HIIRUWUHTXLUHGGXULQJWKH
final stage (RPE 20) of the test. End-test lactate values (see Table 5.1) suggest that this 
³DOO-RXW´HIIRUWUHVXOWs in a greater level of metabolic stress than experienced in sCPET 
testing. The greater level of acidosis and metabolic buffering would therefore increase 
the ventilatory response during high intensity exercise (Milani, Lavie, Mehra & Ventura 
2006). However, Mauger and Sculthorpe (2012)REVHUYHGQRGLIIHUHQFHVLQ9%cE between 
the tests, although a higher 9%c22peak was still achieved in the SPV. Therefore, it is still 
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questionable as to whether or not the higher values are SUHGRPLQDWHO\ D UHVXOW RI DQ
LQFUHDVHLQ9%cE.  
 
Another speculative, possible contribution to the lack of difference in 9%cO2peak for the 
older group might be a result of the known age-related changes that occur at a muscular 
level. Research has suggested that there is a reduced muscle oxidative capacity in older 
populations (Betik & Hepple 2008; Russ & Kent-Braun 2004) due to loss in 
mitochondrial content and function, and a reduction of muscle volume (Conley, 
Esselman, Jubriad, Cress, Inglin et al., 2000). This reduced oxidative capacity is likely to 
affect the a-vO2 diff, which according to the Fick equation, contributes in the attainment 
of 9%cO2peak. Moreover, the distribution of Q may also be altered in older populations. One 
possibility is that due to the reduced lung performance associated with normal age-related 
decline (Chaunchaiyakul, Groeller, Clarke & Taylor 2004; Janssens, Pache & Nicod 
1999), there is an increase in the oxygen cost of breathing meaning that more Q is needed 
to be directed the respiratory muscles to support ventilation during exercise (Proctor, 
Shen, Dietz, Eickhoff, Lawler et al., 1998) which may limit performance. Indeed a 20-
30% decrease in leg blood flow during cycling has been shown in older, compared to 
younger subjects (Proctor, Shen, Dietz, Eickhoff, Lawler et al., 1998). Thus, despite the 
higher work rate achieved, age-related reductions in leg muscle blood flow may have 
limited the extent to which work rate could increase, and therefore oxygen consumption. 
This is evident as the difference in PO between tests was not as great in the middle to old 




Interestingly, in contrast to the current findings, Chidnok et al. (2013) did not find a higher 
9%cO2peak, 9%cE or end-test blood lactate concentration from a SPV protocol compared to a 
sCPET test. However, the differences in the outcomes between this and the current study 
could be attributed to the SPV test protocol designs. As outlined above, the SPV protocol 
IURPWKHFXUUHQWVWXG\UHTXLUHVDQ³DOO-RXW´HIIRUWWREHPDLQWDLQHGIRUWKHGXUDWLRQRIWKH
final stage. This would require pacing on a moment-to-moment basis, rather than pacing 
the maximal effort (RPE 20) as the highest work rate they could sustain for the duration 
of the stage, apparently the requirement in the protocol of Chidnok et al. (2013). This 
fundamental difference between the two test protocols is the likely the reason for the 
disparity between the findings of the two studies. Indeed, data from the current study 
demonstrates a mean decrease in PO in the final stage of 120 W for the young group, and 
:IRUWKHROGHUJURXS ,QFRQWUDVWGDWDIURP&KLGQRN¶VVWXG\GHPRQVWUDWHDPHDQ
reduction in PO of just 20 W during the final stage of their SPV protocol. Thus, the final 
VWDJH³DOO-RXW´HIIRUWPLJKWEHZKDWLVUHTXLUHGLQRUGHUWRVWLPXODWHWKHLQFUHDVHLQ9%cE, 
and thus 9%cO2.  
 
Even though the mean test time for the sCPET protocol in both age groups was between 
the µrecommended¶ 8-12 min duration (Buchfuhrer et al., 1983), there was only 55% in 
the young group and 45% in the older group who completed the test within this time 
frame. The remaining participants (n = 10 from young, n = 12 from older group) were 
either < 8 or > 12 min, which may have influenced the results. Further analysis was 
completed where participants were sub-grouped in to three categories, those who 
completed the sCPET in < 8 min, 8-12 min and > 12 min. This analysis demonstrated that 
in the young group there was a greater LQFUHDVHLQ9%c22peak from the SPV compared to the 
sCPET for those who completed the sCPET in < 8 min (2.66 ml·kg-1·min-1; P = 0.37) and 
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> 12 min (3.13 ml·kg-1·min-1; P = 0.02), compared to those who completed between 8-12 
min (1.14 ml·kg-1·min-1; P = 0.13). These findings would suggest that test time is in fact 
DQLPSRUWDQWIDFWRUZKHQREWDLQLQJRSWLPDO9%c22peak values as suggested by previous work 
(Buchfuhrer et al., 1983). As a consequence, differences seen in the current study between 
protocols could be related to participants not completing the sCPET in the ³optimal´ time. 
However, it must be noted that there were only three participants in the < 8 min category 
compared to the seven in the > 12 min category and twelve in the 8-12 min category. 
Interestingly, in the older aged group there were no significant differences LQ9%c22peak 
between the SPV and the sCPET for the 8-12 min (n = 10) and > 12 min (n = 11) 
categories (P > 0.05). There was only one participant that completed the test < 8 min but 
interestingly this individual achieved a 2.19 ml·kg-1·min-1KLJKHU9%c22peak in the SPV vs. 
the sCPET.  
 
A limitation of the current study is that different cycle ergometers were used to complete 
the sCPET and SPV. It has previously been suggested that different ergometers might 
infer differences in metabolic cost and differences in cardiovascular strain (Reiser, 
Meyer, Kindermann & Daugs 2000). Indeed, various factors like seat angle (Umberger, 
Scheuchenzuber & Manos 1998), body positioning (Too 1991) and seat to pedal distance 
(Too 1993) have been show to influence maximal cycling performance. However, 
different ergometers were a requirement of the different protocols, as the SPV required 
participants to freely adjust their PO, and the sCPET required accurate fixing of PO. 
Indeed, a similar magnitude of GLIIHUHQFHVLQ9%c22peak to those of the current study have 
been found by previous studies who used the same cycle ergometer in both SPV and 
traditional tests (Astorino et al., 2015; Mauger & Sculthorpe 2012). Like the current 
study, Chidnok et al., (2013) also used different cycle ergometers when making 
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comparisons between the SPV and sCPET test and found no significant differences in 
9%c22peak. The authors acknowledge that the use of non-invasive techniques to measure Q 
and SV have previously been criticised for their lack or accuracy and reliability when 
compared against more invasive techniques (e.g. direct Fick method) with the typical 
error being reported to be around 9% for peak Q and SV (Welsman, Bywater, Farr, 
Welford & Armstrong 2005), therefore caution must be taken when making conclusions 
with such measures. There is also movement and respiratory artefact associated with 
exercise which is suggested to affect the results (Siebenmann, Rasmussen, Sorensen, 
Zaar, Hvidtfeldt et al., 2015). One study also suggested that the Physioflow, in particular, 
may overestimate exercising Q by 30-50% (Siebenmann et al., 2015). However, other 
research has demonstrated that non-invasive devices such as the PhysioFlow are a reliable 
and clinically acceptable measure of Q and SV in adults during exercise (Charloux, 
Lonsdorfer-Wolf, Richard, Lampert, Oswald-Mammosser et al., 2000; Richard, 
Lonsdorfer-Wold, Charloux, Doutreleau, Buchheit et al., 2001). Nevertheless the authors 
accept that caution must be taken when making conclusions with such measures. 
 
The SPV allows participants to freely adjust both resistance and cadence. Previous 
research has suggested that large variations in cadence could influence the muscle blood 
flow and Q response to exercise (Gottshall, Bauer & Fahmer 1996). Thus any differences 
in cadence between SPV and sCPET protocols may have influenced the current results. 
However, the study by Gottshall and colleagues (1996) was completed at submaximal 
steady state exercise, and we are unaware of any studies which presented similar data 
obtained during maximal incremental exercise. Therefore, it is difficult to determine 
whether cadence differences were a confounding variable within our study. However, the 
overall mean cadence from both test protocols were very similar in the young (sCPET 76 
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rev.min-1; SPV 78 rev.min-1) and identical in the middle to older aged group (77 rev.min-




In agreement with the findings of previous research, the current study demonstrates that 
the SPV pURGXFHVKLJKHU9%c22peak values compared to a sCPET protocol in a young healthy 
adult SRSXODWLRQ,QWKLVSRSXODWLRQWKHGDWDVXJJHVWVWKDWWKHKLJKHU9%c22peak in the SPV 
protocol is likely the result of an increase in the oxygen delivery (increased Q and 9%cE
UDWKHUWKDQDUHVXOWRIDQ\LQFUHDVHRUFKDQJHLQWKHR[\JHQH[WUDFWLRQDWDPXVFXODUOHYHO
,QFRQWUDVWQRGLIIHUHQFHVLQ9%c22peak between the SPV and sCPET protocols were seen 
in a middle aged to older adult population, despite a higher RER and PO being achieved 
in the SPV. The reasons for this are unclear, although age-related changes in the 
physiological response to exercise are a possible explanation for the differences in the 
response to the SPV protocol between the age groups. It was originall\K\SRWKHVLVHGWKDW
WKH 639 ZRXOG SURGXFH D KLJKHU 9%c22peak, oxygen delivery and enhanced oxygen 
extraction at the working muscles in both the young vs older aged population (H31, H41), 
but due to the lack of differences seen in the older aged group the null hypotheses H30, 
and
 
H40 are accepted. Nonetheless, these findings suggest that the SPV helps participants 
achieve both a physical and physiological workload that is closer to maximum, when 
compared to a sCPET protocol. Whilst this is manifested as a higKHU9%c22peakLQ\RXQJ
SRSXODWLRQVDVLPLODU9%c22peak is observed in middle to older agedSRSXODWLRQV7KHUHIRUH
WKLVVWXG\GHPRQVWUDWHVWKDWWKH639LVDYDOLGGHWHUPLQDQWRI9%c22peak in both young and 
older adults (null hypothesis H20 can be rejected), and produces a cardiovascular response 
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closer to maximal. This finding is particularly important for the overall aim of this thesis, 
as it provides confidence that the SPV be can effectively and safely used in an older 
population, which reflects the ages of those who undertake preoperative CPET. However, 
it is acknowledged that specific patient groups with varying degree of limitations to 
exercise may respond differently to the SPV. 
 
What is already known about this topic 
 
x Some studies have shown the SPV to produce higher sȩK2peak values 
when compared against sCPET protocols. Although reasons behind 
this higher sȩK2peak is unclear.  
x Previous work has shown that cardiac output is higher in the SPV 
compared to a sCPET, suggesting that there is an increase in 
oxygen delivery. It has also been suggested that SPV may enhance 
oxygen extraction at the working muscles as a result of the self-
paced nature and the ability to make slight fluctuations in work 
rate.  
x More of an mechanistic explanation and understanding of the 
SPV was yet to be identified 
What this study adds 
 
x In younger populations, the SPV produces higher sȩK2peak values as 
a result of an increase in oxygen delivery. However, likely due to 
age-related differences in the physiological responses to exercise, 
the middle to older aged group achieved similar sȩK2peak values, 
regardless of them reaching higher workloads.  
x This study shows that the SPV is a valid test of exercise capacity in 







Chapter 6. Reliability and validity of a self-paced 
9ࡆ O2peak test in post-MI patients 
 
Aspects of the following chapter have been included within the following manuscript: 
Jenkins LA., Mauger A., Fisher, J. and Hopker JG. (2017). Reliability and validity of a 
self-paced cardiopulmonary exercise test in post-MI patients. International Journal of 

























The SPV has been shown to produce higher 9%cO2peak values compared to sCPET, but has 
not been tested on any clinical population. This study aimed to assess the validity and 
reliability of the SPV in post Myocardial Infarction (post-MI) patients. Twenty-eight 
post-MI patients completed one sCPET and two SPV in a randomised, counterbalanced 
crossover design. The SPV consisted of 5 × 2-min stages where participants were able to 
self-UHJXODWHWKHLUHIIRUWE\XVLQJLQFUHPHQWDOµFODPSV¶LQRPE (11, 13, 15, 17 and 20). 
The sCPET consisted of a 20 W/min ramp. Results demonstrated the SPV to have a 
coefficient of variation for 9%cO2peak of 8.2%. The limits of agreement were ± 4.22 ml·kg-
1
·min-1, with intraclass correlation coefficient of 0.89. There was a significantly higher 
9%cO2peak achieved in the SPV (23.07 ± 4.90 ml·kg-1·min-1) against the sCPET (21.29 ± 
4.93 ml·kg-1·min-1). We conclude the SPV is a safe, valid and reliable method for 













As previously described, CPET derived parameters have been shown to be strongly 
correlated with overall health status and mortality, and can therefore provide valuable 
diagnostic and prognostic information for various patient populations (Albouaini et al., 
2007; Buys Cornelissen, Van De Bruaene, Stevens, Coeckelberghs et al., 2011; 
Kristensen, Knuuti, Saraste, Anker, Botker et al., 2014; Myers et al., 2002). The 
identification of 9%cO2peak from CPET has become a fundamental procedure when assessing 
cardiorespiratory fitness, monitoring exercise intensity (Bassett & Howley 2000) and 
when risk stratifying individuals prior to major surgical procedures (Beckles, Spiro, 
Colice & Rudd 2003). Moreover, exercise testing soon after a Myocardial Infarction (MI) 
is beneficial as it can provide information on DSDWLHQW¶VIXWXUHULVNRIDVXEVHTXHQWFDUGLDF
event (Davidson & DeBusk 1980) and can be used in individualising exercise 
rehabilitation programmes (Markiewicz, Houston & DeBusk 1977). 
 
$ QXPEHU RI VWXGLHV KDYH DVVHVVHG WKH YDOLGLW\ RI WKH 639 LQ µKHDOWK\ SRSXODWLRQV¶  
(Chidnok et al., 2013; Mauger & Sculthorpe 2012; Mauger et al., 2013; Straub et al., 
2014), however no research has investigated whether or not the SPV can be used in 
clinical populations. Therefore, the aim of this study was to investigate the reliability and 







Twenty-eight post-MI patients (2 females, 26 males) undergoing cardiac rehabilitation 
volunteered to participate (age = 58 ± 8 yr, weight = 89.5 ± 12 kg, stature = 178 ± 8 cm, 
BMI = 28.2, days from MI event = 57 ± 35). All patients recruited for the study already 
had their coronary angiogram and any interventions needed following their MI, and were 
thought to require no further intervention or revascularisation. All patients gave their 
written informed consent. 
 
6.3.2. Experimental Procedures 
All patients were required to complete three exercise tests (a sCPET and two SPV tests) 
LQRUGHUWRGHWHUPLQHWKHWHVWV¶YDOLGLW\DQGUHOLDELOLW\7KHRUGHULQZKLFK the patients 
completed the tests was in a randomised, counterbalanced crossover design (the repeated 
SPV was always completed in the third visit). Each test was separated by at least 24 h and 
all tests were completed at the same time of the day (± 2 h). Participants were asked to 
refrain from drinking alcohol (24 h abstinence), eating (2 h abstinence), smoking (2 h 
abstinence), and not to perform any exercise in the 24 h prior to each test. Prior to the 
main test patients were required to complete a 5-min warm-up at a self-selected intensity 
during which they were also familiarised with the process of freely adjusting their PO on 
the cycle ergometer.  
 
6.3.3. SPV protocol  
The SPV was completed on an air-braked cycle ergometer (Wattbike Trainer, UK), which 
allowed patients to continually vary their PO throughout the test. The SPV was conducted 
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in accordance with the procedures previously outlined in the general methods section 
(Chapter 3).  
 
6.3.4. Standard CPET protocol 
The sCPET was completed on an electro-magnetically braked cycle ergometer (Lode 
Corival), so that PO for each stage could be fixed according to the test requirements. The 
test followed a standard incremental ramp design. As previously used with other clinical 
populations, the test commenced with no resistance and continuously increased by 20 
W.min-1, standardized across all patients (Brutsche, Spiliopoulos, Bolliger, Licker, Frey 
et al., 2000, Eindhoven, van den Bosch, Oemrawsingh, Baggen, Kardys et al., 2016, Gitt, 
Wasserman, Kilkowski, Kleemann, Kilkowski et al., 2002, Kahaly, Wagner, Nieswandt, 
Mohr-Kahaly & Ryan 1999). The test was stopped when the patient felt like they could 
no longer continue or maintain more than 60 rpm, despite verbal encouragement. 
 
6.3.5. Physiological Measures 
Expired gases, HR, PO and cadence were continuously recorded during the tests. A 12-
lead ECG was also recorded through the duration of the test. 9%cO2peak, AT, peak PO and 
peak 9%cE were all determined using the methods stated in Chapter 3. The AT was 
successfully determined in all patients.  
 
6.3.6. Statistical analysis 
Test-retest reliability was assessed via the use of 95% LOA using Bland-Altman plots 
(Bland & Altman 1986), 95% CI of the CV, and ICC (Hopkins 2001) were calculated to 
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assess the variability of the repeated tests. Differences in 9%cO2peak, peak PO, AT, peak HR 
and peak 9%cE were compared from the 1st SPV test to those obtained from the sCPET, 
using a paired-samples t-test. Complete 2nd SPV test data was not achieved for three of 
the patients, and so only data from SPV1 has been used in these cases. The reasons for 
these three missing tests were; one patient had an unrelated illness and was unable to 
attend their final test within the required timeframe; the other two miscalculated their 
work rate during the RPE 17 stage causing a premature end to the test. The data of these 
two patients who did not meet the test requirements for SPV2 has been excluded from the 




The CV for 9%cO2peak between SPV1 and SPV2 was 8.2% (95% CI: 6.6-10.9%). Therefore, 
if a patient achieved a 9%cO2peak of 23 ml·kg-1·min-1 a typical variation of 1.9 ml·kg-1·min-
1 would be expected. The ICC was 0.89, this represents a questionable to high level of 
agreement. The LOA was ± 4.22 ml·kg-1·min-1 for the measure of SPV1 and SPV2 
(Figure 6.1). If we include the SPV2 data for the two patients who were excluded from 
the main analysis, the CV becomes 8.4% (95% CI: 6.8-11%), the ICC is unchanged, and 





Figure 6.1. Bland-Altman plots of differences in 9%c22peak between SPV1 and SPV2 (left 
graph); and differences in AT between SPV1 and SPV2 (right graph). The solid horizontal 
line represents mean difference, whilst the dashed lines represent the 95% LOA.  
 
The CV for AT between SPV1 and SPV2 was 8.4% (95% CI: 6.8-11.2%). The ICC was 
0.86. The LOA was ± 3 ml·kg-1·min-1 for the measure of SPV1 and SPV2 (Figure 6.1). If 
we include the SPV2 data for the two patients who were excluded from the main analysis, 
the CV for AT becomes 8.6% (95% CI: 7-11.4%), the ICC is 0.84, and the LOA remain 
unchanged. There was a CV of 15.1% (95% CI: 12.1-20.4%) for peak PO, 4.7% (95% 
CI: 3.8-6.5%) for peak HR, and 11.5% (95% CI: 9.2-15.4%) for peak 9%cE. The ICC for 
these three variables ZHUHIRU32IRU+5DQGIRU9%cE, demonstrating an 
acceptable to high level of agreement (Vincent 1994, referenced by Atkinson & Nevill 
1998).  
 
As shown in Table 6.1, patients achieved a significantly higher 9%cO2peak (P < 0.01) in the 
SPV compared with the sCPET. Patients also achieved a significantly higher peak PO, 
peak HR and peak 9%cE in the SPV than in the sCPET (P < 0.01). There were no significant 
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differences in AT between the SPV and the sCPET (P > 0.05). Figure 6.2 shows the 9%cO2 
response over time, in the two SPVs and sCPET, of a representative patient. :KHQ
VXEJURXSLQJWKHSDWLHQWVLQWRWKHLUJHQGHUV9%c22peak was higher in the SPV vs. the sCPET, 
although there were only two females recruited for this current study.  
 
Table 6.1: Physiological variables over the sCPET, SPV1 and SPV2 in post-MI patients.  
  sCPET (n = 28) SPV1 (n = 28) SPV2 (n = 25) 
9ࡆ O2peak (L·min-1)  1.90 ± 0.50 2.05 ± 0.48* 2.00 ± 0.43 
9ࡆ O2peak (ml·kg-1·min-1) 21.29 ± 4.93 23.07 ± 4.90* 22.68 ± 4.79 
AT (ml·kg-1·min-1) 12.63 ± 2.41 13.06 ± 2.39 13.21 ± 2.76 
HR (bpm) 129 ± 18 138 ± 14* 136 ± 19 
9ࡆ E (L·min-1) 82.0 ± 27.1 94.5 ± 25.9* 91.1 ± 26.2 
Peak PO (W) 171 ± 43 209 ± 78* 200 ± 64 
TTE (secs) 535 ± 130 600 ± 0* 600 ± 0 





)LJXUH9%c2 UHVSRQVHRYHURI WLPH WRH[KDXVWLRQ77( LQ WKHV&3(7DQGERWK
639VLQDUHSUHVHQWDWLYHSDWLHQW 
 
Table 6.2 displays PO variability within each stage of both repeated SPVs. In SPV1, it 
appears that as mean PO increased with each stage of the protocol, the within stage 
variability also increased, with the highest variability in the final stage. In SPV2, PO 
variability remained consistent through the first four stages of the test, with a large 









Table 6.2: Mean PO and the variability within each stage of SPV1 and SPV2 in post-MI 
patients.   
 Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 
Mean + SD SPV1  49 + 2 74 + 2 103 + 4 132 + 8 145 + 15 
SPV2 42 + 1 60 + 2 89 + 2 125 + 4 153 + 16 
CV (%) SPV1  3.67 (3.28-4.2) 3.07 (2.75-3.52) 4.78 (4.28-5.48) 5.88 (5.26-6.75) 11.11 (9.9-12.79) 





This is the first study to assess the SPV on a clinical population. The results of the current 
study demonstrated the SPV to be a valid and reliable indicator of 9%c22peak in post-MI 
patients. The CV for 9%c22peak in the post-MI patients was 8.2%. In addition, post-MI 
patients achieved a higher 9%c22peak in the SPV compared to a sCPET protocol, which is in 
agreement with previous studies on healthy populations (Mauger & Sculthorpe; Mauger 
et al., 2013). Previously published studies have investigated the reproducibility of 
physiological variables using sCPET protocols. Froelicher et al. (1974) found that when 
using three popular maximal exercise treadmill protocols in a healthy population the CV 
for 9%cO2peak ranged from 4.1-5.8%. In addition, one study completed a succession of CPET 
tests on cardiac failure patients and reported the average CV for 9%cO2peak to be 5.7% 
(Janicki, Gupta, Ferris & McElroy 1990). OthHUVWXGLHVKDYHUHSRUWHG³JRRG´WHVW-retest 
reliability (CV for 9%cO2peak = 3.5-6.9%) during cycling MIE tests in patients with various 
respiratory conditions (Cox et al., 1989; Marciniuk et al., 1993; McKone et al., 1999). 
CV values from previous research investigating the reliability of traditional protocols are 
lower than those from the post-MI group of the current study. However, it is difficult to 




Our results demonstrated a CV for AT of 8.4%, which is considered as acceptable for 
test-retest reliability in clinical populations (Myers, Goldsmith, Keteyian, Brawner, 
Brazil et al., 2010). Kothmann et al. (2009) found a CV of 10% for AT in Abdominal 
Aortic Aneurysm (AAA) patients using a sCPET protocol. Identification of AT from 
CPET has become an increasingly important tool in clinical exercise testing, primarily 
due to it giving an objective assessment of cardiopulmonary function which does not 
require high levels of effort (Older et al., 1999). Previous literature has demonstrated AT 
to be a useful predictor of mortality in patients with chronic heart failure. This information 
can then be used to help prioritise patients for heart transplantation (Gitt et al., 2002). The 
identification of AT prior to major surgery has also been shown on a number of occasions 
to closely correlate with post-operative outcome (Older, Hall & Hader 1999; Wilson, 
Davies, Yates, Redman & Stone 2010). It is reassuring to see that in the current study 
there were no differences in AT when comparing it between the SPV and the sCPET (P 
> 0.05), this combined with the reliability results demonstrate that AT can be reliably 
determined via the SPV, which is of great importance in clinical exercise testing.  
 
As previously mentioned, two post-MI patients were excluded from the main reliability 
analysis as they did not successfully complete a second SPV due to misjudging the 
required work rate during stage RPE 17. One of the key benefits associated with the SPV 
is the fixed test duration, as this aims to ensure that enough exercise data is always 
obtained, although this was not the case for these two patients which raises questions over 
its presumed benefit in clinical populations, especially if they are inactive and unfamiliar 
to exercise. However, it is interesting to note that this miss-pacing occurred on both of 
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the patients second SPV. It is possible to speculate that from completing the previous two 
tests (sCPET and SPV1), the patients may have potentially gained confidence in their 
own ability which may have resulted in them attempting to push harder, but ultimately 
resulting in them overshooting the work rates. Nevertheless, both patients did provide 
enough data to demonstrate a valid AT during SPV2.  
 
In agreement with data from a healthy population (Mauger & Sculthorpe 2012)SRVW0,
SDWLHQWVDFKLHYHGDVLJQLILFDQWO\KLJKHU9%c22peak (+8%) during the SPV compared with the 
sCPET (P < 0.01). Peak HR and 9%cE were also significantly higher in the SPV than in the 
sCPET (P < 0.01), which is in support of previous work (Faulkner et al., 2015; Hogg et 
al., 2014; Mauger et al., 2013),WLVLQWHUHVWLQJWRVHHWKDWSUHYLRXVVWXGLHVZKLFKIDLOHG
WRILQGDQ\GLIIHUHQFHVLQ9%c22peak between the SPV and a sCPET protocol also found no 
differences in HR and 9%cE (Chidnok et al., 2013; Straub et al., 2014)SRWHQWLDOO\OHDGLQJ
WRWKHREVHUYHGGLIIHUHQFHVLQ9%c22peak. A recently published study (Astorino et al., 2015) 
found significantly higher maximal HR and cardiac output during the SPV compared to 
a sCPET protocol (Astorino et al., 2015). Astorino et al. (2015)FRQFOXGHGWKDWWKHJUHDWHU
FDUGLDFRXWSXWLQWKH639VXJJHVWVDJUHDWHUR[\JHQGHOLYHU\WRWKHH[HUFLVLQJPXVFOHV
SHUPLWWLQJDKLJKHU9%c22peak to be achieved. These findings suggest that the SPV allows 
individuals to work to a higher physiological work rate when compared to the sCPET. 
This may be a result of the nature of self-paced exercise providing a more comfortable 
experience for patients. Being able to make slight adjustments in effort may minimise 
fatigue and any peripheral discomfort associated with cycling, particularly in the early 
stages of the test, which may ultimately lead to a greater work rate being able to be 
achieved in the final stage (Astorino et al., 2015). In traditional CPET no adjustments in* 
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effort can be made and the only way to stop any exercise related discomfort would be to 
stop. With all of this in mind, the current findings suggest that in a clinical population, 
where cardiac function might be limited, the self-paced nature may in fact provide the 
patient the opportunity to work harder,SURGXFLQJDJUHDWHUFDUGLDFRXWSXWDQGWKHUHIRUH
UHDFKLQJ D KLJKHU 9%c22peak. However, further research is required to support this 
speculation.  
 
The mean sCPET time-to-exhaustion was 8 min 55 secs (range = 5 min ± 12 min 54 sec) 
compared to the fixed 10 min of the SPV. Even though the sCPET mean test time falls 
within those previously recommended times of 8-12 min (Buchfuhrer et al., 1983), only 
15 (of 28) participants successfully completed the test within this recommended time. 
Therefore, the lower 9%cO2peak in the sCPET could be attributable to only 54% achieving 
the recommended test time. For the nine patients who completed the sCPET in < 8 min, 
there was a 2 ml·kg-1·min-1 KLJKHU9%c22peak in the SPV (P = 0.10). The fifteen patients who 
completed the sCPET between 8-12 min, demonstrated a 2.14 ml·kg-1·min-1 VLJQLILFDQWO\
KLJKHU9%c22peak in the SPV compared to the sCPET (P < 0.01). Finally, there were only 
four patients who completed the sCPET in < 12 min so statistical differences were not 
tested, althougK LQWHUHVWLQJO\ WKH 9%c22peak values were very similar between the SPV 
(26.87 ± 4.53 ml·kg-1·min-1) and sCPET (26.97 ± 2.79 ml·kg-1·min-1). In this population 
it appears that slightly longer test times in a sCPET are more beneficial to obtaining higher
9%c22peak values. This is supported by findings from Agostoni et al., (2005), whoFRQFOXGHG
WKDW 9%c22peak in heart failure patients is lowest when CPET is completed in 5 min, 
compared to 10 and 15 min. Agostoni et al. demonstrated the KLJKHVW 9%c22peak values 




A potential limitation of the current study was that we decided to standardize sCPET work 
rate increments (20W/min) for all patients (Brutsche, Spiliopoulos, Bolliger, Licker, Frey 
et al., 2000; Eindhoven, van den Bosch, Oemrawsingh, Baggen, Kardys et al., 2016; 
Kahaly, Wagner, Nieswandt, Mohr-Kahaly & Ryan 1999)  instead of doing so on an 
individual basis (Myers et al., 1991; Myers et al 2002). Individualising work rate 
increments may have resulted in more patients completing the CPET within the 
recommended time frame, although the subjectivity of such a choice would not have 
guaranteed a successful test in all patients. This issue clearly highlights one of the key 
challenges practitioners face on a day-to-day basis when using CPET with clinical 
populations. Indeed, if patients are unable to exercise for a sufficient time the utility of 
test results is severely limited, resulting in a significant waste of finance and time for both 
patients and health service provider. The SPV eliminates the need to estimate the most 
appropriate starting intensity and work rate increments as it is based on set levels of 
perceived exertion. Moreover, the closed loop nature of the SPV ensures that each test 
lasts 10 min. Thus, a protocol like the SPV may be a more reliable way of acquiring time 
efficient and useable data than sCPET methods. 
 
The significantly higher PO achieved in the SPV suggests that regardless of the self-paced 
nature, participants were willing to tolerate significantly higher work rates in the final 
stage (RPE 20), compared to that demanded by the sCPET. Knowledge of the test end-
point in the SPV vs the open-ended sCPET could contribute to the higher tolerance in 
work rate. Indeed, previous literature has demonstrated that knowledge of exercise 




as they are able to self-adjust their work rate, potentially making the higher perceived 
work rates more tolerable, especially when the end is proximate. If patients are aware of 
thiVSULRUWRWHVWLQJWKHQWKH\PD\EHPRUHµZLOOLQJ¶WRFRPSOHWHWKHWHVW 
 
Further analysis demonstrated that during both SPVs, within stage PO variability was 
greatest at higher work rates. However, variability increased through each stage of SPV1, 
but in SPV2 PO variability remained fairly consistent through the first four stages, with 
a large increase in the final stage. This might suggest a slight behaviour change in how 
the SPV is paced when completed for a 2nd time. Patients demonstrated what might be 
FRQVLGHUHGWREHDPRUH³FDXWLRXV´SDFLQJVWUDWHJ\LQ639 To further support this point
DKLJKHU9%c22peak, HR, 9%c(DQG32ZDVDFKLHYHGLQWKHILUVWFRPSOHWHG639FRPSDUHGWR
SPV2. This pattern was also seen in study 1 (Chapter 4). In Chapter 4 it was suggested 
that there might be potential behaviour changes associated with completing the SPV, and 
that participants may protect themselves in repeated tests to avoid any discomfort they 
experienced in the first test. Thus, familiarisation sessions for the SPV may have a 
negative impact on subsequent SPV tests and could have been a contributing factor for 
the discrepancies reported in previously published literature (Astorino et al., 2015; 
Faulkner et al., 2015; Mauger et al., 2013; Mauger & Sculthorpe 2012; Chidnok et al., 
2013; Straub et al., 2013). 
 
As well as the comparative physiological data, it was also important to determine patient 




preference. Some of the common patient reasons for preferring the sCPET was that they 
found it hard to judge effort when using RPE in the SPV, others stated that they preferred 
the simplicity of the traditional test and that all they needed to focus on was maintaining 
their cadence, a few participants also stated that they preferred the sCPET because it felt 
easier. Common reasons for preferring the SPV were that patients favoured having 
control over their work rate, that they found the SPV more interesting and more realistic, 
and that they felt like they had worked harder. 3UHYLRXVUHVHDUFKKDVVXJJHVWHGWKDWDQ
LQGLYLGXDO¶VSUHIHUUHGWHVWPD\UHVXOWLQDKLJKHU9%c22peak being obtained (Hanson et al., 
2016; Straub et al., 2014). When separating the patients in current study into groups based 
upon their preferred test (sCPET RU6399%c22peak was still significantly higher in SPV1 
compared to the sCPET (P < 0.05). However, there was a bigger difference for those 
patients who preferred the SPV (2.11 ml·kg-1·min-1) to those who preferred the sCPET 
(1.56 ml·kg-1·min-1). Unlike prHYLRXVILQGLQJV+DQVRQHWDO6WUDXEHWDO
LWLVLQWHUHVWLQJWRQRWHWKDWUHJDUGOHVVRISUHIHUHQFHWKLVFOLQLFDOSRSXODWLRQDFKLHYHGD
KLJKHU9%c22peak in the SPV. Interestingly, those patients who preferred the SPV achieved 
a similar9%c22peak in SPV1 compared to SPV2, but those who preferred the sCPET had a  
lower 9%c22peak in SPV2 compared to SPV1, and not significantly different from the sCPET 
(P > 0.05). It is possible to speculate that those patients who did not prefer the SPV, may 
have been less willing/motivated to push as hard in SPV2, which resulted in the lower 
9%c22peak. Participants were also asked which test they felt like they worked harder in, with 
majority of participants stating it to be the SPV (50%) compared to the sCPET (29%), the 
remaining 21% said that they felt the tests were equal. Interestingly 71% of participants 
stated that the SPV made them feel like they had control, with 61% of these stating that 
they felt this was an important factor to maximal exercise testing. These anecdotal reports 
suggest that even though the feedback was very diverse, the majority of the participants 
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felt like they worked harder in the SPV, even though they had control over their own 
work rate. This again provides some support to the notion that, regardless of the self-
paced nature of the exercise, participants were willing to work at higher exercise 
intensities than encountered during sCPET. 
 
There were no adverse events reported for the current study, providing support for the 
current evidence base that maximal exercise testing is a safe procedure to perform on 
cardiac patients (Balady et al., 2010; Kanthan, Tan, Zecchin & Denniss 2012; Roffi, 
Wenaweser, Windecker, Mehta, Eberli et al., 2003).  
 
It should be noted that a limitation of the current study is that different cycle ergometers 
were used to complete the sCPET and SPV. It has previously been suggested that different 
ergometers might infer differences in metabolic cost and differences in cardiovascular 
strain (Reiser, Meyer, Kindermann & Daugs 2000). Indeed, various factors like seat angle 
(Umberger, Scheuchenzuber & Manos 1998), body positioning (Too 1991), and seat to 
pedal distance (Too 1993) have been shown to influence maximal cycling performance. 
The two different ergometers were necessary to support the demands of the different 
exercise protocols; the SPV required participants to freely adjust their PO where as the 
sCPET required PO to be accurately fixed at a given exercise intensity. Even though this 
limitation means that between test comparisons -should be treated with caution, it does 
not deter from the findings that the SPV is both a reliable and safe test for use in the 






The results of the current study demonstrate that the SPV has acceptable levels of 
reliability IRUGHWHUPLQLQJ9%c22peak in post-MI patients. The SPV also DOORZHGSRVW0,
SDUWLFLSDQWVWRDFKLHYHDVLJQLILFDQWO\KLJKHU9%c22peakWKDQWKHV&3(77KLVVWXG\VXJJHVWV
WKDWWKH639LVDVDIHYDOLGDQGUHOLDEOHPHDVXUHRI9%c22peak in a clinical population, and 
should be considered as an accepted means of testing for exercise capacity. These findings 
mean that the null hypothesis H50 stated earlier in this thesis can be rejected, and the 
alternative hypothesis H51 can be accepted. Moreover, the defined test duration and self-
administered work rates associated with the SPV addresses common issues that clinicians 
regularly have to overcome, and go some way to ensuring all patients exercise for the 
recommended duration in order to obtain a valid and reliable CPET. Future research 
should seek to assess the SPV in other clinical populations and the utility of the SPV 










What is already known about this topic 
 
x The SPV is a valid test of exercise capacity in healthy young and 
older aged individuals, although it had not been tested on any 
clinical population. 
 
What this study adds 
 
x This study shows that the SPV can be used as a valid CPET in post-
MI patients. Repeated tests showed the SPV to have acceptable 
levels of reliability for the key CPET derived variables.   
 
Impact on clinical practice  
 
x With the defined test duration and self-administered work rates, 
the SPV may address common issues that clinicians regularly face, 
for example it takes away the need to choose the most appropriate 
work rate increments. The fixed test length may also improve the 
efficiency of running busy clinics. Finally a test which will always 
acquire 10 minutes of exercise data may reduce the risk of 








Chapter 7. The use of self-paced CPET protocol 
in preoperative assessment and its ability to 
predict postoperative outcome in patients 



















CPET has become an essential tool used in preoperative assessment, although the 
standard protocol used has been scrutinised over the years. The SPV attempts to overcome 
some of those issues associated with sCPET. This study aimed to determine if the SPV 
can DVVHVVSDWLHQW¶VSUHRSHUDWLYHULVNVLPLODUWRV&3(7DQGLIH[HUFLVHYDULDEOHVREWDLQHG
from the test can accurately predict post-operative outcome. Fifty patients with 
cardiovascular related co-morbidities completed one sCPET and one SPV in a 
randomised, counterbalanced crossover design, although only thirty of those patients 
went ahead with surgery. After surgery patients were monitored for incidence of 
morbidity on postoperative days 3 and 5, length of hospital stay, and incidence of 
mortality in the 30 days after surgery. The fifty pDWLHQWVDFKLHYHGDVLJQLILFDQWO\KLJKHU
9%c22peak, HR, 9%cE, peak PO and TTE in the SPV compared to the sCPET (P < 0.05). 
Logistic regression analysis demonstrated that for the thirty patients who had surgery, 
none of the CPET variables were associated with postoperative morbidity at either day 3 
or 5 (P > 0.05). Although when combining postoperative morbidity at days 3 and 5, 
logistic regression analysis showed that oxygen pulse at AT obtained from the SPV was 
significantly related to postoperative complications (P < 0.05). Receiver operator 
characteristic (ROC) curve analysis demonstrated oxygen pulse at AT to provide an AUC 
of 0.72 a.u. (95%CI 0.51 to 0.92), with an optimal cut-off point of 8.5 ml·beat-1 which 
provided 72.7% sensitivity and 71.4% specificity. To conclude the SPV was able to assess 
preoperative fitness comparable to the sCPET. Although, none of the CPET variables 






As described earlier in this thesis, CPET is an increasingly popular tool used in 
preoperative assessment (Smith et al., 2009), this is because it provides an objective 
DVVHVVPHQWRIDSDWLHQW¶VDELOLW\WRFRSHZLWKWKHPHWDEROLFGHPDQGVRIPajor surgery 
(Hopker et al., 2011). Major surgery is suggested to place high amount of stress on a 
SDWLHQW¶V FDUGLRSXOPRQDU\ UHVHUYH )RUVKDZ HW DO  ZKLFK LQFUHDVHV WKH
requirement for oxygen (Lees et al., 2009). To match this elevated demand, increases in 
cardiac output and/or oxygen extraction need to occur (Forshaw et al., 2004), failure to 
do so results in oxygen debt and therefore tissue hypoxia. Ultimately, an inability to meet 
the demands of major surgery can lead to systemic inflammation, organ dysfunction and 
ultimately death (Lees et al., 2009). Therefore, using a dynamic test that can objectively 
DVVHVV D SDWLHQW¶V DELOLW\ WR GHDO ZLWK LQFUHDVHG R[\JHQ GHPDQGV is seen as a valid 
approach to risk stratify patients preoperatively. Specific CPET derived variables have 
been demonstrated to be strong predictors of postoperative outcome, in particular 9%cO2peak, 
AT and 9%cE/9%cCO2 at AT have been associated with postoperative outcome (Junejo et al., 
2012; West et al., 2014; West et al., 2016). As previously mentioned, there are some 
disadvantages associated with traditional methods to CPET, which the SPV attempts to 
overcome. 
 
The SPV has now been shown to be a valid test of exercise capacity in both healthy 
(Astorino et al., 2015; Faulkner et al., 2015; Mauger and Sculthorpe 2012; Mauger et al., 
2013) and clinical populations (Chapter 6). The benefit of such a test in a clinical setting 
is that regardless of fitness levels, all patients are exercised for 10 min, this may reduce 
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the risk of acquiring unusable data from tests that do not last long enough. The test also 
takes away the need of practitioners having to decide on the most suitable work rate 
increments to ensure an optimal test which lasts for the recommended time period. The 
QDWXUHRI639PD\DOVREHHQGHHPHGDVDPRUHµpatient-IULHQGO\¶WHVWGXHWRWKHVHOI-
administered work rates and ability to adjust this throughout. Therefore, the aim of the 
current study is to determine if the SPV can assess a SDWLHQW¶VSUHRSHUDWLYHULVNVLPLODUWR
sCPET and if key exercise variables obtained from the test can accurately predict post-





Sixty-four patients with cardiovascular related co-morbidities, who were considered for 
any elective surgery at East Kent Hospitals University NHS Foundation Trust, 
volunteered to participate in the study. Patients were excluded if they were unable to 
successfully complete both CPET, and excluded from the outcome analysis if they did 
not end up having surgery. All patients gave their written informed consent after reading 
the participant information sheet.  
 
7.3.2. Experimental Design 
All patients recruited for the study were required to complete two exercise tests, a sCPET 
and the SPV in a randomised, counter-balanced crossover design. Tests were separated 
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by 2-7 days to allow the patient full recovery, and were completed at the same time of 
day (± 2 h). Prior to each test patients were asked to refrain from drinking alcohol (24 h 
abstinence), eating (2 h abstinence), smoking (2 h abstinence), and instructed not to 
perform any exhaustive exercise in the 24 h prior to each test.  
 
7.3.3. SPV 
The SPV was completed on an air-braked cycle ergometer (Wattbike Trainer, UK), which 
allowed patients to continually vary their PO throughout the test. The SPV was conducted 
in accordance with the procedures outlined in Chapter 3. Patients were able to view their 
cadence and PO throughout the test, they also received feedback on elapsed time 
particularly when approaching the end of each stage. Verbal encouragement was given, 
particularly in the latter stages of the test. 
 
7.3.4. sCPET 
The sCPET was completed on an electro-magnetically braked cycle ergometer (Lode 
Corival), so that PO for each stage could be fixed according to the test requirements. The 
test followed a standard incremental ramp design, where PO gradually increased at a 
continuous rate whilst cadence was kept constant (60-80 rpm). The test commenced with 
a 2 min rest period, followed by a 3 min unloaded pedalling phase, which then continues 
straight into the ramp protocol. The protocol consisted of increments of either 5, 10, 15 
or 20 W.min-1 which was selected on an individual basis in the attempt to optimise the 
protocol for each patient. Patients were asked to continue pedalling until they reached 
volitional exhaustion, or, the test was terminated by the tester when the patient could no 
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longer keep their cadence at or above 60 rpm for more than 5 s. During the test, patients 
were asked to rate their RPE every 2 min.  Verbal encouragement was given in the latter 
stages of the test.  
 
7.3.5. Preoperative measurements 
Patient characteristics recorded on the first test included age, gender, stature, weight, 
surgery type, surgical severity, and the Portsmouth physiological and operative severity 
score (POSSUM; Copeland et al., 1991). Surgical severity was categorised into either 
minor, moderate, major or major complex which were selected following the guidelines 
for the POSSUM scoring system. A resting lung function test was also performed to 
determine forced expiratory volume in one second (FEV1) and forced vital capacity 
(FVC) (MircoLab Mk8 Spirometer, CareFusion). Resting lung function was conducted 
in accordance to the recommendations (Miller, Hankinson, Brusasco, Burgos, Casaburi 
et al., 2005), they were completed in a seated position and repeated at least 3 times. During 
both CPETs, expired gases were measured. HR, 12-lead ECG (Custo Cardio 130, 
Germany), blood pressure, pulse oximetry were also continuously recordHGGXULQJHDFK
WHVW9HQWLODWRU\DQGJDVH[FKDQJHYDULDEOHVGHULYHGIURPH[SLUHGJDVHVLQFOXGHG9%c22, 
9%c&22, 9%cE, 9%cE9%c22, 9%cE9%c&22, 9%c22/HR, and RER $IWHU WKH WHVW 9%c22peak, AT, Peak 
cycling PO and 9%cE were all determined as per the methods stated in chapter 3. Once each 
test had finished patients postoperative 30 day mortality risk was calculated via the 
Carlisle mortality calculator (Carlisle, Danjoux, Kerr, Snowden & Swart 2015) which can 
be accessed through the following link: https://sites.google.com/site/informrisk/home 
(Carlisle 2016). This calculator uses age, stature, weight, body mass index (BMI), 
preoperative haemoglobin and creatinine concentrations, previous medical history 
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(including; MI, heart failure, stroke and peripheral arterial disease), CPET variables 
(including; 9%cO2peak, VO2 at AT, 9%cE9%c&22 at AT and peak PO), and the risk for the type 
of surgery. Inputting the above variables produces an individualised 30 day mortality risk. 
The AT was successfully determined in both sCPET and SPV protocols in all but one 
patient. It is likely that this SDWLHQW¶V tolerance to exercise in both sCPET and SPV was 
below their AT.  
 
7.3.6. Postoperative measurements 
Patients were monitored for the thirty days after surgery for incidence of morbidity, length 
of ICU stay, total hospital stay and mortality. Morbidity was determined at days 3 and 5 
using the 9 domains defined by the Post-Operative Morbidity Survey (POMS) (Bennett-
Guerrero, Welsby, Dunn, Young, Wahl et al., 1999), these days were selected based on 
previous research (Grocott, Browne, Van der Meulen, Matejowsky, Mutch et al., 2007). 
All postoperative information was obtained via patient records, nurses/doctors notes, drug 
charts, fluid charts and discharge summaries. 
 
7.3.7. Statistical Analysis 
Continuous variables are either reported as mean and SD for normally distributed data, 
or median and interquartile range (IQR) for not normally distributed data, distribution 
was determined via the Shapiro-Wilk test. Categorical variables are presented at 
frequency (%). Differences in the CPET variables between the two protocols were 
analysed using a paired samples T-test, or a Wilcoxon signed rank test for not normally 
distributed data. Receiver operator characteristic (ROC) curves wHUHSORWWHGIRU9%c22peak, 
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AT, 9%cE/9%cCO2 at AT, oxygen pulse at AT, and PO to assess their independent ability to 
discriminate between patients with and without morbidity at the specific postoperative 
days. Optimal cut-off points were taken as the uppermost left point on the ROC curve, 
this method was chosen to replicate those previous studies that looked at the predictability 
of CPET on postoperative outcome (West et al., 2014; West et al., 2016). A variable was 
considered able to discriminate between patients if the area under the curve (AUC) was 
> 0.7. Simple univariate logistic regression was used to initially assess the relationship 
between CPET variables and morbidity, variables with p > 0.250 (West, Asher, 
Browning, Minto, Swart et al., 2016) were excluded from a multiple logistic regression 
model. Linearity of the logit of each variable were initially checked to ensure the 
assumptions of logistic regression were not violated, this was assessed by checking that 
the interaction between each CPET predictor variable and its log transformation was not 
significant (> 0.05). Multicollinearity was also checked, to ensure the predictor variables 
were not too highly correlated, by obtaining the tolerance and VIF statistic from a linear 




Fourteen patients were unable to successfully complete both exercise tests, reasons for 
this included; unable to pedal due to orthopaedic discomfort, muscular weakness and 
general discomfort on the cycle ergometer, two patients become ill between tests, there 
were equipment issues meaning the second test for one patient could not be completed in 
the recommended time frame, and one patient had a vasovagal episode at submaximal 
exercise, and was subsequently referred to a cardiologist for further investigations. Out 
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of the fifty patients who successfully completed both tests, thirty of them had surgery. 
Table 7.1 presents the patient characteristics, which is then grouped into those with and 
without postoperative complications at day 3 (with = 11; without 19) and day 5 (with = 
7; without 23).  
 
Fifteen patients (50%) experienced in-hospital morbidity at day 3 and/or 5. Eight patient 
were readmitted to Hospital on a median of 11 days, reasons included; gastrointestinal, 
infectious, cardiovascular and wound complications. Two out of the eight patients who 
were readmitted required further surgery. One patient required laparoscopic adhesiolysis 
and decompression of the small bowel, and one other patient required surgical 
debridement and evacuation of haematoma. Both of these patients had no further 
complications after this. One patient died on day 17, this occurred one day after their 
hospital discharge so there is no information about the cause of death in their health 
records. However, whilst in hospital this patient did experience various complication 
(pulmonary, gastrointestinal, cardiovascular, haematological and infectious), and was 
readmitted after their initial discharge due to wound dehiscence which required further 
surgery. This particular patient had a 9%c22peak of 11.91 ml·kg-1·min-1 and and AT of 9.09 
ml·kg-1·min-1 in the sCPET, and 9%c22peak  of 13.23 ml·kg-1·min-1 and AT of 9.63 ml·kg-
1
·min-1 from the SPV. These values are lower than the average values obtained by the 
patients in this study, but interestingly their surgical risk was only calculated as 0.6% and 






Table 7.1.  Patient demographics and postoperative morbidity at day 3 and day 5. Note: 
the patients split into day 3 and 5 are not the same, some patients only had morbidity in 
one of those days, with only 3 patients having morbidity on both.  
 Overall  
(n = 50) 
Patients who had surgery 
(n = 30) 
  Day 3 Morbidity Day 5 Morbidity 
Yes 
(n = 11) 
No 
(n = 19) 
Yes 
(n = 7) 
No 
(n = 23) 
Age 73 ± 8 73 ± 7 73 ± 9 76 ± 9 72 ± 8 
Sex      
Male 32 (64%)   5 (45%) 13 (68%) 4 (57%) 14 (61%) 
Female 18 (36%) 6 (55%) 6 (32%) 3 (43%) 9 (39%) 
Body mass index (kg/m2) 29 ± 5 30 ± 5 28 ± 4 27 ± 3 29 ± 5 
Haemoglobin 13 ± 1.8 12 ± 2 13 ± 2 12 ± 1 13 ± 2. 
Creatinine 87 (72-106) 87 (76-127) 83 (70-93) 83 (68-87) 87 (71-107) 
FEV1 2.19 ± 0.66 2.01 ± 0.64 2.34 ± 0.65 1.97 ± 0.66 2.29 ± 0.65 
FVC 3.12 ± 0.80 3.00 ± 0.81 3.23 ± 0.87 2.75 ± 1.00 3.26 ± 0.77 
Co-morbidity     
Ischaemic heart disease 29 (58%) 7 (64%) 12 (63%) 2 (29%) 17 (74%) 
Heart failure 11 (22%) 5 (45%) 1 (5%) 0 (0%) 6 (26%) 
Cerebrovascular disease 4 (8%) 0 (0%) 1 (5%) 0 (0%) 1 (4%) 
Diabetes 15 (30%) 4 (36%) 7 (37%) 2 (29%) 9 (39%) 
Hypertension 24 (48%) 6 (54%) 10 (53%) 7 (100%) 9 (39%) 
COPD 5 (10%) 2 (18%) 4 (21%) 1 (14%) 5 (22%) 
Surgical risk      
0Minor 2 (4%) 0 (0%) 2 (11%) 0 (0%) 2 (9%) 
Moderate 11 (22%) 1 (9%) 3 (16%) 2 (29%) 2 (9%) 
Major 28 (56%) 8 (73%) 12 (63%) 4 (57%) 16 (70%) 
Major complex 9 (18%) 2 (18%) 2 (11%) 1 (14%) 3 (13%) 
P-POSSUM      
Mortality (%) 2 (1-6) 3 (1-8) 2 (1-3) 2 (1-6) 2 (1-6) 
Morbidity (%) 40 (24-61) 54 (33-88) 34 (14-48)*^ 39 (15-72) 39 (21-61) 
*Significantly different from patients with morbidity on the same day. ^Significantly 




7.4.1. Differences between the sCPET and SPV 
Differences in the CPET variables between the SPV and sCPET are displayed in table 
3DWLHQWVDFKLHYHGDVLJQLILFDQWO\KLJKHU9%cO2peak (L·min-1 and ml·kg-1·min-1), AT, HR, 
9%cE, 9%cE9%c&22 DW$7SHDN32DQG77(LQWKH639FRPSDUHGWRWKHV&3(73
DQG ZKHQ FRQVLGHULQJ RQO\ WKRVH SDWLHQWV ZKR KDG VXUJHU\ WKHUH ZHUH GLIIHUHQFHV LQ
9%c22peak, HR, 9%cE, peak PO and TTE (P < 0.05). Further analysis was completed where 
males and females were separated )RU WKH WKLUW\WZR PDOH SDWLHQWV WKHUH ZDV D
VLJQLILFDQWO\KLJKHU9%c22peak in the SPV (16.63  ml·kg-1·min-1) compared to the 
sCPET (14.97 ml·kg-1·min-1) (P < 0.01). Although for the eighteen female patients, 
there were no significant differences LQ9%c22peak between the SPV (13.22 ml·kg-
1
·min-1) and the sCPET (12.78 ml·kg-1·min-1) (P = 0.34).  
 
Table 7.2. Represents the CPET derived variables over both the sCPET and SPV. 
 Total (n = 50) Patients who had surgery (n = 30) 
 sCPET SPV P-Value sCPET SPV P-Value 
9ࡆ 22peak (L·min-1) 1.17 ± 0.35 1.28 ± 0.38* < 0.01 1.18 ± 0.34 1.27 ± 0.39* < 0.01 
9ࡆ 22peak (ml·kg-1·min-1) 14.18 ± 3.84 15.40 ± 3.86* < 0.01 14.52 ± 3.71 15.49 ± 3.62* 0.018 
AT (ml·kg-1·min-1) 10.06 ± 1.98 10.49 ± 2.00* 0.017 10.23 ± 2.14 10.60 ± 1.90 0.118 
HR (bpm) 123 ± 20 127 ± 20* < 0.01 124 ± 18 128 ± 17* 0.051 
9ࡆ E (L·min-1) 49.9 ± 15.4 56.9 ± 19.1* < 0.01 49.8 ± 14.9 56.4 ± 19.5* < 0.01 
RER 1.17 ± 0.12 1.18 ± 0.13 0.416 1.16 ± 0.09 1.17 ± 0.13 0.663 
9ࡆ E/VO2 29.1 ± 4.4 29.5 ± 4.8 0.429 29.5 ± 4.2 29.5 ± 4.1 0.974 
9ࡆ E/9ࡆ &22 31.6 ± 4.0 32.6 ± 5.2* 0.049 32.0 ± 4.1 33.0 ± 4.5 0.103 
O2 pulse at AT (ml beat-1) 8.8 ± 2.0 9.0 ± 2.1 0.095 8.8 ± 1.8 8.9 ± 1.9 0.793 
Peak PO (W) 81 ± 33 99 ± 45* < 0.01 83 ± 33 98 ± 42* < 0.01 
TTE (secs) 478 ± 131 600 ± 0* < 0.01 501 ± 129 600 ± 0* < 0.01 
Carlisle Mortality (%) 2.5 ± 2.4 2.6 ± 2.9 0.333 2.1 ± 2.3 2.2 ± 2.1 1.000 
Carlisle Mortality adjusted 
for BMI (%) 1.9 ± 2.2 1.9 ± 2.2 0.793 1.4 ± 2.0 1.6 ± 2.0 0.414 




7.4.2. Postoperative Morbidity  
ROC curve analysis indicated no CPET variables from either test demonstrated the ability 
to independently discriminate between patients with and without morbidity at either 
postoperative day 3, or day 5 (AUC < 0.7). Simple univariate logistic regression analysis 
indicated that for the sCPET, peak PO and oxygen pulse at AT on postoperative day 3 
were suitable for a multivariate regression model (P < 0.250) DQG IRU GD\  9%cO2peak 
(L·min-1) and peak PO (P < 0.250). For SPV, the variables of 9%cO2peak (ml·kg-1·min-1) and 
oxygen pulse were deemed suitable for a multivariate regression model at day 3, with AT 
and peak PO for day 5 (P < 0.250). A multivariate logistic regression model of those 
variables which were deemed suitable was not statistically significant for the sCPET at 
day 3 (Ȥ 2(2) = 1.961, p = 0.375) and day 5 Ȥ 2(2) = 3.570, p = 0.168), or SPV at day 3 (Ȥ 
2(2) = 2.396, p = 0.302) and day 5 Ȥ 2(1) = 1.796, p = 0.183).  
 
When combining postoperative morbidity at day 3 and 5, the proportion of patients with 
morbidity increased to 50%. Simple logistic regression analysis of this combined data 
indicated that for the sCPET, 9%cO2peak (L·min-1), peak PO, and 9%cE9%c&22 DW $7 ZHUH
VXLWDEOHIRUDPXOWLYDULDWHUHJUHVVLRQPRGHO3DQG9%cO2peak (L·min-1), peak PO 
and oxygen pulse at AT were suitable from the SPV (P < 0.250). For the sCPET variables, 
the multivariate regression model was not statistically significant (Ȥ 2(3) = 4.740, p = 
0.192). For the SPV variables, there was a trend in the model predicting postoperative 
morbity (Ȥ 2(3) = 7.094, p = 0.069), with oxygen pulse at AT being a statistically 
significant contributor to the model (odds ratio (OR) = 0.328, 95%CI 0.119 to 0.904; p = 
0.031). This analysis therefore suggests that for every unit decrease in oxygen pulse at 
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AT, the odds of having postoperative morbidity increased by 3.049. Within this combined 
data, oxygen pulse at AT from the SPV test, was the only variable to be associated with 
morbidity according to ROC curve analysis. The oxygen pulse at AT provided an AUC 
of 0.72 a.u. (95%CI 0.51 to 0.92), with an optimal cut-off point of 8.5 ml·beat-1 which 
provided 72.7% sensitivity and 71.4% specificity (figure 7.1). Oxygen pulse at AT was 
also dichotomized with the cut-off point of 8.5 ml beat-1, this slightly improved the model 
fit of the logistic regression model (Ȥ 2(3) = 7.488, p = 0.058), and also its independent 
contribution to the model (OR = 0.030, 95%CI 0.001 to 0.705; p = 0.029). 
 
Figure 7.1. Receiver operating characteristic (ROC) curve for oxygen pulse at AT. Black 
circle indicates the optimal cut-off point obtained by minimizing the distance to the upper 
left corner. Area under the curve: 0.72 a.u..  
 
There were no significant differences in CPET derived variables between those patients 
with postoperative morbidity and those without (P > 0.05). Although there was a trend in 





Table 7.3. CPET derived variables between patients with and without morbidity and both 
day 3 and 5. Differences between the two tests (sCPET vs. SPV), and presence of 
complication were assessed (no complications vs. complications). 
 
No complications (n = 15) Complications (n = 15) 
 
sCPET SPV sCPET SPV 
9ࡆ 22peak (L·min-1) 1.28 ± 0.36 1.37 ± 0.38 1.09 ± 0.30 1.17 ± 0.32* 
9ࡆ 22peak (ml·kg-1·min-1) 15.21 ± 3.81 16.15 ± 3.59 13.83 ± 3.59 14.84 ± 3.66 
AT (ml·kg-1·min-1) 10.38 ± 2.08 10.87 ± 2.01 10.08 ± 2.27 10.33 ± 1.81 
HR (bpm) 123 ± 17 126 ± 15 125 ± 20 130 ± 19 
9ࡆ E (L·min-1) 52.9 ± 15.2 58.2 ± 20.6 46.6 ± 14.3 54.7 ± 18.9* 
RER 
1.16 ± 0.08 1.15 ± 0.10 1.15 ± 0.11 1.19 ± 0.15 
9ࡆ E/VO2 28.6 ± 3.8 29.1 ± 4.7 30.4 ± 4.7 29.8 ± 3.5 
9ࡆ E/9ࡆ &22 31.1 ± 3.3 32.2 ± 4.6 33.0 ± 3.3 33.8 ± 3.1 
O2 pulse at AT (ml beat-1) 9.2 ± 2.1 9.6 ± 2.1 8.5 ± 1.3 8.1 ± 1.2 
Peak PO (W) 95 ± 35 107 ± 44 72 ± 27 89 ± 40* 
TTE (secs) 484 ± 99 600 ± 0* 518 ± 179 600 ± 0 
Carlisle Mortality (%) 2.3 ± 2.6 2.2 ± 2.4 2.2 ± 1.6 2.1 ± 1.4 
Carlisle Mortality 
adjusted for BMI (%) 




7.4.3. Length of hospital stay 
None of the CPET derived variables were correlated with ICU stay, although there were 
only two patient who required ICU postoperatively. Some CPET variable were associated 
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with HDU stay; sCPET oxygen pulse at AT was negatively correlated (r S 
DQG6399%c22peak (L·min-1) (r = -0.379, p = 0.045) and oxygen pulse at AT (r = -
0.489, p = 0.013) was negatively correlated. Total length of hospital stay was QHJDWLYHO\
FRUUHODWHGZLWK9%c22peak (L·min-1 and ml·kg-1·min-1) (r = -0.534, p = 0.002; r = -0.475, p 
= 0.008), AT (r = -0.363, p = 0.049) and peak PO (r S IURPWKHV&3(7
9%c22peak (L·min-1) (r = -0.366, p = 0.047) and PO (r = -0.436, p = 0.016) from the SPV 




The main findings of this study suggests WKDW WKH 639 SURGXFHV VLJQLILFDQWO\ KLJKHU
9%c22peak9%cE, HR and peak PO values when compared against the sCPET (P < 0.05), these 
findings support previous work using self-paced protocols (Astorino et al., 2015; Mauger 
and Sculthorpe 2012; Mauger et al., 2013). None of the CPET derived variables from 
either test were associated with days 3 or 5 postoperative morbidity, although when 
combining both days oxygen pulse at AT obtained from the SPV was associated with 
postoperative morbidity (P < 0.05), suggesting an optimal cut-off point of 8.5 ml beat-1. 
This suggests that a greater sample size was indeed needed to provide a statistical 
significance, and perhaps a larger sample size may be found some more statistical 
significances. A sample size of one hundred patients was originally planned, which was 
based upon the work of Nagamatsu, Shima, Yamana, Fujita, Shirouzu et al., 2001, 





CPET derived variables from both sCPET and SPV protocols failed to demonstrate an 
ability to predict postoperative outcome at either day 3 or 5. These findings are in contrast 
to previous research, that have suggested 9%c2SHDN DQG $7 DUH SUHGLFWRUV RI SRVW
RSHUDWLYHRXWFRPH-XQHMRHWDO:HVWHWDO:HVWHWDO$UHFHQW
PXOWLFHQWUH VWXG\ KDV IRXQG 9%c22peak and AT predict the risk of postoperative 
complications in patients having major elective colorectal surgery (West et al., 2016). 
Other research has identified the predictive ability of CPET in a variety of other major 
surgery types such as lung resection (Walsh, Morice, Putnam, Nesbitt, McMurtrey et al., 
1994) and bariatric surgery (McCullough, Gallagher, deJong, Sandberg, Trivax et al., 
2006). In particular, patients with D9%c22peak of > 20 ml·kg-1·min-1 have no increased risk 
RISRVWRSHUDWLYHFRPSOLFDWLRQVZKHUHDVD9%c22peak of < 15 ml·kg-1·min-1 is perceived as 
an increased risk, with D 9%c22peak of < 10 ml·kg-1·min-1 being a very high risk for 
postoperative complications (Beckles et al., 2003). It has also been suggested that patients 
with an AT of < 11 ml·kg-1·min-1 are at increased risk of postoperative complications and 
should be admitted to ICU after surgery (Older et al., 1993; Older et al., 1999). It is likely 
that the current study failed to demonstrate the same predictive ability of CPET as a result 
of the low sample size. A sample size calculation based on the odds ratios achieved from 
the univariate logistic UHJUHVVLRQ IRU 9%c22peak (ml·kg-1·min-1) and the probability of 
morbidity occurring at day 3 (37%), suggested 94 patients would be needed for the 
sCPET, and 40 for the SPV to achieve a statistical significance of < 0.05 and a power of 
0.95. This lower sample needed for the SPV would suggest that there is less variability
ZKHQ ORRNLQJ DW WKH SUHGLFWDELOLW\ RI 9%c22peak on postoperative morbidity FRPSDUHG WR
9%c22peak from the sCPET. Indeed, not all studies have found CPET to be related to 
outcome (Forshaw, Strauss, Davies, Wilson, Lams et al., 2008; Nugent, Riley, Megarry, 
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2¶5HLOO\0DF0DKRQHWDO, although it was concluded by Nugent et al. (1998) that 
a major limitation of their study was the small sample size (n = 30), which is comparable 
to that of the current study. In addition, it may be that CPET is not as useful predictor of 
outcome in all surgery types. Previous research has shown no predictive ability of CPET 
derived variables on postoperative outcome in surgeries such as oesophagectomy 
(Forshaw et al., 2008). It is possible that the suitability of CPET as a predictor for outcome 
may have influenced the current study findings, particularly as a wide range of surgeries 
were included, withRIWKHVHEHLQJHLWKHUPLQRURUPRGHUDWHULVNSURFHGXUHVZKLFK
ZHUHFODVVLILHGXVLQJ WKH326680VFRULQJ V\VWHP &RSHODQGHW DO +RZHYHU
)RUVKDZHWDOGLGILQGDVLJQLILFDQWGLIIHUHQFHLQ9%c22peak between patients with 
postoperative complications and those without (P < 0.05), again suggesting the lack of 
sample size might have reduced the predictive power of the CPET.  
 
To increase the total sample size, morbidity cases were combined from days 3 and 5. The 
resultant statistical analysis demonstrated oxygen pulse at AT obtained from the SPV was 
associated with postoperative morbidity, suggesting an optimal cut-off point of 8.5 ml 
beat-1. Previous research has also demonstrated that oxygen pulse at AT is able to 
discriminate patients with and without postoperative complications with an optimal cut-
off point of 8.7 (West et al., 2016). However, oxygen pulse at AT has not always been 
shown to predict postoperative complications (West, Lythgoe, Barben, Noble, Kemp et 
al., 2014), with some studies not even including it as a predictor (Junejo et al., 2012; 
Prentis, Trenell, Vasdev, French, Dines et al., 2013). It is interesting to see that only 
oxygen pulse at AT from the SPV was the only CPET variable related to postoperative 
morbidity in the current study. Though not significant, oxygen pulse was lower in the 
SPV compared to the sCPET in those patients with days 3 and 5 morbidity, and because 
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there were no differences in 9%c22 at AT between the tests, this suggests that HR at the 
point of AT may have been enhanced to account for the lower oxygen pulse achieved in 
the SPV. Therefore it may well be that the self-paced nature provides an altered oxygen 
pulse response, although this is highly speculative with further research needed to 
investigate this further.  
 
Unsurprisingly, total length of hospital stay was significantly different between those with 
postoperative morbidity (7 ± 5 days) compared to those without (3 ± 3 days) (P
0RUHLQWHUHVWLQJO\OHQJWKRIKRVSLWDOVWD\ZDVFRUUHODWHGZLWK9%c22peak$7DQGSHDN32
IURPWKHV&3(7DQG9%c22peak and peak PO from the SPV (P < 0.05). However, these 
results should be interpreted with caution as there are many contributing factors which 
LQIOXHQFH D SDWLHQW¶V OHQJWK RI KRVSLWDO VWD\ WKDW PD\ QRW QHFHVVDULO\ EH UHODWHG WR
SRVWRSHUDWLYHPRUELGLW\3UHQWLVHWDO)RUH[DPSOHDSDWLHQW¶VKRVSLWDOVWD\PD\
be prolonged due issues such as lack of transport, insufficient care at their home or even 
what day of the week the surgery took place.  
 
7KHVLJQLILFDQWO\KLJKHU9%c22peak from the SPV seen in the current study, support those 
studies which also compared the SPV with sCPET protocols (Astorino et al., 2015; 
Mauger and Sculthorpe 2012; Mauger et al., 2013). Astorino and colleagues (2015) 
suggested that this enhanced 9%c22peak seen in the SPV is a result of an increase in oxygen 
delivery (Q), which is likely to be in response to the greater work rates achieved. These 
greater work rates achieved in the final stage are suggested to be a result of participants 
adequately pacing their effort to minimise fatigue, particularly in the earlier stages of the 
test, and possibly preserving the use of type II fibres until the final stage (Astorino et al., 
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2015). It is difficult to determine if this is the reasRQIRUWKHLQFUHDVH9%c22peak in the current 
study due to the lack of other physiological measures taken, although a greater peak PO, 
HR and 9%cE was achieved in the SPV compared to the sCPET, which suggest a higher 
physiological work load was achieved. AnotKHUSRWHQWLDO UHDVRQ IRU WKLVGLIIHUHQFH LQ
9%c22peak could be related to test time. Current guidelines suggestWKDWIRURSWLPDO9%c22peak 
values to be achieved, an individual must reach volitional exhaustion between 8-12 min 
(Buchfuhrer et al., 1983), although it is acknowledged that this is not widely supported 
and may differ between populations. Nevertheless, if you look WKHFXUUHQWVWXG\¶VPHDQ
test time for each patient, only 54% of patients completed the test within this 
µUHFRPPHQGHG¶WLPHIUDPH Whereas aOOSDWLHQW¶VFRPSOHWHGPLQRIH[HUFLVHIRUWKH
639WKXVWKLVLQFUHDVHGWHVWWLPHPD\KDYHFRQWULEXWHGWRWKHHQKDQFHG9%c22peak achieved 
from the SPV in the current study. Interestingly when subgrouping patients based on their 
sCPET test time, DVLJQLILFDQWO\KLJKHU9%c22peak was achieved in the SPV for those who 
completed the sCPET in < 8 min and between 8-12 min (P < 0.05), with the greatest 
difference in the < 8 min category (2.10 ml·kg-1·min-1). There were only two patients who 
completed the sCPET in > 12 min but interestingly these two patients demonstrated a 
2.53 ml·kg-1·min-1 higher 9%c22peak in the sCPET compared to the SPV. As previously 
reported by Agostoni et al. (2005), these findings might suggest that longer tests durations 
of the sCPET are beneficial to obtaining higher 9%c22peak values in an older clinical 
population.  
 
An interesting finding of the current study was that there wasVLJQLILFDQWGLIIHUHQFHLQ
9%c22peak between the two test protocols in males (P < 0.01), but no differences in females 
(P = 0.34). This might suggest that the SPV is more beneficial for male populations, with 
potential explanations being both physiological and/or psychological. For example, there 
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are known physiological differences between the sexes in maximal Q and SV, being lower 
in females (Ogawa, Spina, Martin, Kohrt, Schechtman, Holloszy & Ehsani 1992). 
Research has also suggested that there is a greater age-related decrease in peak torque at 
fast velocities in females compared to males, which is predominantly a result of the loss 
in type II fibres (Lindle, Metter, Lynch, Fleg et al., 1997). From a psychological 
perspective, previous research has suggested that sedentary middle-aged (45-64 years) 
males generally have a higher self-efficacy compared to females of a similar age 
(McAuley, Courneya & Lettunich 1991), where age has been shown to be negatively 
related to self-efficacy (Wilcox & Storandt 1996). This could be a likely contributing 
factor to results of the current study, particularly as the mean age of the female cohort 
was 73 ± 9 years. However, it should be acknowledged that there was a lower sample size 
for women (n = 18) compared to the male patients (n = 32) in the current study.  
 
(YHQWKRXJKVWDWLVWLFDOO\GLIIHUHQWWKHPHDQGLIIHUHQFHLQ9%c22peak from sCPET and SPV 
was only ~1 ml·kg-1·min-1. It is debatable whether this statistical difference is actually 
clinically meaningful and would alter clinical decision making. Furthermore, when using 
the Carlisle mortality calculator (Carlisle et al., 2015), there were no differences in 
estimated postoperative 30-day mortality risk between the SPV and sCPET (P!
7KXV WKH GLIIHUHQFH LQ 9%c22peak observed between the two CPET protocols did not 
influence risk stratification and thus suggests that the SPV can assess patient 
postoperative mortality risk, comparable to that of the sCPET. The Carlisle mortality 
calculator has been previously shown as a valid tool for survival estimates which is 
comparable to Kaplan-Meier estimates (Carlisle et al., 2015). However, the validity 
analysis was only completed on patients who were considered for AAA repair, so it is 





The current study used the POMS to assess postoperative morbidity (Grocott et al., 2007). 
The POMS surveys nine domains of postoperative morbidity (pulmonary, infectious, 
renal, gastrointestinal, cardiovascular, neurological, haematological, wound, and pain), 
with specific defined criteria for each domain (Grocott et al., 2007). A number of 
preoperative CPET studies have used POMS to define postoperative morbidity (Junejo et 
al., 2012; West et al., 2014; West et al., 2016), and it is said to be the only published 
prospective method for describing short-term morbidity (Grocott et al., 2007). However, 
a limitation of the POMS is that it does not necessarily capture the severity of 
postoperative complications. The Dindo-Clavien classification system is a 5 grade system 
which defines severity of complications (Dindo, Demartines & Clavien 2004). Previous 
research have used the Dindo-Clavien classification when looking at the predictability of 
CPET derived variables on postoperative complications (Prentis et al., 2013; West et al., 
2014; West et al., 2016). It may have been beneficial to use this severity classification in 
the current study to determine if CPET variables from the SPV could predict the severity 
of complications, although the aim of this initial study was to simply determine the 
presence of morbidity. 
 
Another limitation of the current study is that the POMS scores were not completed by 
the medical staff whilst patients were in-hospital, rather, scores where collected 
retrospectively once the patient had been discharged with the information being obtained 
via patient medical records. Unfortunately, the hospital used for the research study does 
not use the POMS as a post-operative complication scoring system and so it is not possible 
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to collate data whilst the patient was in hospital. As a consequence there is a heavy 
UHOLDQFHRQSDWLHQW¶VLQ-hospital notes being fully completed by the appropriate medical 
VWDII,IFRPSOLFDWLRQVZHUHQRWPHQWLRQHGLQWKHSDWLHQW¶VQRWHVLWKDGWRbe assumed that 
there were no POMS present. Nevertheless, a robust assessment was completed for each 
patient, where their daily notes, fluid balance charts, pathology results, and medicinal 
prescription charts were reviewed on each pre-selected postoperative day. An additional 
POMS limitation was that scores were only recorded on postoperative days 3 and 5. This 
may have resulted in some complications being missed in the intervening days, although 
previous studies have used similar methods (Bennett-Guerrero et al., 1999; Grocott et al., 
2007; West et al., 2016).  
 
A further limitation was that the CPET results were not blinded from the multidisciplinary 
team. Therefore perioperative management might have been influenced by the CPET 
results and ultimately influenced postoperative outcome. This decision was taken due to 
CPET providing information about a paWLHQW¶V ULVN WKDW IHG LQWR WKH Kospital risk 
assessment process. Finally, there was a median of 45 (range = 17-67) days between 
patients first CPET and their surgery. This is comparable to a median of 56 days reported 
by Hartley, Pichel, Grant, Hickey, Lancaster et al. (2012). However, having the shortest 
possible time between CPET and surgery will likely enhance its predictive ability as the 
results will be more indicative of the patient fitness level at the time of surgery. In this 
regard, some previous research that demonstrated predictability of CPET derived 
variables on postoperative outcome documented CPET being completed approximately 2 
weeks before surgery (Colson, Baglin, Bolsin & Grocott 2012; Junejo et al., 2012; 
Nagamatsu et al., 2001, Older et al., 1999; Tolchard et al., 2014). Although, it is also 
important to note that some studies investigating the predictive power of CPET do not 
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mention the length of time between exercise test and surgery (Forshaw et al., 2008; 




The current study demonstrates that none of the CPET derived variables from either test 
were associated with postoperative morbidity in patients with cardiovascular related co-
morbidities. However when combining patients with complications at day 3 and 5, to 
increase the sample size, oxygen pulse at AT obtained from the SPV was associated with 
postoperative morbidity. The lack of significance seen in the other CPET derived 
variables is a likely result of the small sample size and varied surgery types included, 
nevertheless, previous research has demonstrated the ability of sCPET derived variables 
to predict postoperative outcome.  In addition, UHVXOWVIURPWKLVVWXG\GHPRQVWUDWHWKDW
WKH 639 SURGXFHV VLJQLILFDQWO\ KLJKHU 9%c22peak, HR, 9%cE and peak PO (P < 0.05) in 
preoperative patients with cardiovascular related co-morbidities. Although it is 
acknowledged that these differences are likely to lack clinical significance and would not 
be enough to influence risk stratification or clinical decision making according to the 
Carlisle mortality calculator (Carlisle et al., 2015). It was hypothesised that the SPV 
would provide and accurate repUHVHQWDWLRQRIDSDWLHQW¶VFDUGLRYDVFXODUILWQHVVDQGEHD
reliable predictor or post-operative outcome (H61). However, due to the of sample size 
and statistical significance seen in the predictability of the CPET derived variables lack 
on post-operative outcome, at this stage the null hypothesis (H60) must be accepted. 
Nonetheless the SPV still assessed preoperative fitness comparable to the sCPET, and 
when combining postoperative morbidity from days 3 and 5 it was only an SPV variable 
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that was related to outcome. Therefore, the SPV could be considered as an alternative 
means of testing to the sCPET, particularly as the test takes away the need of practitioners 
having to choose the right work rate increments, increasing the chances of obtaining 
useable CPET data. It is clear that clinical CPET provides crucial information for both 
patients and clinicians, therefore any test which may improve the validity and reliability 
of this process should be of interest. Further research should assess the SPVs ability to 
predict postoperative outcome in a larger and more homogeneous sample to determine 
















What is already known about this topic 
 
x CPET is more commonly being used in the preoperative 
assessment of patients going into high risk elective surgery.  
x The SPV has now been shown as a valid test for determining key 
CPET derived variables in a clinical population. 
 
What this study adds 
 
x This study shows that the SPV is able to assess preoperative fitness 
and risk comparable to a sCPET. Although, likely due to the small 
sample size, none of the CPET derived variables from either test 
were associated with postoperative morbidity.  
x Even though none of the variables were associated with 
postoperative outcome, the SPV assessed preoperative fitness 
comparable to sCPET and with the increasing amount of research 
showing the benefits of CPET in preoperative assessment, the SPV 
could be considered as an alternative way of testing. 
 
Impact on clinical practice  
 
x The fixed 10 minutes of the SPV may help improve the general day 
to day running of busy CPET clinics. The SPV also takes away the 
need of clinicians having to choose the most appropriate work rate 
increments to ensure a valid test. The test may also provide 
potential cost savings as the fixed 10 minutes will reduce to risk of 
obtaining unusable data from tests that do not last long enough. 
Increasing the likelihood of acquiring valid CPET data will mean 
that more patients will benefit and have their perioperative care 
best tailored to them, which should ultimately improve their 



























8.1. General discussion 
 
This thesis aimed to assess the ability of a self-paced CPET protocol to determine patient 
fitness prior to major elective surgery and predict postoperative outcomes. A number of 
limitations have been highlighted in regard to the general nature of sCPET protocols 
including: the variable and uncertain test duration, no clear end point to work towards 
and, individuals having no control over their work rate (Noakes 2008). As CPET is an 
important component of a patient perioperative care (West et al., 2011), alternative test 
protocols should be considered if they improve clinical decision-making, the patient 
experience, and/or general working practice for clinicians. The SPV protocol may provide 
a viable alternative to sCPET protocols in clinical practice because it ensures all patients 
exercise for the recommended 10 minutes which will reduce the risk of obtaining invalid 
CPET data, it takes away the need of clinicians having to choose the most appropriate 
work rate increments to ensure a valid test, and it also allows patients to have full control 
over the test and chosen work rates.  
 
The first experimental study of this thesis (Chapter 4) demonstrated the SPV to be a 
reliable indicator of CPET derived variables in young, healthy participants. Prior to this, 
there was limited information about the reliability of the SPV. TKHUHVXOWVIURP&KDSWHU
HVWDEOLVKHGWKH&9IRU9%c22peak (4.7%) to be similar to that found by Straub et al. (2014), 
and also previous findings using sCPET protocols (Froelicher et al., 1974; Janicki et al., 
1990). This is important as good test-retest is essential when conducting CPET in clinical 
environments as often there is only enough time in some clinical pathways for one test to 
be completed (e.g. cancer pathways). The ability of a CPET to provide an indication of 
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patient fitness without the need for familiarisation of the protocol is therefore essential. 
+RZHYHU LW LV DOVR LPSRUWDQW WKDW WKH WHVW SURYLGHV D WUXH UHIOHFWLRQ RI D SDWLHQW¶V
cardiorespiratory fitness. As a consequence Chapter 5 compared the physiological 
responses from the SPV to a sCPET protocol in both young and old healthy populations.  
All previous studies investigating the SPV have been conducted on younger individuals, 
whereas clinical populations tend to be of middle to old age. Results from Chapter 5 
demonstrated that young partLFLSDQWVDFKLHYHGDVLJQLILFDQWO\KLJKHU9%c22peak in the SPV 
vs. the sCPETZKLFKLVFRPSDUDEOHWRSUHYLRXVVWXGLHV$VWRULQRHWDO0DXJHU	
6FXOWKRUSH0DXJHUHWDO,QDGGLWLRQWRWKHKLJKHU9%c22peak, the SPV also 
produced a significDQWO\KLJKHUSHDN4%c699%cE, RER and PO, with a trend for higher 
end-exercise lactate values (P = 0.06). These findings suggest that a higher physiological 




In the older adult group there were QR VLJQLILFDQW GLIIHUHQFHV LQ 9%c22peak RU SHDN 4%c
EHWZHHQWHVWSURWRFROV7KLVDJDLQPD\VXSSRUWVWKHQRWLRQWKDW4%cLVDNH\FRQWULEXWRUWR
9%c22peak. However, interestingly similar to the young group, the older adult SPV data 
showed significantly higher peak RER and PO values, with a statistical trend for a higher 
end-exercise lactate (P = 0.05) compared to the sCPET. These findings suggested that 
despite the older group reaching a higher work load and metaboliFUDWHLQWKH6394%cGLG
QRWDSSHDUWRUHVSRQGLQWKHVDPHZD\DVLQWKH\RXQJJURXS7KHUHDVRQVIRUWKLVDUH
XQFOHDUDOWKRXJKWKHODFNRIGLIIHUHQFHLQ4%cPD\EHDUHVXOWRIWKHQRUPDODJH-related 
changes that occur in cardiac function (Lakatta & Levy SUHYHQWLQJ4%cWRLQFUHDVH
beyond a particular point. Nevertheless, the findings from Chapter 5, combined with 
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previous research (Astorino et al., 2015; Chidnok et al., 2013; Faulkner et al., 2015; 
Mauger and Sculthorpe 2012; Mauger et al., 2013; Straub et al., 2014), provides further 
evidence that the SPV is able to produce similar or superior levels of CPET derived 
variables. The other important finding from the Chapter 5 study was that the SPV could 
be safely used in an older population, reflective of the general ages of those patients 
needing preoperative CPET. Rather than testing a clinical population first, it was deemed 
safer to use a healthy older adult population as some have suggested the SPV might 
provide heightened risks for older clinical populations (Eston, Crockett & Jones 2014). 
 
The principle aim of Chapter 6 was to assess the utility of the SPV in a clinical population. 
Specifically, the study aimed to determine the validity and reliability of the639SURWRFRO
IRU DVVHVVLQJ FDUGLRSXOPRQDU\ ILWQHVV LQ D VWDEOH FOLQLFDO SRSXODWLRQ HDUO\ SRVW0,
SDWLHQWV5HVXOWVGHPRQVWUDWHGWKH639WRUHOLDEO\SURGXFHKLJKHU9%c22peak values, along 
with significantly higher peak HR, 9%cE and PO values. This is surprLVLQJDVWKHROGHUDGXOW
JURXS LQ &KDSWHU  GHPRQVWUDWHG VLPLODU 9%c22peak YDOXHV EHWZHHQ 639 DQG V&3(7
SURWRFROVHYHQWKRXJKPHDQDJHVZHUHVLPLODUEHWZHHQSDUWLFLSDQWV&KDSWHU
\HDUV&KDSWHU\HDUV9%c22peak). A possible explanation might be provided by 
differences in peak PO between the sCPET and SPV between the two studies; there was 
a greater difference between SPV and sCPET protocols in the post-MI patients (~35 W) 
compared to the healthy older population (~19 W). This greater diffHUHQFHLQ32EHWZHHQ
SURWRFROVLQWKHSRVW0,SDWLHQWVLVDOLNHO\UHDVRQZK\WKH\DOVRGLVSOD\DVLJQLILFDQWO\
KLJKHU9%c22peak in study 3 (Chapter 6), and may also be why there is a lack of difference 




The primary aim of Chapter 7 was to assess the ability of the SPV protocol to predict 
postoperative outcomes in the preoperative assessment of patients having elective 
surgery, compared to a sCPET protocol. In contrast to previous research (Junejo et al., 
2012; West et al., 2014; West et al., 2016), none of the CPET derived variables from 
either protocol were associated with postoperative morbidity. It is likely this is a result of 
the low sample size and wide range of surgery types used in the study. Due to the small 
sample size for morbidity cases, statistical power was increased by combining 3 and 5 
day POMS census points. Resultant logistic regression analysis demonstrated that oxygen 
pulse at AT obtained from the SPV was the only variable to be associated with 
postoperative morbidity. In addition, ROC curve analysis suggested an optimal cut-off 
point of 8.5 ml beat-1, which is comparable to previous research (West et al., 2016). The 
reasons for this finding, and why oxygen pulse at AT was only significant from the SPV 
protocol is unclear. Additional research would be needed to investigate this further.  
 
As with earlier chapters in this thesis, results from Chapter 7 demonstrated the SPV 
produced a significantly higher 9%c22peak9%cE, HR and peak PO values when compared to 
the sCPET. However, it is acknowledged that the average difference of ~1 ml·kg-1·min-1 
from chapter 7 and ~2 ml·kg-1·min-1 from Chapter 6 is not likely to be a clinically 
meaningful difference. To support this, the study outlined in ChDSWHU  IRXQG QR
GLIIHUHQFHVLQWKH&DUOLVOHGD\PRUWDOLW\VFRUH&DUOLVOHHWDOZKLFKVXJJHVWV
WKDWWKHREVHUYHGGLIIHUHQFHLQ9%c22peak would not influence risk stratification and thus 





Previous research has suggested that the SPV may reduce the physiological demand of an 
incremental exercise test in comparison to a sCPET (Lander et al., 2009); a possible 
reason for the higher 9%c22peak being achieved by participants. However, data from the 
current thesis suggests the contrary; data from the three experimental chapters that 
compared physiological parameters between SPV and sCPET protocols (Chapter 5, 6 & 
7), all suggest that there is an enhanced physiological workload achieved in the SPV. 
Specifically, a higher HR, VE, and RER was found in all three comparative studies 
(Chapter 5, 6 &7), and higher Q, SV and blood lactate seen in study 2 (Chapter 5). 
Therefore, it seems that the SPV simply provides individuals with the opportunity to work 
at high work rates which in turn drive 9%c22 to a greater level. Even though the SPV is 
completely self-paced, participants were generally willing to work at higher intensities 
than seen in the sCPET. This could be a result of the defined test duration and the 
participants knowing the test was going to end within a defined time period may have 
motivated them to work harder in the final stage. It is also possible that the continuous 
fluctuation in PO and adequate pacing in the earlier stages of the test may have 
contributed in minimising early fatigue, leading to a greater work rate being achieved in 
the final stage of the SPV.  
 
Throughout this thesis there has been a reoccurring discussion concerning optimal CPET 
test duration. Current guidelines suggest that a CPET should last between 8-12 minutes 
(American Thoracic Society/American College of Chest Physicians 2003), which was 
based on the work by Buchfuhrer et al. (1983). For this test duration to be achieved, the 
test administrator must select the most appropriate starting intensity and work rate 
increments to ensure exhaustion within the 8-12 min period to prevent obtaining invalid 
CPET data. However, that results of this thesis (Chapter 5, 6 & 7) suggest that guideline 
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PLQ!PLQ!PLQ7KHUHZDVQRGLIIHUHQFHLQ9%c22peak for those who completed the 
sCPET within the 8-12 min time period, supporting findings of SUHYLRXV ZRUN
%XFKIXKUHU HW DO  +RZHYHU LW LV LPSRUWDQW WR QRWH WKDW RQO\  SDUWLFLSDQWV
FRPSOHWHG WKH WHVW LQ   PLQ ,QWHUHVWLQJO\ LQ ERWK FOLQLFDO VWXGLHV &KDSWHU 	 
9%c22peak was higher in the SPV compared to the sCPET for patients who FRPSOHWHGWKH
V&3(7LQPLQDQGPLQ7KHUHZHUHRQO\IRXUSDWLHQWVIURPVWXG\DQGWZR
SDWLHQWVIURPVWXG\ZKRFRPSOHWHGWKHV&3(7LQ!PLQEXW9%c22peak was higher in 
the sCPET in all individuals. These findings support previous research (Agostoni et al., 
2005), in suggestting longer CPET durations might be beneficial for clinical populations. 
However, further research is required to establish optimal CPET durations for a variety 
of different populations (Midgley et al., 2008). Selecting the most appropriate work rate 
increments for each individual is essential to ensure that valid CPET data is obtained. If 
selected work rates are too hard for the patient they are likely to stop early giving invalid 
and limited CPET information. Conversely, LIWKHLQFUHPHQWVDUHWRRORZWKHSDWLHQWPD\
QRWGULYH9%c22 VXIILFLHQWO\WRREWDLQDWUXH9%c22peak prior to the development of significant 
peripheral fatigue. The SPV provides all patients the opportunity to exercise for 10 min, 
therefore increasing the likelihood of obtaining more valid and useable CPET data.  
 
There are potential benefits associated with using the SPV in a clinical environment. For 
example, there could be potential health service cost savings, the standardised 10 min test 
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may reduce the risk of having unusable data from tests that do not last long enough. If 
unusable data is obtained then the test may need to be repeated, or have patient 
preoperative risk being calculated using traditional, less direct methods which may under- 
or over-predict risk. In turn this may increase costs associated with postoperative care 
needed for that patient. The fixed test duration is also likely to improve the efficiency of 
busy CPET clinics and ensure allocated appointment timeslots are adhered to. From a 
FOLQLFLDQ¶V SHUVSHFWLYH WKH 639 UHPRYHV WKH QHHG WR HVWLPDWH WKH PRVW DSSURSULDWH
starting intensity and increment rates, which will ensure a maximal stress is applied to the 
cardiorespiratory system within the 10 min test duration.  From a patient perspective, the 
SPV provides an individual with control over the exercise intensity, so that they can freely 
regulate their work rate throughout the test. The patient also has knowledge of test 
duration which may help motivate them to complete the full 10 min duration of the test. 
Finally, by providing useable and valid CPET data the SPV will ensure that the most 
appropriate perioperative care is provided for the patient, which will ultimately assist in 
improving their postoperative outcome.  
 
8.2. General Limitations  
 
$VVWDWHGHDUOLHUZLWKLQWKLVWKHVLVWKH&3(7GXUDWLRQLVDQLPSRUWDQWIDFWRUWKDWQHHGWR
EH FRQVLGHUHG LQ RUGHU WR REWDLQ YDOLG 9%c22 peak data. Guidelines suggest that a CPET 
should last between 8-12 min (American Thoracic Society/American College of Chest 
Physicians 2003; Buchfuhrer et al., 1983). However, this duration was not achieved by 
all participants; in fact there was only 50% of patients in studies 2 and 4, and 54% in 
study 3, who achieved this recommended time frame. Clearly, having only approximately 
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half of the participants in each study (Chapter 5, 6 & 7) complete the sCPET within the 
µUHFRPPHQGHG¶RSWLPDOZLQGRZRI-12 minutes is a major limitation. Thus, conclusions 
made in this thesis need to be taken with caution as it could be suggested that optimal 
CPET data was not obtained in those who did not reach volitional exhaustion between 8-
12 minutes.  
 
The sCPET protocols used in this thesis were devised in an attempt to minimise the risk 
of participants exercising for durations outsiGHRIWKHµUHFRPPHQGHG¶WLPHZLQGRZ)RU
example, in study 3 (Chapter 6) work rate was standardized using a 20 W.min-1 ramp for 
all patients, based upon previous research completed on clinical populations (Brutsche et 
al., 2000; Eindhoven et al., 2016; Gitt et al., 2002; Kahaly et al., 1999), although 
individualising work rate increments may have resulted in more patients completing the 
sCPET in the optimal time. Individualised work rate increments (from a preselected 
range) were used in studies 2 and 4 (Chapter 5 & 7) based on the individuals physical 
activity level (i.e. ability to walk up a flight of stairs). This was decided as the most 
suitable approach for both of these studies (Chapter 5 & 7) due to a diverse range of 
participant characteristics and physical activity levels. However, the individualisation of 
work rate increments still did not increase the number of participants completing the 
V&3(7LQWKHµUHFRPPHQGHG¶WLPH6RPHSUHYLRXVUHVHDUFKKDVXVHGHTXDWLRQVEDVHGRQ
height, weight and age estimate the most appropriate work rate increments (Agnew 2010; 
Smith et al., 2009), although these do not take into account important variables such as 
disease state or training status, and so were not deemed to be suitable methods for the 
study populations. These issues highlight one of the disadvantages associated with sCPET 




Due to the nature of the fixed exercise intensity in the sCPET and variable intensity in the 
SPV, the same cycle ergometer could not be used across both protocols. Therefore, the 
experimental studies documented in Chapters 5, 6 & 7 had to use of different ergometers 
to complete the sCPET and SPV protocols. Previous research has suggested that using 
different ergometers may cause differences in the metabolic cost and cardiovascular strain 
of exercise (Reiser, Meyer, Kindermann & Daugs 2000). However, it is questionable as 
to whether the differences in resistance offered by electromagnetic (Lode) vs. air 
resistance (Wattbike) would be able explain the physiological effects seen between 
protocols in the experimental chapters of this thesis. Factors such as seat angle (Umberger 
et al., 1998) and body position (Too 1991) have also been shown to influence maximal 
exercise performance. Therefore, the use of different ergometers may have contributed to 
some of the differences seen in the CPET derived variables between the sCPET and SPV, 
which must be taken into considering when interpreting the findings from this thesis. 
However, ergometer set-up was replicated as closely as possible between ergometers used 
with each experimental study to attempt to reduce the impact of seat angle and body 
position.  
 
8.3. Future directions 
 
It is clear that the findings from this thesis contribute to the current body of literature 
surrounding the SPV protocol, although these findings have highlighted specific areas 
that warrant further research. Firstly, it is evident from Chapter 5 that there are potential 
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mechanistic differences associated with the SPV protocol, compared to sCPET. Although 
as a result of some methodological limitations, further investigation would be needed to 
provide a clearer understanding of the physiological responses to the SPV. Indeed those 
findings of Chapter 5 combined with those found by Astorino et al. (2015) certainly 
suggest an enhancement in Q, but due to the lack of accuracy and reliability associated 
with non-invasive techniques to measure Q (Welsman et al., 2005), further research 
should seek to use more accurate invasive techniques during the SPV. This would 
hopefully provide a clearer insight into the underlining response to the SPV, and whether 
the test is truly appropriate in testing maximal levels in all clinical populations. 
 
Secondly, the patients used in Chapter 6 were early post-MI, therefore it is unclear 
whether the SPV can be used to the same effect in other specific clinical populations (e.g. 
respiratory disorders). Indeed, the physiological responses to CPET has been suggested 
to be altered depending on the disease state (Palange et al., 2007). Therefore, future 
research should assess the ability of the SPV to accurately determine CPET derived 
variables in various other clinical populations.  
 
Finally, as a result of the lack of significance seen in Chapter 7, future research should 
assess the SPVs ability to predict postoperative outcome in a much larger sample size and 
with making the sample more homogeneous i.e. using a specific population and including 
only one particular surgery type that has previously been shown to benefit from the use 
of preoperative CPET. This would likely improve the statistical power and determine 
whether or not the CPET derived variables obtained from the SPV can accurately predict 





The overall aim of this thesis was to assess the ability of a self-paced CPET protocol to 
determine patient fitness prior to elective surgery and its ability to predict postoperative 
outcomes. Each experimental chapter aimed to support this overall aim. The main 
findings from this thesis are that the SPV is a valid and reliable test for assessing exercise 
capacity in cardiovascular patients. These preliminary findings indicate that the SPV 
could be considered as an alternative means of assessing patient cardiorespiratory fitness, 
particularly as it reduces the chance of obtaining unusable CPET data from tests that do 
not last long enough. In addition, the SPV removes the need for clinicians to have to select 
the most appropriate work rate increments, it allows patients to have full control over the 
test, and the fixed test duration may help to improve the efficiency of running busy CPET 
clinics. There are clear benefits for using the SPV in a clinical environment, although it 
is evident that further research is necessary to assess its ability to predict postoperative 
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Appendix A ± Ethical Approval for Clinical Studies (Chapter 6 & 7) 
  
        Please reply Research & Development Directorate  
  Post Graduate Centre  
Buckland Hospital  
  Coombe Valley Road  
Dover  Kent.      
CT17 OHD  
  Telephone:  01304 222561  
  Fax:  01304 222690  




Dr Jane Fisher  
Consultant Cardiologist  
William Harvey Hospital  




TN24 0LZ  
  
  
Dear Dr Jane Fisher  
  
The use of a self-paced VO2max protocol for assessing maximal oxygen uptake 
in pre-and postoperative patient care  
  
R&D Ref  2010/CARDIO/01  
REC Ref  12/LO/1737  
   
Documents received  
  
REC Favourable Opinion Letter  12/12/2012  
Protocol ± v. 1.0  10/09/2012  
Participant Information Letter ± Phase I ± v. 1.0 ( revised wording)  09/10/2012  
Participant Information Letter ± Phase II ± v. 1.0 ( revised wording)  09/10/2012  
Participant Consent Form ± v. 1.0  10/09/2012  
GP/Consultant Information Sheets ± v. 1.0  10/09/2012  
Questionnaire ± pre-screening Health Questionnaire ± v. 1.0  10/09/2012  
  
  
Thank you for submitting the above referenced protocol to the R&D Department.  I am 
pleased to confirm that your study has now been granted NHS Permission by the 
Trust provided that you comply with the conditions of Trust R&D NHS Permission 




You are advised to study this letter and the attached Conditions of Trust NHS 
Permission carefully.  
NB - Commencement of the above trial is confirmation of your compliance to 
these Trust NHS Permission Conditions   
All research undertaken within the NHS requires both management NHS Permission 
from R&D offices, NHS Research Ethics Committee favourable opinion and any other 
applicable regulatory approvals. Research may not commence at any NHS site until 
these have been obtained.  
You must ensure that you are fully aware of your responsibilities and that your 
activities are conducted in line with the Local Research Governance Framework for 
Health and Social Care 2nd Edition, Research Ethics Committee conditions, The 
Medicines for Human Use (Clinical Trial) Regulations 2004 and Amendment 
Regulations 2006.   
Pharmaceutical clinical trials involving an investigational medicinal product shall be 
conducted in accordance with the conditions and principles of International 
Conference on Harmonisation of Technical Requirements for Registration of 
Pharmaceuticals for Human Use (ICH GCP)  
  
Investigators of other research should be conducting their activities to similar 
standards and good clinical practice systems.      
Safety Reporting    
Researchers should follow the safety reporting requirements of the protocol and study 
sponsor, Trust R&D SOP9, - Serious Adverse Event Reporting, and the Trust Policy 
for the Management of incidents  http://www.ekhuft.nhs.uk/staff/systems/datix-
incident-reporting/.  All staff are responsible for reporting adverse incidents, whether 
or not related to research in accordance with the above.   
  
Amendments  
The study sponsor is responsible for ensuring that amendments are submitted, as 
applicable, to the REC and the MHRA, and for ensuring that amendments are notified 
to PIs and the R&D Department.  The sponsor is responsible for providing any 
updated documentation and regulatory approvals to the PI/research team.  
  
Principal Investigators must ensure that amendments are not implemented until all 
applicable regulatory approvals and R&D acceptances are in place (unless an urgent 
safety measure).    
  
Further guidance and examples of substantial and non-substantial amendments can 
be found on the NRES website www.nres.nhs.uk  
  
Service Support Departments ±  Medical Records, Radiology, Pathology, 
Pharmacy  
Principal Investigators participating in a CTIMP are responsible for identifying trial 
patients in the study on all referral requests to service support departments such as 
Pathology, Radiology, Pharmacy and medical records are marked for retention. This 
will enable the necessary archiving in compliance with the Medicines for Human Use 
(Clinical Trials) Regulations [SI 2004 1031] & Amendment Regulations 2006 [SI 2006 
1928].  
  
Principal Investigators are required to regularly provide relevant support departments 




Service Support Departments (SSDs), (if supporting the study) should be notified 
immediately of any amendments to the study and provided with a current version of 
the protocol.    
  
Monitoring  
The sponsor is responsible for ensuring studies are appropriately monitored, 
particularly CTIMPs   
  
The R&D Department may conduct on-site monitoring visits on a risk-based basis.    
  
All Principal Investigators will have access to the R&D Database ± Reda - to upload 
study documents and study information.  As a condition of Trust NHS Permission 
Investigators are required to use the Reda database to provide regular updates to 
R&D on their studies,  
  
Accrual  
It is a condition of NHS Permission that PIs regularly provide accrual figures by 
uploading this information to Reda database.  Failure to provide such 
information may result in the withdrawal of Trust NHS Permission.  
  
End of Study Reports  
Researchers must submit End of Study reports to R&D when all study activity, 
including recruitment, follow-up etc, has ended.  
  
Training  
For all interventional studies, including CTIMPs, medical devices etc, you agree to 
attend Good Clinical Practice training and updates.  The PI is responsible for ensuring 
that the research team are competent and appropriately qualified to carry out their 
research roles, and have received appropriate GCP training.  The PI is also 
responsible for ensuring the research team have trial specific training, particularly in 
completing CRFs and reporting of SAEs.    
  
Delegation logs  
Principal Investigators are responsible for ensuring that an up to date delegation log 
for the study is maintained detailing the roles and responsibilities delegated to 
research team members.  
  
Breach of NHS Permission conditions  
Failure to comply with these conditions or failure to provide the information when 
requested will result in the study being suspended and may lead to Trust approval 
being withdrawn.   
  





Dr Art Ationu (BSc, MSc, PhD, PG Dip, CBiol, MIBiol, CSci, FIBMS)  














School of Sport & Exercise Sciences 
Research Ethics and Advisory Group (REAG) 




Ethics Reference: Prop 
79_2012_13 
 
Date: 4th September 2013 
______________________________________________________________________ 
 
Dear Ms Lauren Jenkins, 
Re: Reliability of a novel self-paced VO2max test. 
I am now delighted to confirm that SSES REAG has approved your research study 
(REF No. Prop 79_2012_13) and you are now permitted to recruit participants and 
commence testing. 
 
If there is the need to amend any aspect of your research, please ensure you 
inform SSES REAG by completing a request for amendment form and submitting 
all revised paperwork (participant information sheet, questionnaires, etc.). 
 
If there should happen to be any adverse event during your study, please also 
ensure SSES REAG is kept informed. 
 
I hope you have a successful study. 
 
With kindest regards, 
Steve Meadows 








Appendix D ± RPE scale instructions  
Rate of Perceived Exertion (RPE) 
The Rate of Perceived Exertion (RPE) scale is a subjective rating of exercise 
intensity, based on how hard you feel like your body, as a whole, is working. It is 
based on physical sensations that you may experience during the exercise, 
including an increase in your heart rate, breathing rate, sweating, and feelings of 
muscle fatigue/tiredness. Try not to concern yourself with just one of these 
sensations, try to focus on your total feeling of exertion.  Try to evaluate your 
feelings of exertion as honestly as possible, as it is your own personal feeling of 
effort, not compared to other peoples.  
 
6  No exertion at all ± sitting down  
7  Very, very light (Rest) 
8   
9  Very light - gentle walking, very low effort 
10           50%  
11  Fairly light - does not require much effort 
12           60%  
13  Somewhat hard - steady pace which requires slightly more            
effort  
14           70%  
15  Hard (heavy) - hard and tiring but can continue 
16           80% 
17  Very hard - very strenuous, can continue but you really                   
have to push yourself and you are very tired.  
18           90% 
19  Very, very hard ±extremely strenuous, for some people                         
it feels like the most exertion they have ever experienced.  
20  Maximal exertion                 100%
                     
